'barite'
(id=167894 ; fe=barite ; type=1 ; niveau=200 ; luminosité=50 ; somme entrante=6831 creation date=2009-06-09 touchdate=2025-09-26 10:21:41.000)

≈ 1255 relations sortantes barite -- r_associated #0: 416 / 1 -> zoologie n1=barite | n2=zoologie | rel=r_associated | relid=0 | w=416 barite -- r_associated #0: 288 / 0.692 -> minéralogie n1=barite | n2=minéralogie | rel=r_associated | relid=0 | w=288 barite -- r_associated #0: 288 / 0.692 -> oiseaux n1=barite | n2=oiseaux | rel=r_associated | relid=0 | w=288 barite -- r_associated #0: 256 / 0.615 -> chimie n1=barite | n2=chimie | rel=r_associated | relid=0 | w=256 barite -- r_associated #0: 243 / 0.584 -> ornithologie n1=barite | n2=ornithologie | rel=r_associated | relid=0 | w=243 barite -- r_associated #0: 117 / 0.281 -> substance n1=barite | n2=substance | rel=r_associated | relid=0 | w=117 barite -- r_associated #0: 92 / 0.221 -> baryté n1=barite | n2=baryté | rel=r_associated | relid=0 | w=92 barite -- r_associated #0: 91 / 0.219 -> Chimie n1=barite | n2=Chimie | rel=r_associated | relid=0 | w=91 barite -- r_associated #0: 88 / 0.212 -> produit de contraste n1=barite | n2=produit de contraste | rel=r_associated | relid=0 | w=88 barite -- r_associated #0: 86 / 0.207 -> Minéralogie n1=barite | n2=Minéralogie | rel=r_associated | relid=0 | w=86 barite -- r_associated #0: 82 / 0.197 -> oiseau n1=barite | n2=oiseau | rel=r_associated | relid=0 | w=82 barite -- r_associated #0: 81 / 0.195 -> barytine n1=barite | n2=barytine | rel=r_associated | relid=0 | w=81 barite -- r_associated #0: 79 / 0.19 -> caustique n1=barite | n2=caustique | rel=r_associated | relid=0 | w=79 barite -- r_associated #0: 79 / 0.19 -> sulfate de baryte n1=barite | n2=sulfate de baryte | rel=r_associated | relid=0 | w=79 barite -- r_associated #0: 78 / 0.188 -> bleu charron n1=barite | n2=bleu charron | rel=r_associated | relid=0 | w=78 barite -- r_associated #0: 74 / 0.178 -> barite chauve n1=barite | n2=barite chauve | rel=r_associated | relid=0 | w=74 barite -- r_associated #0: 60 / 0.144 -> barytique n1=barite | n2=barytique | rel=r_associated | relid=0 | w=60 barite -- r_associated #0: 59 / 0.142 -> barote n1=barite | n2=barote | rel=r_associated | relid=0 | w=59 barite -- r_associated #0: 58 / 0.139 -> baryum n1=barite | n2=baryum | rel=r_associated | relid=0 | w=58 barite -- r_associated #0: 57 / 0.137 -> bluteau n1=barite | n2=bluteau | rel=r_associated | relid=0 | w=57 barite -- r_associated #0: 57 / 0.137 -> chimie minérale n1=barite | n2=chimie minérale | rel=r_associated | relid=0 | w=57 barite -- r_associated #0: 54 / 0.13 -> chimie inorganique n1=barite | n2=chimie inorganique | rel=r_associated | relid=0 | w=54 barite -- r_associated #0: 53 / 0.127 -> baryter n1=barite | n2=baryter | rel=r_associated | relid=0 | w=53 barite -- r_associated #0: 53 / 0.127 -> blutoir n1=barite | n2=blutoir | rel=r_associated | relid=0 | w=53 barite -- r_associated #0: 52 / 0.125 -> en:barium sulphate n1=barite | n2=en:barium sulphate | rel=r_associated | relid=0 | w=52 barite -- r_associated #0: 51 / 0.123 -> en:barium meal n1=barite | n2=en:barium meal | rel=r_associated | relid=0 | w=51 barite -- r_associated #0: 51 / 0.123 -> en:barium sulfate n1=barite | n2=en:barium sulfate | rel=r_associated | relid=0 | w=51 barite -- r_associated #0: 51 / 0.123 -> oxyde de baryum n1=barite | n2=oxyde de baryum | rel=r_associated | relid=0 | w=51 barite -- r_associated #0: 49 / 0.118 -> en:barite n1=barite | n2=en:barite | rel=r_associated | relid=0 | w=49 barite -- r_associated #0: 47 / 0.113 -> minéral n1=barite | n2=minéral | rel=r_associated | relid=0 | w=47 barite -- r_associated #0: 46 / 0.111 -> dispositif mécanique n1=barite | n2=dispositif mécanique | rel=r_associated | relid=0 | w=46 barite -- r_associated #0: 45 / 0.108 -> en:baryta n1=barite | n2=en:baryta | rel=r_associated | relid=0 | w=45 barite -- r_associated #0: 43 / 0.103 -> médecine n1=barite | n2=médecine | rel=r_associated | relid=0 | w=43 barite -- r_associated #0: 36 / 0.087 -> baryte n1=barite | n2=baryte | rel=r_associated | relid=0 | w=36 barite -- r_associated #0: 35 / 0.084 -> en:5-fitc-labeled gi-heptapeptide n1=barite | n2=en:5-fitc-labeled gi-heptapeptide | rel=r_associated | relid=0 | w=35 barite -- r_associated #0: 35 / 0.084 -> en:ad-reic/dkk3 vaccine n1=barite | n2=en:ad-reic/dkk3 vaccine | rel=r_associated | relid=0 | w=35 barite -- r_associated #0: 35 / 0.084 -> en:allogeneic irradiated melanoma cell vaccine csf470 n1=barite | n2=en:allogeneic irradiated melanoma cell vaccine csf470 | rel=r_associated | relid=0 | w=35 barite -- r_associated #0: 35 / 0.084 -> en:alvelestat n1=barite | n2=en:alvelestat | rel=r_associated | relid=0 | w=35 barite -- r_associated #0: 35 / 0.084 -> en:anti-cea/anti-dtpa-in (f6-734) bispecific antibody n1=barite | n2=en:anti-cea/anti-dtpa-in (f6-734) bispecific antibody | rel=r_associated | relid=0 | w=35 barite -- r_associated #0: 35 / 0.084 -> en:anti-idiotypic monoclonal antibody bec2 n1=barite | n2=en:anti-idiotypic monoclonal antibody bec2 | rel=r_associated | relid=0 | w=35 barite -- r_associated #0: 35 / 0.084 -> en:antibody-drug conjugate pf-06647020 n1=barite | n2=en:antibody-drug conjugate pf-06647020 | rel=r_associated | relid=0 | w=35 barite -- r_associated #0: 35 / 0.084 -> en:antiperspirant cream f511 n1=barite | n2=en:antiperspirant cream f511 | rel=r_associated | relid=0 | w=35 barite -- r_associated #0: 35 / 0.084 -> en:apixaban n1=barite | n2=en:apixaban | rel=r_associated | relid=0 | w=35 barite -- r_associated #0: 35 / 0.084 -> en:autologous cea-specific cytotoxic t-lymphocytes n1=barite | n2=en:autologous cea-specific cytotoxic t-lymphocytes | rel=r_associated | relid=0 | w=35 barite -- r_associated #0: 35 / 0.084 -> en:autologous renal cell carcinoma tumor lysate-pulsed dendritic cell vaccine n1=barite | n2=en:autologous renal cell carcinoma tumor lysate-pulsed dendritic cell vaccine | rel=r_associated | relid=0 | w=35 barite -- r_associated #0: 35 / 0.084 -> en:bacitracin n1=barite | n2=en:bacitracin | rel=r_associated | relid=0 | w=35 barite -- r_associated #0: 35 / 0.084 -> en:baking powder n1=barite | n2=en:baking powder | rel=r_associated | relid=0 | w=35 barite -- r_associated #0: 35 / 0.084 -> en:barium so4 pwdr 18oz,rtl n1=barite | n2=en:barium so4 pwdr 18oz,rtl | rel=r_associated | relid=0 | w=35 barite -- r_associated #0: 35 / 0.084 -> en:benzethonium chloride/benzocaine n1=barite | n2=en:benzethonium chloride/benzocaine | rel=r_associated | relid=0 | w=35 barite -- r_associated #0: 35 / 0.084 -> en:benznidazole n1=barite | n2=en:benznidazole | rel=r_associated | relid=0 | w=35 barite -- r_associated #0: 35 / 0.084 -> en:benzocaine / methyl salicylate n1=barite | n2=en:benzocaine / methyl salicylate | rel=r_associated | relid=0 | w=35 barite -- r_associated #0: 35 / 0.084 -> en:benzocaine/camphor/ephedrine/zinc oxide n1=barite | n2=en:benzocaine/camphor/ephedrine/zinc oxide | rel=r_associated | relid=0 | w=35 barite -- r_associated #0: 35 / 0.084 -> en:bepridil n1=barite | n2=en:bepridil | rel=r_associated | relid=0 | w=35 barite -- r_associated #0: 35 / 0.084 -> en:beta sitosterol / zinc citrate n1=barite | n2=en:beta sitosterol / zinc citrate | rel=r_associated | relid=0 | w=35 barite -- r_associated #0: 35 / 0.084 -> en:bloodstop ex n1=barite | n2=en:bloodstop ex | rel=r_associated | relid=0 | w=35 barite -- r_associated #0: 35 / 0.084 -> en:boronophenylalanine-fructose complex n1=barite | n2=en:boronophenylalanine-fructose complex | rel=r_associated | relid=0 | w=35 barite -- r_associated #0: 35 / 0.084 -> en:buparlisib n1=barite | n2=en:buparlisib | rel=r_associated | relid=0 | w=35 barite -- r_associated #0: 35 / 0.084 -> en:cabergoline n1=barite | n2=en:cabergoline | rel=r_associated | relid=0 | w=35 barite -- r_associated #0: 35 / 0.084 -> en:carbon c 13 phytofluene n1=barite | n2=en:carbon c 13 phytofluene | rel=r_associated | relid=0 | w=35 barite -- r_associated #0: 35 / 0.084 -> en:carbon c 14 vemurafenib n1=barite | n2=en:carbon c 14 vemurafenib | rel=r_associated | relid=0 | w=35 barite -- r_associated #0: 35 / 0.084 -> en:carbon c-13 dextromethorphan n1=barite | n2=en:carbon c-13 dextromethorphan | rel=r_associated | relid=0 | w=35 barite -- r_associated #0: 35 / 0.084 -> en:ccr2 antagonist pf-04136309 n1=barite | n2=en:ccr2 antagonist pf-04136309 | rel=r_associated | relid=0 | w=35 barite -- r_associated #0: 35 / 0.084 -> en:cefotaxime n1=barite | n2=en:cefotaxime | rel=r_associated | relid=0 | w=35 barite -- r_associated #0: 35 / 0.084 -> en:chlorhexidine/ethyl alcohol mouthwash n1=barite | n2=en:chlorhexidine/ethyl alcohol mouthwash | rel=r_associated | relid=0 | w=35 barite -- r_associated #0: 35 / 0.084 -> en:cintredekin besudotox n1=barite | n2=en:cintredekin besudotox | rel=r_associated | relid=0 | w=35 barite -- r_associated #0: 35 / 0.084 -> en:citalopram hydrobromide n1=barite | n2=en:citalopram hydrobromide | rel=r_associated | relid=0 | w=35 barite -- r_associated #0: 35 / 0.084 -> en:clevudine n1=barite | n2=en:clevudine | rel=r_associated | relid=0 | w=35 barite -- r_associated #0: 35 / 0.084 -> en:cobalamin n1=barite | n2=en:cobalamin | rel=r_associated | relid=0 | w=35 barite -- r_associated #0: 35 / 0.084 -> en:combretastatin a1 diphosphate n1=barite | n2=en:combretastatin a1 diphosphate | rel=r_associated | relid=0 | w=35 barite -- r_associated #0: 35 / 0.084 -> en:copper cu 64-dota-anti-her3 monoclonal antibody u3-1287 n1=barite | n2=en:copper cu 64-dota-anti-her3 monoclonal antibody u3-1287 | rel=r_associated | relid=0 | w=35 barite -- r_associated #0: 35 / 0.084 -> en:cxcr4 inhibitor pol6326 n1=barite | n2=en:cxcr4 inhibitor pol6326 | rel=r_associated | relid=0 | w=35 barite -- r_associated #0: 35 / 0.084 -> en:cyp17/androgen receptor inhibitor odm 204 n1=barite | n2=en:cyp17/androgen receptor inhibitor odm 204 | rel=r_associated | relid=0 | w=35 barite -- r_associated #0: 35 / 0.084 -> en:cysteine-rich non-denatured whey protein isolate imn1207 n1=barite | n2=en:cysteine-rich non-denatured whey protein isolate imn1207 | rel=r_associated | relid=0 | w=35 barite -- r_associated #0: 35 / 0.084 -> en:dacarbazine n1=barite | n2=en:dacarbazine | rel=r_associated | relid=0 | w=35 barite -- r_associated #0: 35 / 0.084 -> en:danazol n1=barite | n2=en:danazol | rel=r_associated | relid=0 | w=35 barite -- r_associated #0: 35 / 0.084 -> en:di-leu16-il2 immunocytokine n1=barite | n2=en:di-leu16-il2 immunocytokine | rel=r_associated | relid=0 | w=35 barite -- r_associated #0: 35 / 0.084 -> en:dornase alfa n1=barite | n2=en:dornase alfa | rel=r_associated | relid=0 | w=35 barite -- r_associated #0: 35 / 0.084 -> en:nonenzyme proteolytic agent n1=barite | n2=en:nonenzyme proteolytic agent | rel=r_associated | relid=0 | w=35 barite -- r_associated #0: 34 / 0.082 -> en:11c topotecan n1=barite | n2=en:11c topotecan | rel=r_associated | relid=0 | w=34 barite -- r_associated #0: 34 / 0.082 -> en:akt inhibitor arq 092 n1=barite | n2=en:akt inhibitor arq 092 | rel=r_associated | relid=0 | w=34 barite -- r_associated #0: 34 / 0.082 -> en:alfentanil hydrochloride n1=barite | n2=en:alfentanil hydrochloride | rel=r_associated | relid=0 | w=34 barite -- r_associated #0: 34 / 0.082 -> en:alk-fak inhibitor cep-37440 n1=barite | n2=en:alk-fak inhibitor cep-37440 | rel=r_associated | relid=0 | w=34 barite -- r_associated #0: 34 / 0.082 -> en:allogeneic hla-a2/4-1bb ligand-expressing melanoma vaccine n1=barite | n2=en:allogeneic hla-a2/4-1bb ligand-expressing melanoma vaccine | rel=r_associated | relid=0 | w=34 barite -- r_associated #0: 34 / 0.082 -> en:almurtide n1=barite | n2=en:almurtide | rel=r_associated | relid=0 | w=34 barite -- r_associated #0: 34 / 0.082 -> en:altretamine n1=barite | n2=en:altretamine | rel=r_associated | relid=0 | w=34 barite -- r_associated #0: 34 / 0.082 -> en:anti-c4.4a antibody-drug conjugate bay1129980 n1=barite | n2=en:anti-c4.4a antibody-drug conjugate bay1129980 | rel=r_associated | relid=0 | w=34 barite -- r_associated #0: 34 / 0.082 -> en:anti-cd33 monoclonal antibody bi 836858 n1=barite | n2=en:anti-cd33 monoclonal antibody bi 836858 | rel=r_associated | relid=0 | w=34 barite -- r_associated #0: 34 / 0.082 -> en:anti-cd45 monoclonal antibody n1=barite | n2=en:anti-cd45 monoclonal antibody | rel=r_associated | relid=0 | w=34 barite -- r_associated #0: 34 / 0.082 -> en:anti-cd98 monoclonal antibody khk2898 n1=barite | n2=en:anti-cd98 monoclonal antibody khk2898 | rel=r_associated | relid=0 | w=34 barite -- r_associated #0: 34 / 0.082 -> en:anti-egfr monoclonal antibody syn004 n1=barite | n2=en:anti-egfr monoclonal antibody syn004 | rel=r_associated | relid=0 | w=34 barite -- r_associated #0: 34 / 0.082 -> en:anti-psma/cd3 bite monoclonal antibody mt112 n1=barite | n2=en:anti-psma/cd3 bite monoclonal antibody mt112 | rel=r_associated | relid=0 | w=34 barite -- r_associated #0: 34 / 0.082 -> en:anti-thymocyte globulin n1=barite | n2=en:anti-thymocyte globulin | rel=r_associated | relid=0 | w=34 barite -- r_associated #0: 34 / 0.082 -> en:anti-tlr2 monoclonal antibody opn-305 n1=barite | n2=en:anti-tlr2 monoclonal antibody opn-305 | rel=r_associated | relid=0 | w=34 barite -- r_associated #0: 34 / 0.082 -> en:antineoplaston a10 n1=barite | n2=en:antineoplaston a10 | rel=r_associated | relid=0 | w=34 barite -- r_associated #0: 34 / 0.082 -> en:antiviral agent csj148 n1=barite | n2=en:antiviral agent csj148 | rel=r_associated | relid=0 | w=34 barite -- r_associated #0: 34 / 0.082 -> en:autologous anti-cd19 car-expressing t lymphocytes n1=barite | n2=en:autologous anti-cd19 car-expressing t lymphocytes | rel=r_associated | relid=0 | w=34 barite -- r_associated #0: 34 / 0.082 -> en:autologous cultured acute myeloid leukemia-specific cytotoxic t lymphocytes n1=barite | n2=en:autologous cultured acute myeloid leukemia-specific cytotoxic t lymphocytes | rel=r_associated | relid=0 | w=34 barite -- r_associated #0: 34 / 0.082 -> en:autologous gm-csf-secreting lethally irradiated leukemia cell vaccine n1=barite | n2=en:autologous gm-csf-secreting lethally irradiated leukemia cell vaccine | rel=r_associated | relid=0 | w=34 barite -- r_associated #0: 34 / 0.082 -> en:autologous trimix-dc melanoma vaccine n1=barite | n2=en:autologous trimix-dc melanoma vaccine | rel=r_associated | relid=0 | w=34 barite -- r_associated #0: 34 / 0.082 -> en:azd5438 n1=barite | n2=en:azd5438 | rel=r_associated | relid=0 | w=34 barite -- r_associated #0: 34 / 0.082 -> en:baritop n1=barite | n2=en:baritop | rel=r_associated | relid=0 | w=34 barite -- r_associated #0: 34 / 0.082 -> en:belladonna/kaolin/pectin/sodium benzoate n1=barite | n2=en:belladonna/kaolin/pectin/sodium benzoate | rel=r_associated | relid=0 | w=34 barite -- r_associated #0: 34 / 0.082 -> en:benzoyl peroxide + sulfur n1=barite | n2=en:benzoyl peroxide + sulfur | rel=r_associated | relid=0 | w=34 barite -- r_associated #0: 34 / 0.082 -> en:benzydamine hydrochloride n1=barite | n2=en:benzydamine hydrochloride | rel=r_associated | relid=0 | w=34 barite -- r_associated #0: 34 / 0.082 -> en:bet inhibitor bms-986158 n1=barite | n2=en:bet inhibitor bms-986158 | rel=r_associated | relid=0 | w=34 barite -- r_associated #0: 34 / 0.082 -> en:beta-glucan n1=barite | n2=en:beta-glucan | rel=r_associated | relid=0 | w=34 barite -- r_associated #0: 34 / 0.082 -> en:betamethasone + clotrimazole n1=barite | n2=en:betamethasone + clotrimazole | rel=r_associated | relid=0 | w=34 barite -- r_associated #0: 34 / 0.082 -> en:bioflavonoid n1=barite | n2=en:bioflavonoid | rel=r_associated | relid=0 | w=34 barite -- r_associated #0: 34 / 0.082 -> en:biomed 101 n1=barite | n2=en:biomed 101 | rel=r_associated | relid=0 | w=34 barite -- r_associated #0: 34 / 0.082 -> en:bismuth subgallate/kaolin/opium/pectin/zinc phenosulfonate n1=barite | n2=en:bismuth subgallate/kaolin/opium/pectin/zinc phenosulfonate | rel=r_associated | relid=0 | w=34 barite -- r_associated #0: 34 / 0.082 -> en:bitter melon (pharmacologic substance) n1=barite | n2=en:bitter melon (pharmacologic substance) | rel=r_associated | relid=0 | w=34 barite -- r_associated #0: 34 / 0.082 -> en:blue citrus-based herbal capsule n1=barite | n2=en:blue citrus-based herbal capsule | rel=r_associated | relid=0 | w=34 barite -- r_associated #0: 34 / 0.082 -> en:bms-214662 n1=barite | n2=en:bms-214662 | rel=r_associated | relid=0 | w=34 barite -- r_associated #0: 34 / 0.082 -> en:bromodiphenhydramine+codeine n1=barite | n2=en:bromodiphenhydramine+codeine | rel=r_associated | relid=0 | w=34 barite -- r_associated #0: 34 / 0.082 -> en:btk inhibitor ono-4059 n1=barite | n2=en:btk inhibitor ono-4059 | rel=r_associated | relid=0 | w=34 barite -- r_associated #0: 34 / 0.082 -> en:budesonide + formoterol n1=barite | n2=en:budesonide + formoterol | rel=r_associated | relid=0 | w=34 barite -- r_associated #0: 34 / 0.082 -> en:buspirone hydrochloride n1=barite | n2=en:buspirone hydrochloride | rel=r_associated | relid=0 | w=34 barite -- r_associated #0: 34 / 0.082 -> en:carbamazepine n1=barite | n2=en:carbamazepine | rel=r_associated | relid=0 | w=34 barite -- r_associated #0: 34 / 0.082 -> en:carboplatin-taxol regimen n1=barite | n2=en:carboplatin-taxol regimen | rel=r_associated | relid=0 | w=34 barite -- r_associated #0: 34 / 0.082 -> en:cetirizine n1=barite | n2=en:cetirizine | rel=r_associated | relid=0 | w=34 barite -- r_associated #0: 34 / 0.082 -> en:citicoline n1=barite | n2=en:citicoline | rel=r_associated | relid=0 | w=34 barite -- r_associated #0: 34 / 0.082 -> en:colchicine n1=barite | n2=en:colchicine | rel=r_associated | relid=0 | w=34 barite -- r_associated #0: 34 / 0.082 -> en:daflon 500 n1=barite | n2=en:daflon 500 | rel=r_associated | relid=0 | w=34 barite -- r_associated #0: 34 / 0.082 -> en:dapsone n1=barite | n2=en:dapsone | rel=r_associated | relid=0 | w=34 barite -- r_associated #0: 34 / 0.082 -> en:dendritic cell-recombinant prostate-specific membrane antigen vaccine n1=barite | n2=en:dendritic cell-recombinant prostate-specific membrane antigen vaccine | rel=r_associated | relid=0 | w=34 barite -- r_associated #0: 34 / 0.082 -> en:denenicokin n1=barite | n2=en:denenicokin | rel=r_associated | relid=0 | w=34 barite -- r_associated #0: 34 / 0.082 -> en:dhap regimen n1=barite | n2=en:dhap regimen | rel=r_associated | relid=0 | w=34 barite -- r_associated #0: 34 / 0.082 -> en:diphenhydramine/lidocaine/antacid mouthwash n1=barite | n2=en:diphenhydramine/lidocaine/antacid mouthwash | rel=r_associated | relid=0 | w=34 barite -- r_associated #0: 34 / 0.082 -> en:dna minor groove binding agent sg2000 n1=barite | n2=en:dna minor groove binding agent sg2000 | rel=r_associated | relid=0 | w=34 barite -- r_associated #0: 34 / 0.082 -> en:nutritional supplement drink n1=barite | n2=en:nutritional supplement drink | rel=r_associated | relid=0 | w=34 barite -- r_associated #0: 33 / 0.079 -> en:18-f-fluoroacetate n1=barite | n2=en:18-f-fluoroacetate | rel=r_associated | relid=0 | w=33 barite -- r_associated #0: 33 / 0.079 -> en:abarelix n1=barite | n2=en:abarelix | rel=r_associated | relid=0 | w=33 barite -- r_associated #0: 33 / 0.079 -> en:ad-hcmv-tk n1=barite | n2=en:ad-hcmv-tk | rel=r_associated | relid=0 | w=33 barite -- r_associated #0: 33 / 0.079 -> en:adenosine a3 receptor agonist cf102 n1=barite | n2=en:adenosine a3 receptor agonist cf102 | rel=r_associated | relid=0 | w=33 barite -- r_associated #0: 33 / 0.079 -> en:adenosine-a2a receptor antagonist cpi-444 n1=barite | n2=en:adenosine-a2a receptor antagonist cpi-444 | rel=r_associated | relid=0 | w=33 barite -- r_associated #0: 33 / 0.079 -> en:adenovirus b7-1 n1=barite | n2=en:adenovirus b7-1 | rel=r_associated | relid=0 | w=33 barite -- r_associated #0: 33 / 0.079 -> en:akt/erk inhibitor onc201 n1=barite | n2=en:akt/erk inhibitor onc201 | rel=r_associated | relid=0 | w=33 barite -- r_associated #0: 33 / 0.079 -> en:alk/ros1 inhibitor pf-06463922 n1=barite | n2=en:alk/ros1 inhibitor pf-06463922 | rel=r_associated | relid=0 | w=33 barite -- r_associated #0: 33 / 0.079 -> en:alpha-lipoic acid-palladium/vitamin/mineral supplement n1=barite | n2=en:alpha-lipoic acid-palladium/vitamin/mineral supplement | rel=r_associated | relid=0 | w=33 barite -- r_associated #0: 33 / 0.079 -> en:alvac(2) melanoma multi-antigen therapeutic vaccine n1=barite | n2=en:alvac(2) melanoma multi-antigen therapeutic vaccine | rel=r_associated | relid=0 | w=33 barite -- r_associated #0: 33 / 0.079 -> en:aminolevulinic acid hydrochloride n1=barite | n2=en:aminolevulinic acid hydrochloride | rel=r_associated | relid=0 | w=33 barite -- r_associated #0: 33 / 0.079 -> en:aminopterin n1=barite | n2=en:aminopterin | rel=r_associated | relid=0 | w=33 barite -- r_associated #0: 33 / 0.079 -> en:amt2003 n1=barite | n2=en:amt2003 | rel=r_associated | relid=0 | w=33 barite -- r_associated #0: 33 / 0.079 -> en:anakinra n1=barite | n2=en:anakinra | rel=r_associated | relid=0 | w=33 barite -- r_associated #0: 33 / 0.079 -> en:androgen receptor antagonist shr3680 n1=barite | n2=en:androgen receptor antagonist shr3680 | rel=r_associated | relid=0 | w=33 barite -- r_associated #0: 33 / 0.079 -> en:anti-alpha5beta1 integrin antibody mint1526a n1=barite | n2=en:anti-alpha5beta1 integrin antibody mint1526a | rel=r_associated | relid=0 | w=33 barite -- r_associated #0: 33 / 0.079 -> en:anti-cd19-car fmc63-28z retroviral vector-transduced allogeneic t-lymphocytes n1=barite | n2=en:anti-cd19-car fmc63-28z retroviral vector-transduced allogeneic t-lymphocytes | rel=r_associated | relid=0 | w=33 barite -- r_associated #0: 33 / 0.079 -> en:anti-cd22 monoclonal antibody-mmae conjugate dcdt2980s n1=barite | n2=en:anti-cd22 monoclonal antibody-mmae conjugate dcdt2980s | rel=r_associated | relid=0 | w=33 barite -- r_associated #0: 33 / 0.079 -> en:anti-cd3 immunotoxin a-dmdt390-bisfv(ucht1) n1=barite | n2=en:anti-cd3 immunotoxin a-dmdt390-bisfv(ucht1) | rel=r_associated | relid=0 | w=33 barite -- r_associated #0: 33 / 0.079 -> en:anti-cd38 monoclonal antibody mor03087 n1=barite | n2=en:anti-cd38 monoclonal antibody mor03087 | rel=r_associated | relid=0 | w=33 barite -- r_associated #0: 33 / 0.079 -> en:anti-cd7 immunotoxin n1=barite | n2=en:anti-cd7 immunotoxin | rel=r_associated | relid=0 | w=33 barite -- r_associated #0: 33 / 0.079 -> en:anti-cea bite monoclonal antibody amg211 n1=barite | n2=en:anti-cea bite monoclonal antibody amg211 | rel=r_associated | relid=0 | w=33 barite -- r_associated #0: 33 / 0.079 -> en:anti-ctgf monoclonal antibody fg-3019 n1=barite | n2=en:anti-ctgf monoclonal antibody fg-3019 | rel=r_associated | relid=0 | w=33 barite -- r_associated #0: 33 / 0.079 -> en:anti-egfr monoclonal antibody ro5083945 n1=barite | n2=en:anti-egfr monoclonal antibody ro5083945 | rel=r_associated | relid=0 | w=33 barite -- r_associated #0: 33 / 0.079 -> en:anti-endosialin monoclonal antibody morab-004 n1=barite | n2=en:anti-endosialin monoclonal antibody morab-004 | rel=r_associated | relid=0 | w=33 barite -- r_associated #0: 33 / 0.079 -> en:anti-erbb3 monoclonal antibody av-203 n1=barite | n2=en:anti-erbb3 monoclonal antibody av-203 | rel=r_associated | relid=0 | w=33 barite -- r_associated #0: 33 / 0.079 -> en:anti-fgf23 igg1 monoclonal antibody krn23 n1=barite | n2=en:anti-fgf23 igg1 monoclonal antibody krn23 | rel=r_associated | relid=0 | w=33 barite -- r_associated #0: 33 / 0.079 -> en:anti-napi2b/mmae antibody-drug conjugate dnib0600a n1=barite | n2=en:anti-napi2b/mmae antibody-drug conjugate dnib0600a | rel=r_associated | relid=0 | w=33 barite -- r_associated #0: 33 / 0.079 -> en:anti-nectin 4 antibody-drug conjugate asg-22ce n1=barite | n2=en:anti-nectin 4 antibody-drug conjugate asg-22ce | rel=r_associated | relid=0 | w=33 barite -- r_associated #0: 33 / 0.079 -> en:anti-rspo3 monoclonal antibody omp-131r10 n1=barite | n2=en:anti-rspo3 monoclonal antibody omp-131r10 | rel=r_associated | relid=0 | w=33 barite -- r_associated #0: 33 / 0.079 -> en:anti-tweak monoclonal antibody ro5458640 n1=barite | n2=en:anti-tweak monoclonal antibody ro5458640 | rel=r_associated | relid=0 | w=33 barite -- r_associated #0: 33 / 0.079 -> en:antidiuretic n1=barite | n2=en:antidiuretic | rel=r_associated | relid=0 | w=33 barite -- r_associated #0: 33 / 0.079 -> en:antimetabolite n1=barite | n2=en:antimetabolite | rel=r_associated | relid=0 | w=33 barite -- r_associated #0: 33 / 0.079 -> en:artichoke whole phytocomplex concentrate n1=barite | n2=en:artichoke whole phytocomplex concentrate | rel=r_associated | relid=0 | w=33 barite -- r_associated #0: 33 / 0.079 -> en:asaley n1=barite | n2=en:asaley | rel=r_associated | relid=0 | w=33 barite -- r_associated #0: 33 / 0.079 -> en:aspirin n1=barite | n2=en:aspirin | rel=r_associated | relid=0 | w=33 barite -- r_associated #0: 33 / 0.079 -> en:atm kinase inhibitor azd0156 n1=barite | n2=en:atm kinase inhibitor azd0156 | rel=r_associated | relid=0 | w=33 barite -- r_associated #0: 33 / 0.079 -> en:atomoxetine hydrochloride n1=barite | n2=en:atomoxetine hydrochloride | rel=r_associated | relid=0 | w=33 barite -- r_associated #0: 33 / 0.079 -> en:autologous dendritic cell-allogeneic melanoma tumor cell lysate vaccine n1=barite | n2=en:autologous dendritic cell-allogeneic melanoma tumor cell lysate vaccine | rel=r_associated | relid=0 | w=33 barite -- r_associated #0: 33 / 0.079 -> en:autologous muc1-mannan fusion protein pulsed dendritic cell vaccine n1=barite | n2=en:autologous muc1-mannan fusion protein pulsed dendritic cell vaccine | rel=r_associated | relid=0 | w=33 barite -- r_associated #0: 33 / 0.079 -> en:autologous nsclc dna-transfected semi-allogeneic fibroblasts mrc-5 vaccine n1=barite | n2=en:autologous nsclc dna-transfected semi-allogeneic fibroblasts mrc-5 vaccine | rel=r_associated | relid=0 | w=33 barite -- r_associated #0: 33 / 0.079 -> en:avn944 n1=barite | n2=en:avn944 | rel=r_associated | relid=0 | w=33 barite -- r_associated #0: 33 / 0.079 -> en:barley grass preparation n1=barite | n2=en:barley grass preparation | rel=r_associated | relid=0 | w=33 barite -- r_associated #0: 33 / 0.079 -> en:belagenpumatucel-l n1=barite | n2=en:belagenpumatucel-l | rel=r_associated | relid=0 | w=33 barite -- r_associated #0: 33 / 0.079 -> en:belinostat n1=barite | n2=en:belinostat | rel=r_associated | relid=0 | w=33 barite -- r_associated #0: 33 / 0.079 -> en:belladonna/kaolin/opium/pectin n1=barite | n2=en:belladonna/kaolin/opium/pectin | rel=r_associated | relid=0 | w=33 barite -- r_associated #0: 33 / 0.079 -> en:benazepril/hydrochlorothiazide n1=barite | n2=en:benazepril/hydrochlorothiazide | rel=r_associated | relid=0 | w=33 barite -- r_associated #0: 33 / 0.079 -> en:benzalkonium chloride/edetate/polyvinyl alcohol n1=barite | n2=en:benzalkonium chloride/edetate/polyvinyl alcohol | rel=r_associated | relid=0 | w=33 barite -- r_associated #0: 33 / 0.079 -> en:benzocaine / cetalkonium chloride n1=barite | n2=en:benzocaine / cetalkonium chloride | rel=r_associated | relid=0 | w=33 barite -- r_associated #0: 33 / 0.079 -> en:benzocaine + phenol n1=barite | n2=en:benzocaine + phenol | rel=r_associated | relid=0 | w=33 barite -- r_associated #0: 33 / 0.079 -> en:benzothonium n1=barite | n2=en:benzothonium | rel=r_associated | relid=0 | w=33 barite -- r_associated #0: 33 / 0.079 -> en:bet inhibitor ft-1101 n1=barite | n2=en:bet inhibitor ft-1101 | rel=r_associated | relid=0 | w=33 barite -- r_associated #0: 33 / 0.079 -> en:beta-d-galactose/maltodextrin n1=barite | n2=en:beta-d-galactose/maltodextrin | rel=r_associated | relid=0 | w=33 barite -- r_associated #0: 33 / 0.079 -> en:beta-glucan/lactobacillus casei/bifidobacterium lactis-based supplement n1=barite | n2=en:beta-glucan/lactobacillus casei/bifidobacterium lactis-based supplement | rel=r_associated | relid=0 | w=33 barite -- r_associated #0: 33 / 0.079 -> en:beta-hydroxy-beta-methylbutyrate supplement n1=barite | n2=en:beta-hydroxy-beta-methylbutyrate supplement | rel=r_associated | relid=0 | w=33 barite -- r_associated #0: 33 / 0.079 -> en:bh3 mimetic abt-737 n1=barite | n2=en:bh3 mimetic abt-737 | rel=r_associated | relid=0 | w=33 barite -- r_associated #0: 33 / 0.079 -> en:biafine cream n1=barite | n2=en:biafine cream | rel=r_associated | relid=0 | w=33 barite -- r_associated #0: 33 / 0.079 -> en:bile salt n1=barite | n2=en:bile salt | rel=r_associated | relid=0 | w=33 barite -- r_associated #0: 33 / 0.079 -> en:bilirubin/blood,occult/glucose/ketone/nitrite/ph/protein/urobili n1=barite | n2=en:bilirubin/blood,occult/glucose/ketone/nitrite/ph/protein/urobili | rel=r_associated | relid=0 | w=33 barite -- r_associated #0: 33 / 0.079 -> en:biological factors n1=barite | n2=en:biological factors | rel=r_associated | relid=0 | w=33 barite -- r_associated #0: 33 / 0.079 -> en:biotene n1=barite | n2=en:biotene | rel=r_associated | relid=0 | w=33 barite -- r_associated #0: 33 / 0.079 -> en:boron n1=barite | n2=en:boron | rel=r_associated | relid=0 | w=33 barite -- r_associated #0: 33 / 0.079 -> en:bortezomib n1=barite | n2=en:bortezomib | rel=r_associated | relid=0 | w=33 barite -- r_associated #0: 33 / 0.079 -> en:brentuximab vedotin n1=barite | n2=en:brentuximab vedotin | rel=r_associated | relid=0 | w=33 barite -- r_associated #0: 33 / 0.079 -> en:brn01 n1=barite | n2=en:brn01 | rel=r_associated | relid=0 | w=33 barite -- r_associated #0: 33 / 0.079 -> en:bropirimine n1=barite | n2=en:bropirimine | rel=r_associated | relid=0 | w=33 barite -- r_associated #0: 33 / 0.079 -> en:bryonia preparation n1=barite | n2=en:bryonia preparation | rel=r_associated | relid=0 | w=33 barite -- r_associated #0: 33 / 0.079 -> en:bupivacaine/epinephrine/lidocaine n1=barite | n2=en:bupivacaine/epinephrine/lidocaine | rel=r_associated | relid=0 | w=33 barite -- r_associated #0: 33 / 0.079 -> en:calusterone n1=barite | n2=en:calusterone | rel=r_associated | relid=0 | w=33 barite -- r_associated #0: 33 / 0.079 -> en:carbon c 14 anlotinib hydrochloride n1=barite | n2=en:carbon c 14 anlotinib hydrochloride | rel=r_associated | relid=0 | w=33 barite -- r_associated #0: 33 / 0.079 -> en:carbon c 14 gilteritinib n1=barite | n2=en:carbon c 14 gilteritinib | rel=r_associated | relid=0 | w=33 barite -- r_associated #0: 33 / 0.079 -> en:carboxyamidotriazole n1=barite | n2=en:carboxyamidotriazole | rel=r_associated | relid=0 | w=33 barite -- r_associated #0: 33 / 0.079 -> en:casein/whey protein/soy protein/pea protein/fat mix/epa/dha-based nutritional supplement n1=barite | n2=en:casein/whey protein/soy protein/pea protein/fat mix/epa/dha-based nutritional supplement | rel=r_associated | relid=0 | w=33 barite -- r_associated #0: 33 / 0.079 -> en:cd5789 cream n1=barite | n2=en:cd5789 cream | rel=r_associated | relid=0 | w=33 barite -- r_associated #0: 33 / 0.079 -> en:cenersen n1=barite | n2=en:cenersen | rel=r_associated | relid=0 | w=33 barite -- r_associated #0: 33 / 0.079 -> en:ceramide n1=barite | n2=en:ceramide | rel=r_associated | relid=0 | w=33 barite -- r_associated #0: 33 / 0.079 -> en:cetuximab n1=barite | n2=en:cetuximab | rel=r_associated | relid=0 | w=33 barite -- r_associated #0: 33 / 0.079 -> en:chimeric fibril-reactive monoclonal antibody 111f4 n1=barite | n2=en:chimeric fibril-reactive monoclonal antibody 111f4 | rel=r_associated | relid=0 | w=33 barite -- r_associated #0: 33 / 0.079 -> en:choline kinase alpha inhibitor tcd-717 n1=barite | n2=en:choline kinase alpha inhibitor tcd-717 | rel=r_associated | relid=0 | w=33 barite -- r_associated #0: 33 / 0.079 -> en:ciclopirox olamine lotion n1=barite | n2=en:ciclopirox olamine lotion | rel=r_associated | relid=0 | w=33 barite -- r_associated #0: 33 / 0.079 -> en:cixutumumab n1=barite | n2=en:cixutumumab | rel=r_associated | relid=0 | w=33 barite -- r_associated #0: 33 / 0.079 -> en:clindamycin/hydrocortisone lotion n1=barite | n2=en:clindamycin/hydrocortisone lotion | rel=r_associated | relid=0 | w=33 barite -- r_associated #0: 33 / 0.079 -> en:cmvpp65-a*0201 peptide vaccine n1=barite | n2=en:cmvpp65-a*0201 peptide vaccine | rel=r_associated | relid=0 | w=33 barite -- r_associated #0: 33 / 0.079 -> en:crystalline genistein formulation axp107-11 n1=barite | n2=en:crystalline genistein formulation axp107-11 | rel=r_associated | relid=0 | w=33 barite -- r_associated #0: 33 / 0.079 -> en:cytembena n1=barite | n2=en:cytembena | rel=r_associated | relid=0 | w=33 barite -- r_associated #0: 33 / 0.079 -> en:dc-ova vaccine n1=barite | n2=en:dc-ova vaccine | rel=r_associated | relid=0 | w=33 barite -- r_associated #0: 33 / 0.079 -> en:deglycosylated ricin a chain-conjugated anti-cd19/anti-cd22 immunotoxins n1=barite | n2=en:deglycosylated ricin a chain-conjugated anti-cd19/anti-cd22 immunotoxins | rel=r_associated | relid=0 | w=33 barite -- r_associated #0: 33 / 0.079 -> en:detox-b adjuvant n1=barite | n2=en:detox-b adjuvant | rel=r_associated | relid=0 | w=33 barite -- r_associated #0: 33 / 0.079 -> en:dextropropoxyphene hydrochloride n1=barite | n2=en:dextropropoxyphene hydrochloride | rel=r_associated | relid=0 | w=33 barite -- r_associated #0: 33 / 0.079 -> en:didemnin b n1=barite | n2=en:didemnin b | rel=r_associated | relid=0 | w=33 barite -- r_associated #0: 33 / 0.079 -> en:diethylstilbestrol n1=barite | n2=en:diethylstilbestrol | rel=r_associated | relid=0 | w=33 barite -- r_associated #0: 33 / 0.079 -> en:diltiazem hydrochloride n1=barite | n2=en:diltiazem hydrochloride | rel=r_associated | relid=0 | w=33 barite -- r_associated #0: 33 / 0.079 -> en:dimethicone-containing botanicals-based lotion n1=barite | n2=en:dimethicone-containing botanicals-based lotion | rel=r_associated | relid=0 | w=33 barite -- r_associated #0: 33 / 0.079 -> en:diphtheria toxin fragment-interleukin-2 fusion protein e7777 n1=barite | n2=en:diphtheria toxin fragment-interleukin-2 fusion protein e7777 | rel=r_associated | relid=0 | w=33 barite -- r_associated #0: 33 / 0.079 -> en:distilled water n1=barite | n2=en:distilled water | rel=r_associated | relid=0 | w=33 barite -- r_associated #0: 33 / 0.079 -> en:diuretic n1=barite | n2=en:diuretic | rel=r_associated | relid=0 | w=33 barite -- r_associated #0: 33 / 0.079 -> en:dlk1/epha2/hbb/nrp1/rgs5/tem1 peptide-pulsed alpha-type-1 polarized dendritic cell vaccine n1=barite | n2=en:dlk1/epha2/hbb/nrp1/rgs5/tem1 peptide-pulsed alpha-type-1 polarized dendritic cell vaccine | rel=r_associated | relid=0 | w=33 barite -- r_associated #0: 33 / 0.079 -> en:doxorubicin-eluting beads n1=barite | n2=en:doxorubicin-eluting beads | rel=r_associated | relid=0 | w=33 barite -- r_associated #0: 33 / 0.079 -> en:dt(388)il3 fusion protein sl-401 n1=barite | n2=en:dt(388)il3 fusion protein sl-401 | rel=r_associated | relid=0 | w=33 barite -- r_associated #0: 33 / 0.079 -> en:micropaque oral n1=barite | n2=en:micropaque oral | rel=r_associated | relid=0 | w=33 barite -- r_associated #0: 32 / 0.077 -> en:3,4-methylenedioxymethamphetamine n1=barite | n2=en:3,4-methylenedioxymethamphetamine | rel=r_associated | relid=0 | w=32 barite -- r_associated #0: 32 / 0.077 -> en:5-fluoropyrimidinone n1=barite | n2=en:5-fluoropyrimidinone | rel=r_associated | relid=0 | w=32 barite -- r_associated #0: 32 / 0.077 -> en:ade regimen n1=barite | n2=en:ade regimen | rel=r_associated | relid=0 | w=32 barite -- r_associated #0: 32 / 0.077 -> en:adenoviral transduced hil-12-expressing autologous dendritic cells inxn-3001 plus activator ligand inxn-1001 n1=barite | n2=en:adenoviral transduced hil-12-expressing autologous dendritic cells inxn-3001 plus activator ligand inxn-1001 | rel=r_associated | relid=0 | w=32 barite -- r_associated #0: 32 / 0.077 -> en:adenovirus 5-cd40 ligand n1=barite | n2=en:adenovirus 5-cd40 ligand | rel=r_associated | relid=0 | w=32 barite -- r_associated #0: 32 / 0.077 -> en:adenovirus encoding tyrosinase/mart-1/magea6-transduced autologous dendritic cell vaccine n1=barite | n2=en:adenovirus encoding tyrosinase/mart-1/magea6-transduced autologous dendritic cell vaccine | rel=r_associated | relid=0 | w=32 barite -- r_associated #0: 32 / 0.077 -> en:adenovirus-psa prostate cancer vaccine n1=barite | n2=en:adenovirus-psa prostate cancer vaccine | rel=r_associated | relid=0 | w=32 barite -- r_associated #0: 32 / 0.077 -> en:afatinib dimaleate n1=barite | n2=en:afatinib dimaleate | rel=r_associated | relid=0 | w=32 barite -- r_associated #0: 32 / 0.077 -> en:ak 3012 n1=barite | n2=en:ak 3012 | rel=r_associated | relid=0 | w=32 barite -- r_associated #0: 32 / 0.077 -> en:alk5 inhibitor tew-7197 n1=barite | n2=en:alk5 inhibitor tew-7197 | rel=r_associated | relid=0 | w=32 barite -- r_associated #0: 32 / 0.077 -> en:allogeneic aml antigen-expressing dendritic cell vaccine n1=barite | n2=en:allogeneic aml antigen-expressing dendritic cell vaccine | rel=r_associated | relid=0 | w=32 barite -- r_associated #0: 32 / 0.077 -> en:allogeneic gm-csf-secreting tumor vaccine panc 10.05 pcdna-1/gm-neo n1=barite | n2=en:allogeneic gm-csf-secreting tumor vaccine panc 10.05 pcdna-1/gm-neo | rel=r_associated | relid=0 | w=32 barite -- r_associated #0: 32 / 0.077 -> en:aloe vera gel n1=barite | n2=en:aloe vera gel | rel=r_associated | relid=0 | w=32 barite -- r_associated #0: 32 / 0.077 -> en:alpha-folate receptor-targeting thymidylate synthase inhibitor onx-0801 n1=barite | n2=en:alpha-folate receptor-targeting thymidylate synthase inhibitor onx-0801 | rel=r_associated | relid=0 | w=32 barite -- r_associated #0: 32 / 0.077 -> en:alpha-type-1 polarized dendritic cells n1=barite | n2=en:alpha-type-1 polarized dendritic cells | rel=r_associated | relid=0 | w=32 barite -- r_associated #0: 32 / 0.077 -> en:alum compounds n1=barite | n2=en:alum compounds | rel=r_associated | relid=0 | w=32 barite -- r_associated #0: 32 / 0.077 -> en:alvac-hb7.1 n1=barite | n2=en:alvac-hb7.1 | rel=r_associated | relid=0 | w=32 barite -- r_associated #0: 32 / 0.077 -> en:amantadine hydrochloride n1=barite | n2=en:amantadine hydrochloride | rel=r_associated | relid=0 | w=32 barite -- r_associated #0: 32 / 0.077 -> en:amifostine n1=barite | n2=en:amifostine | rel=r_associated | relid=0 | w=32 barite -- r_associated #0: 32 / 0.077 -> en:aminocamptothecin n1=barite | n2=en:aminocamptothecin | rel=r_associated | relid=0 | w=32 barite -- r_associated #0: 32 / 0.077 -> en:amolimogene bepiplasmid n1=barite | n2=en:amolimogene bepiplasmid | rel=r_associated | relid=0 | w=32 barite -- r_associated #0: 32 / 0.077 -> en:anlotinib hydrochloride n1=barite | n2=en:anlotinib hydrochloride | rel=r_associated | relid=0 | w=32 barite -- r_associated #0: 32 / 0.077 -> en:anti-amyloid monoclonal antibody neod001 n1=barite | n2=en:anti-amyloid monoclonal antibody neod001 | rel=r_associated | relid=0 | w=32 barite -- r_associated #0: 32 / 0.077 -> en:anti-angiopoietin monoclonal antibody amg 780 n1=barite | n2=en:anti-angiopoietin monoclonal antibody amg 780 | rel=r_associated | relid=0 | w=32 barite -- r_associated #0: 32 / 0.077 -> en:anti-c-met monoclonal antibody abt-700 n1=barite | n2=en:anti-c-met monoclonal antibody abt-700 | rel=r_associated | relid=0 | w=32 barite -- r_associated #0: 32 / 0.077 -> en:anti-cd19 monoclonal antibody mdx-1342 n1=barite | n2=en:anti-cd19 monoclonal antibody mdx-1342 | rel=r_associated | relid=0 | w=32 barite -- r_associated #0: 32 / 0.077 -> en:anti-cd19/cd28/cd3zeta car gammaretroviral vector-transduced autologous t lymphocytes kte-c19 n1=barite | n2=en:anti-cd19/cd28/cd3zeta car gammaretroviral vector-transduced autologous t lymphocytes kte-c19 | rel=r_associated | relid=0 | w=32 barite -- r_associated #0: 32 / 0.077 -> en:anti-cd3/anti-cd20 trifunctional bispecific monoclonal antibody fbta05 n1=barite | n2=en:anti-cd3/anti-cd20 trifunctional bispecific monoclonal antibody fbta05 | rel=r_associated | relid=0 | w=32 barite -- r_associated #0: 32 / 0.077 -> en:anti-fgfr2 antibody bay1179470 n1=barite | n2=en:anti-fgfr2 antibody bay1179470 | rel=r_associated | relid=0 | w=32 barite -- r_associated #0: 32 / 0.077 -> en:anti-flt3 monoclonal antibody imc-eb10 n1=barite | n2=en:anti-flt3 monoclonal antibody imc-eb10 | rel=r_associated | relid=0 | w=32 barite -- r_associated #0: 32 / 0.077 -> en:anti-icos agonist antibody gsk3359609 n1=barite | n2=en:anti-icos agonist antibody gsk3359609 | rel=r_associated | relid=0 | w=32 barite -- r_associated #0: 32 / 0.077 -> en:anti-muc1 car-transduced autologous t-lymphocytes n1=barite | n2=en:anti-muc1 car-transduced autologous t-lymphocytes | rel=r_associated | relid=0 | w=32 barite -- r_associated #0: 32 / 0.077 -> en:anti-ox40 monoclonal antibody moxr0916 n1=barite | n2=en:anti-ox40 monoclonal antibody moxr0916 | rel=r_associated | relid=0 | w=32 barite -- r_associated #0: 32 / 0.077 -> en:anti-pd-1 monoclonal antibody bgb-a317 n1=barite | n2=en:anti-pd-1 monoclonal antibody bgb-a317 | rel=r_associated | relid=0 | w=32 barite -- r_associated #0: 32 / 0.077 -> en:anti-vegfr3 monoclonal antibody imc-3c5 n1=barite | n2=en:anti-vegfr3 monoclonal antibody imc-3c5 | rel=r_associated | relid=0 | w=32 barite -- r_associated #0: 32 / 0.077 -> en:antineoplastic agent combination sm-88 n1=barite | n2=en:antineoplastic agent combination sm-88 | rel=r_associated | relid=0 | w=32 barite -- r_associated #0: 32 / 0.077 -> en:antirheumatic agents n1=barite | n2=en:antirheumatic agents | rel=r_associated | relid=0 | w=32 barite -- r_associated #0: 32 / 0.077 -> en:apatinib n1=barite | n2=en:apatinib | rel=r_associated | relid=0 | w=32 barite -- r_associated #0: 32 / 0.077 -> en:ar ligand binding domain-targeting agent azd3514 n1=barite | n2=en:ar ligand binding domain-targeting agent azd3514 | rel=r_associated | relid=0 | w=32 barite -- r_associated #0: 32 / 0.077 -> en:autologous interferon-producing killer dendritic cells n1=barite | n2=en:autologous interferon-producing killer dendritic cells | rel=r_associated | relid=0 | w=32 barite -- r_associated #0: 32 / 0.077 -> en:autologous lymphoma cell/autologous dendritic cell electrofusion hybrid vaccine n1=barite | n2=en:autologous lymphoma cell/autologous dendritic cell electrofusion hybrid vaccine | rel=r_associated | relid=0 | w=32 barite -- r_associated #0: 32 / 0.077 -> en:autologous peripheral blood lymphocytes cotransduced with retroviral vectors encoding inducible il-12 and anti-ny-eso-1 tcr n1=barite | n2=en:autologous peripheral blood lymphocytes cotransduced with retroviral vectors encoding inducible il-12 and anti-ny-eso-1 tcr | rel=r_associated | relid=0 | w=32 barite -- r_associated #0: 32 / 0.077 -> en:baby oil n1=barite | n2=en:baby oil | rel=r_associated | relid=0 | w=32 barite -- r_associated #0: 32 / 0.077 -> en:bafetinib n1=barite | n2=en:bafetinib | rel=r_associated | relid=0 | w=32 barite -- r_associated #0: 32 / 0.077 -> en:baicalin n1=barite | n2=en:baicalin | rel=r_associated | relid=0 | w=32 barite -- r_associated #0: 32 / 0.077 -> en:barbital/hyoscyamine/hyoscyamus/passion/scopolamine/valerian n1=barite | n2=en:barbital/hyoscyamine/hyoscyamus/passion/scopolamine/valerian | rel=r_associated | relid=0 | w=32 barite -- r_associated #0: 32 / 0.077 -> en:bardoxolone n1=barite | n2=en:bardoxolone | rel=r_associated | relid=0 | w=32 barite -- r_associated #0: 32 / 0.077 -> en:barium so4 98% pwdr,oral n1=barite | n2=en:barium so4 98% pwdr,oral | rel=r_associated | relid=0 | w=32 barite -- r_associated #0: 32 / 0.077 -> en:behenoxy dimethicone n1=barite | n2=en:behenoxy dimethicone | rel=r_associated | relid=0 | w=32 barite -- r_associated #0: 32 / 0.077 -> en:benazepril hydrochloride n1=barite | n2=en:benazepril hydrochloride | rel=r_associated | relid=0 | w=32 barite -- r_associated #0: 32 / 0.077 -> en:benzaldehyde n1=barite | n2=en:benzaldehyde | rel=r_associated | relid=0 | w=32 barite -- r_associated #0: 32 / 0.077 -> en:benzalkonium/calcium chloride/hydrochloric acid/magnesium chlori n1=barite | n2=en:benzalkonium/calcium chloride/hydrochloric acid/magnesium chlori | rel=r_associated | relid=0 | w=32 barite -- r_associated #0: 32 / 0.077 -> en:benzocaine/calamine/diphenhydramine/menthol n1=barite | n2=en:benzocaine/calamine/diphenhydramine/menthol | rel=r_associated | relid=0 | w=32 barite -- r_associated #0: 32 / 0.077 -> en:benzocaine/camphor/menthol n1=barite | n2=en:benzocaine/camphor/menthol | rel=r_associated | relid=0 | w=32 barite -- r_associated #0: 32 / 0.077 -> en:benzyl alcohol/cetylpyridinium chloride n1=barite | n2=en:benzyl alcohol/cetylpyridinium chloride | rel=r_associated | relid=0 | w=32 barite -- r_associated #0: 32 / 0.077 -> en:betaine/protease n1=barite | n2=en:betaine/protease | rel=r_associated | relid=0 | w=32 barite -- r_associated #0: 32 / 0.077 -> en:bilirubin/blood/glucose/ketone/nitrite/ph/protein/urobilinogen n1=barite | n2=en:bilirubin/blood/glucose/ketone/nitrite/ph/protein/urobilinogen | rel=r_associated | relid=0 | w=32 barite -- r_associated #0: 32 / 0.077 -> en:bilirubin/blood/glucose/ketone/ph/protein/specific gravity test n1=barite | n2=en:bilirubin/blood/glucose/ketone/ph/protein/specific gravity test | rel=r_associated | relid=0 | w=32 barite -- r_associated #0: 32 / 0.077 -> en:bisacodyl/castor oil n1=barite | n2=en:bisacodyl/castor oil | rel=r_associated | relid=0 | w=32 barite -- r_associated #0: 32 / 0.077 -> en:bisacodyl/phospho soda n1=barite | n2=en:bisacodyl/phospho soda | rel=r_associated | relid=0 | w=32 barite -- r_associated #0: 32 / 0.077 -> en:bl22 immunotoxin n1=barite | n2=en:bl22 immunotoxin | rel=r_associated | relid=0 | w=32 barite -- r_associated #0: 32 / 0.077 -> en:black radish n1=barite | n2=en:black radish | rel=r_associated | relid=0 | w=32 barite -- r_associated #0: 32 / 0.077 -> en:blood/glucose/ph/protein test n1=barite | n2=en:blood/glucose/ph/protein test | rel=r_associated | relid=0 | w=32 barite -- r_associated #0: 32 / 0.077 -> en:boric acid/sodium borate n1=barite | n2=en:boric acid/sodium borate | rel=r_associated | relid=0 | w=32 barite -- r_associated #0: 32 / 0.077 -> en:brompheniramine / guaifenesin / pseudoephedrine n1=barite | n2=en:brompheniramine / guaifenesin / pseudoephedrine | rel=r_associated | relid=0 | w=32 barite -- r_associated #0: 32 / 0.077 -> en:bryostatin 1 n1=barite | n2=en:bryostatin 1 | rel=r_associated | relid=0 | w=32 barite -- r_associated #0: 32 / 0.077 -> en:c-myb antisense oligonucleotide g4460 n1=barite | n2=en:c-myb antisense oligonucleotide g4460 | rel=r_associated | relid=0 | w=32 barite -- r_associated #0: 32 / 0.077 -> en:canertinib dihydrochloride n1=barite | n2=en:canertinib dihydrochloride | rel=r_associated | relid=0 | w=32 barite -- r_associated #0: 32 / 0.077 -> en:caricotamide/tretazicar n1=barite | n2=en:caricotamide/tretazicar | rel=r_associated | relid=0 | w=32 barite -- r_associated #0: 32 / 0.077 -> en:carmustine n1=barite | n2=en:carmustine | rel=r_associated | relid=0 | w=32 barite -- r_associated #0: 32 / 0.077 -> en:carmustine sustained-release implant wafer n1=barite | n2=en:carmustine sustained-release implant wafer | rel=r_associated | relid=0 | w=32 barite -- r_associated #0: 32 / 0.077 -> en:casopitant mesylate n1=barite | n2=en:casopitant mesylate | rel=r_associated | relid=0 | w=32 barite -- r_associated #0: 32 / 0.077 -> en:cathelicidin ll-37 n1=barite | n2=en:cathelicidin ll-37 | rel=r_associated | relid=0 | w=32 barite -- r_associated #0: 32 / 0.077 -> en:cc-401 n1=barite | n2=en:cc-401 | rel=r_associated | relid=0 | w=32 barite -- r_associated #0: 32 / 0.077 -> en:cd19car-cd28zeta-4-1bb-expressing allogeneic t lymphocytes n1=barite | n2=en:cd19car-cd28zeta-4-1bb-expressing allogeneic t lymphocytes | rel=r_associated | relid=0 | w=32 barite -- r_associated #0: 32 / 0.077 -> en:cef regimen n1=barite | n2=en:cef regimen | rel=r_associated | relid=0 | w=32 barite -- r_associated #0: 32 / 0.077 -> en:ceftazidime/avibactam sodium n1=barite | n2=en:ceftazidime/avibactam sodium | rel=r_associated | relid=0 | w=32 barite -- r_associated #0: 32 / 0.077 -> en:certolizumab n1=barite | n2=en:certolizumab | rel=r_associated | relid=0 | w=32 barite -- r_associated #0: 32 / 0.077 -> en:cholecalciferol n1=barite | n2=en:cholecalciferol | rel=r_associated | relid=0 | w=32 barite -- r_associated #0: 32 / 0.077 -> en:cis-urocanic acid n1=barite | n2=en:cis-urocanic acid | rel=r_associated | relid=0 | w=32 barite -- r_associated #0: 32 / 0.077 -> en:claudiximab n1=barite | n2=en:claudiximab | rel=r_associated | relid=0 | w=32 barite -- r_associated #0: 32 / 0.077 -> en:coenzyme q10 n1=barite | n2=en:coenzyme q10 | rel=r_associated | relid=0 | w=32 barite -- r_associated #0: 32 / 0.077 -> en:controlled substance n1=barite | n2=en:controlled substance | rel=r_associated | relid=0 | w=32 barite -- r_associated #0: 32 / 0.077 -> en:copdac regimen n1=barite | n2=en:copdac regimen | rel=r_associated | relid=0 | w=32 barite -- r_associated #0: 32 / 0.077 -> en:corticorelin acetate n1=barite | n2=en:corticorelin acetate | rel=r_associated | relid=0 | w=32 barite -- r_associated #0: 32 / 0.077 -> en:daunorubicin-dna complex n1=barite | n2=en:daunorubicin-dna complex | rel=r_associated | relid=0 | w=32 barite -- r_associated #0: 32 / 0.077 -> en:dbve-pc regimen n1=barite | n2=en:dbve-pc regimen | rel=r_associated | relid=0 | w=32 barite -- r_associated #0: 32 / 0.077 -> en:dendritic cell-gp100-mart-1 antigen vaccine n1=barite | n2=en:dendritic cell-gp100-mart-1 antigen vaccine | rel=r_associated | relid=0 | w=32 barite -- r_associated #0: 32 / 0.077 -> en:desflurane n1=barite | n2=en:desflurane | rel=r_associated | relid=0 | w=32 barite -- r_associated #0: 32 / 0.077 -> en:deuterium oxide n1=barite | n2=en:deuterium oxide | rel=r_associated | relid=0 | w=32 barite -- r_associated #0: 32 / 0.077 -> en:dexmedetomidine hydrochloride n1=barite | n2=en:dexmedetomidine hydrochloride | rel=r_associated | relid=0 | w=32 barite -- r_associated #0: 32 / 0.077 -> en:doxifluridine n1=barite | n2=en:doxifluridine | rel=r_associated | relid=0 | w=32 barite -- r_associated #0: 32 / 0.077 -> en:eye agent n1=barite | n2=en:eye agent | rel=r_associated | relid=0 | w=32 barite -- r_associated #0: 32 / 0.077 -> en:pharmaceutical preparations, dental n1=barite | n2=en:pharmaceutical preparations, dental | rel=r_associated | relid=0 | w=32 barite -- r_associated #0: 32 / 0.077 -> en:phenazopyridine + butabarbital + hyoscyamine n1=barite | n2=en:phenazopyridine + butabarbital + hyoscyamine | rel=r_associated | relid=0 | w=32 barite -- r_associated #0: 32 / 0.077 -> en:propyliodone n1=barite | n2=en:propyliodone | rel=r_associated | relid=0 | w=32 barite -- r_associated #0: 31 / 0.075 -> en:18f-labeled mini-peg spacered rgd dimer n1=barite | n2=en:18f-labeled mini-peg spacered rgd dimer | rel=r_associated | relid=0 | w=31 barite -- r_associated #0: 31 / 0.075 -> en:851b gel n1=barite | n2=en:851b gel | rel=r_associated | relid=0 | w=31 barite -- r_associated #0: 31 / 0.075 -> en:abbv-221 n1=barite | n2=en:abbv-221 | rel=r_associated | relid=0 | w=31 barite -- r_associated #0: 31 / 0.075 -> en:abexinostat n1=barite | n2=en:abexinostat | rel=r_associated | relid=0 | w=31 barite -- r_associated #0: 31 / 0.075 -> en:acarbose n1=barite | n2=en:acarbose | rel=r_associated | relid=0 | w=31 barite -- r_associated #0: 31 / 0.075 -> en:acitretin n1=barite | n2=en:acitretin | rel=r_associated | relid=0 | w=31 barite -- r_associated #0: 31 / 0.075 -> en:activated marrow infiltrating lymphocytes n1=barite | n2=en:activated marrow infiltrating lymphocytes | rel=r_associated | relid=0 | w=31 barite -- r_associated #0: 31 / 0.075 -> en:ad5-cmv-nis n1=barite | n2=en:ad5-cmv-nis | rel=r_associated | relid=0 | w=31 barite -- r_associated #0: 31 / 0.075 -> en:adenovirus-mediated human interleukin-12 inxn-2001 plus activator ligand inxn-1001 n1=barite | n2=en:adenovirus-mediated human interleukin-12 inxn-2001 plus activator ligand inxn-1001 | rel=r_associated | relid=0 | w=31 barite -- r_associated #0: 31 / 0.075 -> en:alanosine n1=barite | n2=en:alanosine | rel=r_associated | relid=0 | w=31 barite -- r_associated #0: 31 / 0.075 -> en:aldesleukin n1=barite | n2=en:aldesleukin | rel=r_associated | relid=0 | w=31 barite -- r_associated #0: 31 / 0.075 -> en:allogeneic cd56-positive cd3-negative natural killer cells n1=barite | n2=en:allogeneic cd56-positive cd3-negative natural killer cells | rel=r_associated | relid=0 | w=31 barite -- r_associated #0: 31 / 0.075 -> en:allogeneic cytomegalovirus-specific cytotoxic t lymphocytes n1=barite | n2=en:allogeneic cytomegalovirus-specific cytotoxic t lymphocytes | rel=r_associated | relid=0 | w=31 barite -- r_associated #0: 31 / 0.075 -> en:allogeneic glioblastoma stem-like cell line lysate-pulsed autologous dendritic cell vaccine n1=barite | n2=en:allogeneic glioblastoma stem-like cell line lysate-pulsed autologous dendritic cell vaccine | rel=r_associated | relid=0 | w=31 barite -- r_associated #0: 31 / 0.075 -> en:allogeneic multipotent adult progenitor cells n1=barite | n2=en:allogeneic multipotent adult progenitor cells | rel=r_associated | relid=0 | w=31 barite -- r_associated #0: 31 / 0.075 -> en:allogeneic tumor cell vaccine n1=barite | n2=en:allogeneic tumor cell vaccine | rel=r_associated | relid=0 | w=31 barite -- r_associated #0: 31 / 0.075 -> en:alteplase n1=barite | n2=en:alteplase | rel=r_associated | relid=0 | w=31 barite -- r_associated #0: 31 / 0.075 -> en:amilomer n1=barite | n2=en:amilomer | rel=r_associated | relid=0 | w=31 barite -- r_associated #0: 31 / 0.075 -> en:anti-ags-16 monoclonal antibody ags-16m18 n1=barite | n2=en:anti-ags-16 monoclonal antibody ags-16m18 | rel=r_associated | relid=0 | w=31 barite -- r_associated #0: 31 / 0.075 -> en:anti-cd19 antibody-drug conjugate sgn-cd19b n1=barite | n2=en:anti-cd19 antibody-drug conjugate sgn-cd19b | rel=r_associated | relid=0 | w=31 barite -- r_associated #0: 31 / 0.075 -> en:anti-cd20 monoclonal antibody sct400 n1=barite | n2=en:anti-cd20 monoclonal antibody sct400 | rel=r_associated | relid=0 | w=31 barite -- r_associated #0: 31 / 0.075 -> en:anti-cd30 monoclonal antibody xmab2513 n1=barite | n2=en:anti-cd30 monoclonal antibody xmab2513 | rel=r_associated | relid=0 | w=31 barite -- r_associated #0: 31 / 0.075 -> en:anti-cd30/cd16a monoclonal antibody afm13 n1=barite | n2=en:anti-cd30/cd16a monoclonal antibody afm13 | rel=r_associated | relid=0 | w=31 barite -- r_associated #0: 31 / 0.075 -> en:anti-cd47 monoclonal antibody hu5f9-g4 n1=barite | n2=en:anti-cd47 monoclonal antibody hu5f9-g4 | rel=r_associated | relid=0 | w=31 barite -- r_associated #0: 31 / 0.075 -> en:anti-cd70 monoclonal antibody mdx-1411 n1=barite | n2=en:anti-cd70 monoclonal antibody mdx-1411 | rel=r_associated | relid=0 | w=31 barite -- r_associated #0: 31 / 0.075 -> en:anti-cea tcr retroviral vector-transduced autologous peripheral blood lymphocytes n1=barite | n2=en:anti-cea tcr retroviral vector-transduced autologous peripheral blood lymphocytes | rel=r_associated | relid=0 | w=31 barite -- r_associated #0: 31 / 0.075 -> en:anti-denatured collagen monoclonal antibody trc093 n1=barite | n2=en:anti-denatured collagen monoclonal antibody trc093 | rel=r_associated | relid=0 | w=31 barite -- r_associated #0: 31 / 0.075 -> en:anti-egfr monoclonal antibody gc1118 n1=barite | n2=en:anti-egfr monoclonal antibody gc1118 | rel=r_associated | relid=0 | w=31 barite -- r_associated #0: 31 / 0.075 -> en:anti-erbb2/anti-erbb3 bispecific monoclonal antibody mm-111 n1=barite | n2=en:anti-erbb2/anti-erbb3 bispecific monoclonal antibody mm-111 | rel=r_associated | relid=0 | w=31 barite -- r_associated #0: 31 / 0.075 -> en:anti-gitr agonistic monoclonal antibody incagn01876 n1=barite | n2=en:anti-gitr agonistic monoclonal antibody incagn01876 | rel=r_associated | relid=0 | w=31 barite -- r_associated #0: 31 / 0.075 -> en:anti-gitr monoclonal antibody mk-4166 n1=barite | n2=en:anti-gitr monoclonal antibody mk-4166 | rel=r_associated | relid=0 | w=31 barite -- r_associated #0: 31 / 0.075 -> en:anti-gpc3 monoclonal antibody gc33 n1=barite | n2=en:anti-gpc3 monoclonal antibody gc33 | rel=r_associated | relid=0 | w=31 barite -- r_associated #0: 31 / 0.075 -> en:anti-hif-1alpha lna antisense oligonucleotide ezn-2968 n1=barite | n2=en:anti-hif-1alpha lna antisense oligonucleotide ezn-2968 | rel=r_associated | relid=0 | w=31 barite -- r_associated #0: 31 / 0.075 -> en:anti-il-13 humanized monoclonal antibody tnx-650 n1=barite | n2=en:anti-il-13 humanized monoclonal antibody tnx-650 | rel=r_associated | relid=0 | w=31 barite -- r_associated #0: 31 / 0.075 -> en:anti-mesothelin car vector-transduced autologous t-lymphocytes n1=barite | n2=en:anti-mesothelin car vector-transduced autologous t-lymphocytes | rel=r_associated | relid=0 | w=31 barite -- r_associated #0: 31 / 0.075 -> en:anti-mesothelin/mmae antibody-drug conjugate dmot4039a n1=barite | n2=en:anti-mesothelin/mmae antibody-drug conjugate dmot4039a | rel=r_associated | relid=0 | w=31 barite -- r_associated #0: 31 / 0.075 -> en:anti-pd-l1/tgfbetarii fusion protein msb0011359c n1=barite | n2=en:anti-pd-l1/tgfbetarii fusion protein msb0011359c | rel=r_associated | relid=0 | w=31 barite -- r_associated #0: 31 / 0.075 -> en:anti-prolactin receptor antibody lfa102 n1=barite | n2=en:anti-prolactin receptor antibody lfa102 | rel=r_associated | relid=0 | w=31 barite -- r_associated #0: 31 / 0.075 -> en:anti-vista monoclonal antibody jnj 61610588 n1=barite | n2=en:anti-vista monoclonal antibody jnj 61610588 | rel=r_associated | relid=0 | w=31 barite -- r_associated #0: 31 / 0.075 -> en:antibody-drug conjugate abbv-838 n1=barite | n2=en:antibody-drug conjugate abbv-838 | rel=r_associated | relid=0 | w=31 barite -- r_associated #0: 31 / 0.075 -> en:antibody-drug conjugate bay79-4620 n1=barite | n2=en:antibody-drug conjugate bay79-4620 | rel=r_associated | relid=0 | w=31 barite -- r_associated #0: 31 / 0.075 -> en:antibody-drug conjugate pf-06664178 n1=barite | n2=en:antibody-drug conjugate pf-06664178 | rel=r_associated | relid=0 | w=31 barite -- r_associated #0: 31 / 0.075 -> en:ar antagonist bms-641988 n1=barite | n2=en:ar antagonist bms-641988 | rel=r_associated | relid=0 | w=31 barite -- r_associated #0: 31 / 0.075 -> en:arginine/omega-3 fatty acids/nucleotides oral supplement n1=barite | n2=en:arginine/omega-3 fatty acids/nucleotides oral supplement | rel=r_associated | relid=0 | w=31 barite -- r_associated #0: 31 / 0.075 -> en:argipressin n1=barite | n2=en:argipressin | rel=r_associated | relid=0 | w=31 barite -- r_associated #0: 31 / 0.075 -> en:artemisia vulgaris n1=barite | n2=en:artemisia vulgaris | rel=r_associated | relid=0 | w=31 barite -- r_associated #0: 31 / 0.075 -> en:ashwagandha root powder extract n1=barite | n2=en:ashwagandha root powder extract | rel=r_associated | relid=0 | w=31 barite -- r_associated #0: 31 / 0.075 -> en:aurora kinase inhibitor bi 811283 n1=barite | n2=en:aurora kinase inhibitor bi 811283 | rel=r_associated | relid=0 | w=31 barite -- r_associated #0: 31 / 0.075 -> en:autologous anti-cd123 car tcr/4-1bb-expressing t-lymphocytes n1=barite | n2=en:autologous anti-cd123 car tcr/4-1bb-expressing t-lymphocytes | rel=r_associated | relid=0 | w=31 barite -- r_associated #0: 31 / 0.075 -> en:autologous cd123car-cd28-cd3zeta-egfrt-expressing t lymphocytes n1=barite | n2=en:autologous cd123car-cd28-cd3zeta-egfrt-expressing t lymphocytes | rel=r_associated | relid=0 | w=31 barite -- r_associated #0: 31 / 0.075 -> en:autologous colorectal tumor antigen-pulsed dendritic cell vaccine n1=barite | n2=en:autologous colorectal tumor antigen-pulsed dendritic cell vaccine | rel=r_associated | relid=0 | w=31 barite -- r_associated #0: 31 / 0.075 -> en:autologous cytotoxic t-lymphocytes induced with muc1 gene-transfected dendritic cells n1=barite | n2=en:autologous cytotoxic t-lymphocytes induced with muc1 gene-transfected dendritic cells | rel=r_associated | relid=0 | w=31 barite -- r_associated #0: 31 / 0.075 -> en:autologous expanded mesenchymal stem cells oti-010 n1=barite | n2=en:autologous expanded mesenchymal stem cells oti-010 | rel=r_associated | relid=0 | w=31 barite -- r_associated #0: 31 / 0.075 -> en:autologous prostate cancer antigen-expressing dendritic cell vaccine bpx-101 n1=barite | n2=en:autologous prostate cancer antigen-expressing dendritic cell vaccine bpx-101 | rel=r_associated | relid=0 | w=31 barite -- r_associated #0: 31 / 0.075 -> en:azaserine n1=barite | n2=en:azaserine | rel=r_associated | relid=0 | w=31 barite -- r_associated #0: 31 / 0.075 -> en:bacitracin//neomycin/polymyxin/pramoxine n1=barite | n2=en:bacitracin//neomycin/polymyxin/pramoxine | rel=r_associated | relid=0 | w=31 barite -- r_associated #0: 31 / 0.075 -> en:banoxantrone n1=barite | n2=en:banoxantrone | rel=r_associated | relid=0 | w=31 barite -- r_associated #0: 31 / 0.075 -> en:baricitinib n1=barite | n2=en:baricitinib | rel=r_associated | relid=0 | w=31 barite -- r_associated #0: 31 / 0.075 -> en:barium so4 650mg tab n1=barite | n2=en:barium so4 650mg tab | rel=r_associated | relid=0 | w=31 barite -- r_associated #0: 31 / 0.075 -> en:barium so4 70% susp,rtl n1=barite | n2=en:barium so4 70% susp,rtl | rel=r_associated | relid=0 | w=31 barite -- r_associated #0: 31 / 0.075 -> en:barium solution n1=barite | n2=en:barium solution | rel=r_associated | relid=0 | w=31 barite -- r_associated #0: 31 / 0.075 -> en:batabulin sodium n1=barite | n2=en:batabulin sodium | rel=r_associated | relid=0 | w=31 barite -- r_associated #0: 31 / 0.075 -> en:bay 86-4367 n1=barite | n2=en:bay 86-4367 | rel=r_associated | relid=0 | w=31 barite -- r_associated #0: 31 / 0.075 -> en:becatecarin n1=barite | n2=en:becatecarin | rel=r_associated | relid=0 | w=31 barite -- r_associated #0: 31 / 0.075 -> en:belladonna/chlorpheniramine/phenylephrine/pyrilamine n1=barite | n2=en:belladonna/chlorpheniramine/phenylephrine/pyrilamine | rel=r_associated | relid=0 | w=31 barite -- r_associated #0: 31 / 0.075 -> en:bendroflumethiazide n1=barite | n2=en:bendroflumethiazide | rel=r_associated | relid=0 | w=31 barite -- r_associated #0: 31 / 0.075 -> en:bendroflumethiazide/rauwolfia serpentina n1=barite | n2=en:bendroflumethiazide/rauwolfia serpentina | rel=r_associated | relid=0 | w=31 barite -- r_associated #0: 31 / 0.075 -> en:benzalkonium chloride/benzocaine/zinc chloride n1=barite | n2=en:benzalkonium chloride/benzocaine/zinc chloride | rel=r_associated | relid=0 | w=31 barite -- r_associated #0: 31 / 0.075 -> en:benzoin/camphor/eucalyptus oil/thymol n1=barite | n2=en:benzoin/camphor/eucalyptus oil/thymol | rel=r_associated | relid=0 | w=31 barite -- r_associated #0: 31 / 0.075 -> en:benzophenone-3/lanolin/mineral oil/polyethylene glycol-4 n1=barite | n2=en:benzophenone-3/lanolin/mineral oil/polyethylene glycol-4 | rel=r_associated | relid=0 | w=31 barite -- r_associated #0: 31 / 0.075 -> en:benzylpenicilloyl polylysine n1=barite | n2=en:benzylpenicilloyl polylysine | rel=r_associated | relid=0 | w=31 barite -- r_associated #0: 31 / 0.075 -> en:bet inhibitor incb054329 n1=barite | n2=en:bet inhibitor incb054329 | rel=r_associated | relid=0 | w=31 barite -- r_associated #0: 31 / 0.075 -> en:betahistine n1=barite | n2=en:betahistine | rel=r_associated | relid=0 | w=31 barite -- r_associated #0: 31 / 0.075 -> en:betulinic acid n1=barite | n2=en:betulinic acid | rel=r_associated | relid=0 | w=31 barite -- r_associated #0: 31 / 0.075 -> en:bifidobacterium lactis/lactobacillus acidophilus/l. plantarum/l. salivarius probiotic supplement n1=barite | n2=en:bifidobacterium lactis/lactobacillus acidophilus/l. plantarum/l. salivarius probiotic supplement | rel=r_associated | relid=0 | w=31 barite -- r_associated #0: 31 / 0.075 -> en:bilirubin/blood/glucose/ketone/leukocytes/nitrite/ph/protein/spe n1=barite | n2=en:bilirubin/blood/glucose/ketone/leukocytes/nitrite/ph/protein/spe | rel=r_associated | relid=0 | w=31 barite -- r_associated #0: 31 / 0.075 -> en:bimagrumab n1=barite | n2=en:bimagrumab | rel=r_associated | relid=0 | w=31 barite -- r_associated #0: 31 / 0.075 -> en:bisacodyl/electrolytes/peg-3350 n1=barite | n2=en:bisacodyl/electrolytes/peg-3350 | rel=r_associated | relid=0 | w=31 barite -- r_associated #0: 31 / 0.075 -> en:bisacodyl/magnesium citrate/magnesium sulfate/senna/sucrose n1=barite | n2=en:bisacodyl/magnesium citrate/magnesium sulfate/senna/sucrose | rel=r_associated | relid=0 | w=31 barite -- r_associated #0: 31 / 0.075 -> en:bismuth bi213 monoclonal antibody m195 n1=barite | n2=en:bismuth bi213 monoclonal antibody m195 | rel=r_associated | relid=0 | w=31 barite -- r_associated #0: 31 / 0.075 -> en:bisoprolol, hydrochlorothiazide drug combination n1=barite | n2=en:bisoprolol, hydrochlorothiazide drug combination | rel=r_associated | relid=0 | w=31 barite -- r_associated #0: 31 / 0.075 -> en:black seed oil n1=barite | n2=en:black seed oil | rel=r_associated | relid=0 | w=31 barite -- r_associated #0: 31 / 0.075 -> en:bosentan n1=barite | n2=en:bosentan | rel=r_associated | relid=0 | w=31 barite -- r_associated #0: 31 / 0.075 -> en:braf inhibitor arq 736 n1=barite | n2=en:braf inhibitor arq 736 | rel=r_associated | relid=0 | w=31 barite -- r_associated #0: 31 / 0.075 -> en:brivudine n1=barite | n2=en:brivudine | rel=r_associated | relid=0 | w=31 barite -- r_associated #0: 31 / 0.075 -> en:brompheniramine / codeine / phenylephrine n1=barite | n2=en:brompheniramine / codeine / phenylephrine | rel=r_associated | relid=0 | w=31 barite -- r_associated #0: 31 / 0.075 -> en:brompheniramine/guaifenesin/phenylephrine/phenylpropanolamine n1=barite | n2=en:brompheniramine/guaifenesin/phenylephrine/phenylpropanolamine | rel=r_associated | relid=0 | w=31 barite -- r_associated #0: 31 / 0.075 -> en:butyric acid n1=barite | n2=en:butyric acid | rel=r_associated | relid=0 | w=31 barite -- r_associated #0: 31 / 0.075 -> en:c-met inhibitor jnj-38877605 n1=barite | n2=en:c-met inhibitor jnj-38877605 | rel=r_associated | relid=0 | w=31 barite -- r_associated #0: 31 / 0.075 -> en:caix inhibitor dtp348 n1=barite | n2=en:caix inhibitor dtp348 | rel=r_associated | relid=0 | w=31 barite -- r_associated #0: 31 / 0.075 -> en:capecitabine n1=barite | n2=en:capecitabine | rel=r_associated | relid=0 | w=31 barite -- r_associated #0: 31 / 0.075 -> en:carbidopa n1=barite | n2=en:carbidopa | rel=r_associated | relid=0 | w=31 barite -- r_associated #0: 31 / 0.075 -> en:carbohydrate supplement drink n1=barite | n2=en:carbohydrate supplement drink | rel=r_associated | relid=0 | w=31 barite -- r_associated #0: 31 / 0.075 -> en:carbon c 14 selumetinib n1=barite | n2=en:carbon c 14 selumetinib | rel=r_associated | relid=0 | w=31 barite -- r_associated #0: 31 / 0.075 -> en:cd19car-cd3zeta-expressing autologous t lymphocytes n1=barite | n2=en:cd19car-cd3zeta-expressing autologous t lymphocytes | rel=r_associated | relid=0 | w=31 barite -- r_associated #0: 31 / 0.075 -> en:cgp-6809 n1=barite | n2=en:cgp-6809 | rel=r_associated | relid=0 | w=31 barite -- r_associated #0: 31 / 0.075 -> en:chinese herbal medicine compound tpe-1 n1=barite | n2=en:chinese herbal medicine compound tpe-1 | rel=r_associated | relid=0 | w=31 barite -- r_associated #0: 31 / 0.075 -> en:chloroquinoxaline sulfonamide n1=barite | n2=en:chloroquinoxaline sulfonamide | rel=r_associated | relid=0 | w=31 barite -- r_associated #0: 31 / 0.075 -> en:chlorozotocin n1=barite | n2=en:chlorozotocin | rel=r_associated | relid=0 | w=31 barite -- r_associated #0: 31 / 0.075 -> en:chop regimen n1=barite | n2=en:chop regimen | rel=r_associated | relid=0 | w=31 barite -- r_associated #0: 31 / 0.075 -> en:cilengitide n1=barite | n2=en:cilengitide | rel=r_associated | relid=0 | w=31 barite -- r_associated #0: 31 / 0.075 -> en:cisatracurium besylate n1=barite | n2=en:cisatracurium besylate | rel=r_associated | relid=0 | w=31 barite -- r_associated #0: 31 / 0.075 -> en:cobiprostone n1=barite | n2=en:cobiprostone | rel=r_associated | relid=0 | w=31 barite -- r_associated #0: 31 / 0.075 -> en:conatumumab n1=barite | n2=en:conatumumab | rel=r_associated | relid=0 | w=31 barite -- r_associated #0: 31 / 0.075 -> en:contrast agent cs-1000 n1=barite | n2=en:contrast agent cs-1000 | rel=r_associated | relid=0 | w=31 barite -- r_associated #0: 31 / 0.075 -> en:copp regimen n1=barite | n2=en:copp regimen | rel=r_associated | relid=0 | w=31 barite -- r_associated #0: 31 / 0.075 -> en:coxsackievirus a21 n1=barite | n2=en:coxsackievirus a21 | rel=r_associated | relid=0 | w=31 barite -- r_associated #0: 31 / 0.075 -> en:cpg-28 oligodeoxynucleotide n1=barite | n2=en:cpg-28 oligodeoxynucleotide | rel=r_associated | relid=0 | w=31 barite -- r_associated #0: 31 / 0.075 -> en:cryoprotective agent n1=barite | n2=en:cryoprotective agent | rel=r_associated | relid=0 | w=31 barite -- r_associated #0: 31 / 0.075 -> en:cyclin b1 peptide-pulsed autologous dendritic cell vaccine n1=barite | n2=en:cyclin b1 peptide-pulsed autologous dendritic cell vaccine | rel=r_associated | relid=0 | w=31 barite -- r_associated #0: 31 / 0.075 -> en:defined green tea catechin extract n1=barite | n2=en:defined green tea catechin extract | rel=r_associated | relid=0 | w=31 barite -- r_associated #0: 31 / 0.075 -> en:denileukin diftitox n1=barite | n2=en:denileukin diftitox | rel=r_associated | relid=0 | w=31 barite -- r_associated #0: 31 / 0.075 -> en:designer drugs n1=barite | n2=en:designer drugs | rel=r_associated | relid=0 | w=31 barite -- r_associated #0: 31 / 0.075 -> en:desmopressin acetate n1=barite | n2=en:desmopressin acetate | rel=r_associated | relid=0 | w=31 barite -- r_associated #0: 31 / 0.075 -> en:dexpanthenol mouthwash n1=barite | n2=en:dexpanthenol mouthwash | rel=r_associated | relid=0 | w=31 barite -- r_associated #0: 31 / 0.075 -> en:dezaguanine n1=barite | n2=en:dezaguanine | rel=r_associated | relid=0 | w=31 barite -- r_associated #0: 31 / 0.075 -> en:diazoxide n1=barite | n2=en:diazoxide | rel=r_associated | relid=0 | w=31 barite -- r_associated #0: 31 / 0.075 -> en:diclofenac epolamine patch n1=barite | n2=en:diclofenac epolamine patch | rel=r_associated | relid=0 | w=31 barite -- r_associated #0: 31 / 0.075 -> en:didox n1=barite | n2=en:didox | rel=r_associated | relid=0 | w=31 barite -- r_associated #0: 31 / 0.075 -> en:diflunisal n1=barite | n2=en:diflunisal | rel=r_associated | relid=0 | w=31 barite -- r_associated #0: 31 / 0.075 -> en:digoxin n1=barite | n2=en:digoxin | rel=r_associated | relid=0 | w=31 barite -- r_associated #0: 31 / 0.075 -> en:diprotrizoic acid n1=barite | n2=en:diprotrizoic acid | rel=r_associated | relid=0 | w=31 barite -- r_associated #0: 31 / 0.075 -> en:dipyridamole n1=barite | n2=en:dipyridamole | rel=r_associated | relid=0 | w=31 barite -- r_associated #0: 31 / 0.075 -> en:docetaxel emulsion anx-514 n1=barite | n2=en:docetaxel emulsion anx-514 | rel=r_associated | relid=0 | w=31 barite -- r_associated #0: 31 / 0.075 -> en:donafenib n1=barite | n2=en:donafenib | rel=r_associated | relid=0 | w=31 barite -- r_associated #0: 31 / 0.075 -> en:dpt/typhoid/staphylococcus aureus/paratyphoid a/paratyphoid b vaccine n1=barite | n2=en:dpt/typhoid/staphylococcus aureus/paratyphoid a/paratyphoid b vaccine | rel=r_associated | relid=0 | w=31 barite -- r_associated #0: 31 / 0.075 -> en:dromostanolone propionate n1=barite | n2=en:dromostanolone propionate | rel=r_associated | relid=0 | w=31 barite -- r_associated #0: 31 / 0.075 -> en:fillcanal n1=barite | n2=en:fillcanal | rel=r_associated | relid=0 | w=31 barite -- r_associated #0: 31 / 0.075 -> en:fluorescein sodium injection n1=barite | n2=en:fluorescein sodium injection | rel=r_associated | relid=0 | w=31 barite -- r_associated #0: 31 / 0.075 -> en:hypoglycemic agents n1=barite | n2=en:hypoglycemic agents | rel=r_associated | relid=0 | w=31 barite -- r_associated #0: 31 / 0.075 -> en:medicine n1=barite | n2=en:medicine | rel=r_associated | relid=0 | w=31 barite -- r_associated #0: 31 / 0.075 -> en:solution n1=barite | n2=en:solution | rel=r_associated | relid=0 | w=31 barite -- r_associated #0: 31 / 0.075 -> en:valtrac n1=barite | n2=en:valtrac | rel=r_associated | relid=0 | w=31 barite -- r_associated #0: 31 / 0.075 -> en:vegfr2-targeted contrast agent br55 n1=barite | n2=en:vegfr2-targeted contrast agent br55 | rel=r_associated | relid=0 | w=31 barite -- r_associated #0: 31 / 0.075 -> en:yellow wax n1=barite | n2=en:yellow wax | rel=r_associated | relid=0 | w=31 barite -- r_associated #0: 30 / 0.072 -> en:2-fluoropropionyl-labeled pegylated dimeric rgd peptide n1=barite | n2=en:2-fluoropropionyl-labeled pegylated dimeric rgd peptide | rel=r_associated | relid=0 | w=30 barite -- r_associated #0: 30 / 0.072 -> en:6-azauridine n1=barite | n2=en:6-azauridine | rel=r_associated | relid=0 | w=30 barite -- r_associated #0: 30 / 0.072 -> en:absorbable gelatin sponge n1=barite | n2=en:absorbable gelatin sponge | rel=r_associated | relid=0 | w=30 barite -- r_associated #0: 30 / 0.072 -> en:acoustic imaging contrast agent n1=barite | n2=en:acoustic imaging contrast agent | rel=r_associated | relid=0 | w=30 barite -- r_associated #0: 30 / 0.072 -> en:ad5cmv-p53 gene n1=barite | n2=en:ad5cmv-p53 gene | rel=r_associated | relid=0 | w=30 barite -- r_associated #0: 30 / 0.072 -> en:adenovirus encoding rat her-2/neu n1=barite | n2=en:adenovirus encoding rat her-2/neu | rel=r_associated | relid=0 | w=30 barite -- r_associated #0: 30 / 0.072 -> en:adenovirus-encoding e.coli pnp n1=barite | n2=en:adenovirus-encoding e.coli pnp | rel=r_associated | relid=0 | w=30 barite -- r_associated #0: 30 / 0.072 -> en:aee788 n1=barite | n2=en:aee788 | rel=r_associated | relid=0 | w=30 barite -- r_associated #0: 30 / 0.072 -> en:aerosol sargramostim n1=barite | n2=en:aerosol sargramostim | rel=r_associated | relid=0 | w=30 barite -- r_associated #0: 30 / 0.072 -> en:afp464 n1=barite | n2=en:afp464 | rel=r_associated | relid=0 | w=30 barite -- r_associated #0: 30 / 0.072 -> en:aim2(-1)/ht001(-1)/taf1b(-1) frameshift peptide vaccine n1=barite | n2=en:aim2(-1)/ht001(-1)/taf1b(-1) frameshift peptide vaccine | rel=r_associated | relid=0 | w=30 barite -- r_associated #0: 30 / 0.072 -> en:allogeneic cd19-specific car-modified cd8 plus central memory-derived virus-specific t cells n1=barite | n2=en:allogeneic cd19-specific car-modified cd8 plus central memory-derived virus-specific t cells | rel=r_associated | relid=0 | w=30 barite -- r_associated #0: 30 / 0.072 -> en:allogeneic melanoma vaccine agi-101h n1=barite | n2=en:allogeneic melanoma vaccine agi-101h | rel=r_associated | relid=0 | w=30 barite -- r_associated #0: 30 / 0.072 -> en:allogeneic natural killer cell line mg4101 n1=barite | n2=en:allogeneic natural killer cell line mg4101 | rel=r_associated | relid=0 | w=30 barite -- r_associated #0: 30 / 0.072 -> en:alpelisib n1=barite | n2=en:alpelisib | rel=r_associated | relid=0 | w=30 barite -- r_associated #0: 30 / 0.072 -> en:alvac-cea vaccine n1=barite | n2=en:alvac-cea vaccine | rel=r_associated | relid=0 | w=30 barite -- r_associated #0: 30 / 0.072 -> en:aminocaproic acid n1=barite | n2=en:aminocaproic acid | rel=r_associated | relid=0 | w=30 barite -- r_associated #0: 30 / 0.072 -> en:aml mrna positive lysate loaded autologous dendritic cell vaccine n1=barite | n2=en:aml mrna positive lysate loaded autologous dendritic cell vaccine | rel=r_associated | relid=0 | w=30 barite -- r_associated #0: 30 / 0.072 -> en:amsacrine n1=barite | n2=en:amsacrine | rel=r_associated | relid=0 | w=30 barite -- r_associated #0: 30 / 0.072 -> en:anagrelide hydrochloride n1=barite | n2=en:anagrelide hydrochloride | rel=r_associated | relid=0 | w=30 barite -- r_associated #0: 30 / 0.072 -> en:androstane steroid he3235 n1=barite | n2=en:androstane steroid he3235 | rel=r_associated | relid=0 | w=30 barite -- r_associated #0: 30 / 0.072 -> en:anti-cd123 monoclonal antibody csl362 n1=barite | n2=en:anti-cd123 monoclonal antibody csl362 | rel=r_associated | relid=0 | w=30 barite -- r_associated #0: 30 / 0.072 -> en:anti-cd123/cd3 monoclonal antibody mgd006 n1=barite | n2=en:anti-cd123/cd3 monoclonal antibody mgd006 | rel=r_associated | relid=0 | w=30 barite -- r_associated #0: 30 / 0.072 -> en:anti-cd157 monoclonal antibody men1112 n1=barite | n2=en:anti-cd157 monoclonal antibody men1112 | rel=r_associated | relid=0 | w=30 barite -- r_associated #0: 30 / 0.072 -> en:anti-cd19 monoclonal antibody xmab5574 n1=barite | n2=en:anti-cd19 monoclonal antibody xmab5574 | rel=r_associated | relid=0 | w=30 barite -- r_associated #0: 30 / 0.072 -> en:anti-cd19-dm4 immunoconjugate sar3419 n1=barite | n2=en:anti-cd19-dm4 immunoconjugate sar3419 | rel=r_associated | relid=0 | w=30 barite -- r_associated #0: 30 / 0.072 -> en:anti-cd20 monoclonal antibody-interferon-alpha fusion protein ign002 n1=barite | n2=en:anti-cd20 monoclonal antibody-interferon-alpha fusion protein ign002 | rel=r_associated | relid=0 | w=30 barite -- r_associated #0: 30 / 0.072 -> en:anti-cd37 mmae antibody-drug conjugate ags67e n1=barite | n2=en:anti-cd37 mmae antibody-drug conjugate ags67e | rel=r_associated | relid=0 | w=30 barite -- r_associated #0: 30 / 0.072 -> en:anti-cd40 monoclonal antibody chi lob 7/4 n1=barite | n2=en:anti-cd40 monoclonal antibody chi lob 7/4 | rel=r_associated | relid=0 | w=30 barite -- r_associated #0: 30 / 0.072 -> en:anti-cd45 monoclonal antibody bc8 n1=barite | n2=en:anti-cd45 monoclonal antibody bc8 | rel=r_associated | relid=0 | w=30 barite -- r_associated #0: 30 / 0.072 -> en:anti-gpa33/cd3 monoclonal antibody mgd007 n1=barite | n2=en:anti-gpa33/cd3 monoclonal antibody mgd007 | rel=r_associated | relid=0 | w=30 barite -- r_associated #0: 30 / 0.072 -> en:anti-il-1 alpha monoclonal antibody ca-18c3 n1=barite | n2=en:anti-il-1 alpha monoclonal antibody ca-18c3 | rel=r_associated | relid=0 | w=30 barite -- r_associated #0: 30 / 0.072 -> en:anti-m-csf monoclonal antibody mcs110 n1=barite | n2=en:anti-m-csf monoclonal antibody mcs110 | rel=r_associated | relid=0 | w=30 barite -- r_associated #0: 30 / 0.072 -> en:anti-melanin monoclonal antibody pti-6d2 n1=barite | n2=en:anti-melanin monoclonal antibody pti-6d2 | rel=r_associated | relid=0 | w=30 barite -- r_associated #0: 30 / 0.072 -> en:anti-mesothelin icasp9m28z car-transduced autologous t lymphocytes n1=barite | n2=en:anti-mesothelin icasp9m28z car-transduced autologous t lymphocytes | rel=r_associated | relid=0 | w=30 barite -- r_associated #0: 30 / 0.072 -> en:anti-met monoclonal antibody mixture sym015 n1=barite | n2=en:anti-met monoclonal antibody mixture sym015 | rel=r_associated | relid=0 | w=30 barite -- r_associated #0: 30 / 0.072 -> en:anti-tim-3 monoclonal antibody mbg453 n1=barite | n2=en:anti-tim-3 monoclonal antibody mbg453 | rel=r_associated | relid=0 | w=30 barite -- r_associated #0: 30 / 0.072 -> en:antimetabolite ff-10502 n1=barite | n2=en:antimetabolite ff-10502 | rel=r_associated | relid=0 | w=30 barite -- r_associated #0: 30 / 0.072 -> en:antrodia cinnamomea supplement n1=barite | n2=en:antrodia cinnamomea supplement | rel=r_associated | relid=0 | w=30 barite -- r_associated #0: 30 / 0.072 -> en:apaziquone n1=barite | n2=en:apaziquone | rel=r_associated | relid=0 | w=30 barite -- r_associated #0: 30 / 0.072 -> en:apf530 n1=barite | n2=en:apf530 | rel=r_associated | relid=0 | w=30 barite -- r_associated #0: 30 / 0.072 -> en:apolizumab n1=barite | n2=en:apolizumab | rel=r_associated | relid=0 | w=30 barite -- r_associated #0: 30 / 0.072 -> en:archexin n1=barite | n2=en:archexin | rel=r_associated | relid=0 | w=30 barite -- r_associated #0: 30 / 0.072 -> en:ask1 inhibitor gs-4997 n1=barite | n2=en:ask1 inhibitor gs-4997 | rel=r_associated | relid=0 | w=30 barite -- r_associated #0: 30 / 0.072 -> en:asp9521 n1=barite | n2=en:asp9521 | rel=r_associated | relid=0 | w=30 barite -- r_associated #0: 30 / 0.072 -> en:asulacrine isethionate n1=barite | n2=en:asulacrine isethionate | rel=r_associated | relid=0 | w=30 barite -- r_associated #0: 30 / 0.072 -> en:atezolizumab n1=barite | n2=en:atezolizumab | rel=r_associated | relid=0 | w=30 barite -- r_associated #0: 30 / 0.072 -> en:atr-101 n1=barite | n2=en:atr-101 | rel=r_associated | relid=0 | w=30 barite -- r_associated #0: 30 / 0.072 -> en:aurora b/c kinase inhibitor gsk1070916a n1=barite | n2=en:aurora b/c kinase inhibitor gsk1070916a | rel=r_associated | relid=0 | w=30 barite -- r_associated #0: 30 / 0.072 -> en:aurora kinase inhibitor ttp607 n1=barite | n2=en:aurora kinase inhibitor ttp607 | rel=r_associated | relid=0 | w=30 barite -- r_associated #0: 30 / 0.072 -> en:aurora kinase/vegfr2 inhibitor cyc116 n1=barite | n2=en:aurora kinase/vegfr2 inhibitor cyc116 | rel=r_associated | relid=0 | w=30 barite -- r_associated #0: 30 / 0.072 -> en:autologous anti-cd19car-4-1bb-cd3zeta-egfrt-expressing cd4+/cd8+ t-lymphocytes jcar017 n1=barite | n2=en:autologous anti-cd19car-4-1bb-cd3zeta-egfrt-expressing cd4+/cd8+ t-lymphocytes jcar017 | rel=r_associated | relid=0 | w=30 barite -- r_associated #0: 30 / 0.072 -> en:autologous cd19car-cd28-cd3zeta-egfrt-expressing tcm-enriched t cells n1=barite | n2=en:autologous cd19car-cd28-cd3zeta-egfrt-expressing tcm-enriched t cells | rel=r_associated | relid=0 | w=30 barite -- r_associated #0: 30 / 0.072 -> en:autologous dendritic cell-based immunotherapeutic av0113 n1=barite | n2=en:autologous dendritic cell-based immunotherapeutic av0113 | rel=r_associated | relid=0 | w=30 barite -- r_associated #0: 30 / 0.072 -> en:autologous gm-csf-secreting breast cancer vaccine n1=barite | n2=en:autologous gm-csf-secreting breast cancer vaccine | rel=r_associated | relid=0 | w=30 barite -- r_associated #0: 30 / 0.072 -> en:autologous ovarian tumor cell lysate-pulsed dendritic cell vaccine n1=barite | n2=en:autologous ovarian tumor cell lysate-pulsed dendritic cell vaccine | rel=r_associated | relid=0 | w=30 barite -- r_associated #0: 30 / 0.072 -> en:autologous tarp peptide-pulsed dendritic cell vaccine n1=barite | n2=en:autologous tarp peptide-pulsed dendritic cell vaccine | rel=r_associated | relid=0 | w=30 barite -- r_associated #0: 30 / 0.072 -> en:avelumab n1=barite | n2=en:avelumab | rel=r_associated | relid=0 | w=30 barite -- r_associated #0: 30 / 0.072 -> en:aziridinylbenzoquinone rh1 n1=barite | n2=en:aziridinylbenzoquinone rh1 | rel=r_associated | relid=0 | w=30 barite -- r_associated #0: 30 / 0.072 -> en:b43-pap immunotoxin n1=barite | n2=en:b43-pap immunotoxin | rel=r_associated | relid=0 | w=30 barite -- r_associated #0: 30 / 0.072 -> en:baclofen/amitriptyline/ketamine gel n1=barite | n2=en:baclofen/amitriptyline/ketamine gel | rel=r_associated | relid=0 | w=30 barite -- r_associated #0: 30 / 0.072 -> en:barium so4 420gm pwdr,rtl n1=barite | n2=en:barium so4 420gm pwdr,rtl | rel=r_associated | relid=0 | w=30 barite -- r_associated #0: 30 / 0.072 -> en:barium so4 5% susp,rtl n1=barite | n2=en:barium so4 5% susp,rtl | rel=r_associated | relid=0 | w=30 barite -- r_associated #0: 30 / 0.072 -> en:barium so4 600gm pwdr,rtl n1=barite | n2=en:barium so4 600gm pwdr,rtl | rel=r_associated | relid=0 | w=30 barite -- r_associated #0: 30 / 0.072 -> en:bavituximab n1=barite | n2=en:bavituximab | rel=r_associated | relid=0 | w=30 barite -- r_associated #0: 30 / 0.072 -> en:bc-819 plasmid/polyethylenimine complex n1=barite | n2=en:bc-819 plasmid/polyethylenimine complex | rel=r_associated | relid=0 | w=30 barite -- r_associated #0: 30 / 0.072 -> en:bcg vaccine n1=barite | n2=en:bcg vaccine | rel=r_associated | relid=0 | w=30 barite -- r_associated #0: 30 / 0.072 -> en:bcr-abl peptide vaccine n1=barite | n2=en:bcr-abl peptide vaccine | rel=r_associated | relid=0 | w=30 barite -- r_associated #0: 30 / 0.072 -> en:benactyzine n1=barite | n2=en:benactyzine | rel=r_associated | relid=0 | w=30 barite -- r_associated #0: 30 / 0.072 -> en:bentiromide n1=barite | n2=en:bentiromide | rel=r_associated | relid=0 | w=30 barite -- r_associated #0: 30 / 0.072 -> en:bentonite magma/calamine/calcium hydroxide/glycerin/zinc oxide n1=barite | n2=en:bentonite magma/calamine/calcium hydroxide/glycerin/zinc oxide | rel=r_associated | relid=0 | w=30 barite -- r_associated #0: 30 / 0.072 -> en:benzalkonium chloride/benzocaine n1=barite | n2=en:benzalkonium chloride/benzocaine | rel=r_associated | relid=0 | w=30 barite -- r_associated #0: 30 / 0.072 -> en:benzocaine / clove oil n1=barite | n2=en:benzocaine / clove oil | rel=r_associated | relid=0 | w=30 barite -- r_associated #0: 30 / 0.072 -> en:benzocaine/chloroxylenol/isopropyl/resorcinol/salicylic acid n1=barite | n2=en:benzocaine/chloroxylenol/isopropyl/resorcinol/salicylic acid | rel=r_associated | relid=0 | w=30 barite -- r_associated #0: 30 / 0.072 -> en:benzocaine/phenol/vitamin e/zinc oxide n1=barite | n2=en:benzocaine/phenol/vitamin e/zinc oxide | rel=r_associated | relid=0 | w=30 barite -- r_associated #0: 30 / 0.072 -> en:berberine chloride n1=barite | n2=en:berberine chloride | rel=r_associated | relid=0 | w=30 barite -- r_associated #0: 30 / 0.072 -> en:berberis extract n1=barite | n2=en:berberis extract | rel=r_associated | relid=0 | w=30 barite -- r_associated #0: 30 / 0.072 -> en:bet inhibitor gsk2820151 n1=barite | n2=en:bet inhibitor gsk2820151 | rel=r_associated | relid=0 | w=30 barite -- r_associated #0: 30 / 0.072 -> en:bet inhibitor ten-010 n1=barite | n2=en:bet inhibitor ten-010 | rel=r_associated | relid=0 | w=30 barite -- r_associated #0: 30 / 0.072 -> en:betazole n1=barite | n2=en:betazole | rel=r_associated | relid=0 | w=30 barite -- r_associated #0: 30 / 0.072 -> en:betony n1=barite | n2=en:betony | rel=r_associated | relid=0 | w=30 barite -- r_associated #0: 30 / 0.072 -> en:bile salts/dehydrocholic acid/pancreatin/pepsin n1=barite | n2=en:bile salts/dehydrocholic acid/pancreatin/pepsin | rel=r_associated | relid=0 | w=30 barite -- r_associated #0: 30 / 0.072 -> en:bilirubin/blood/glucose/ketone/leukocytes/ph/protein test n1=barite | n2=en:bilirubin/blood/glucose/ketone/leukocytes/ph/protein test | rel=r_associated | relid=0 | w=30 barite -- r_associated #0: 30 / 0.072 -> en:bismuth subnitrate / calcium carbonate / magnesium carbonate n1=barite | n2=en:bismuth subnitrate / calcium carbonate / magnesium carbonate | rel=r_associated | relid=0 | w=30 barite -- r_associated #0: 30 / 0.072 -> en:bismuth subsalicylate n1=barite | n2=en:bismuth subsalicylate | rel=r_associated | relid=0 | w=30 barite -- r_associated #0: 30 / 0.072 -> en:bismuth subsalicylate/codeine/kaolin/pectin n1=barite | n2=en:bismuth subsalicylate/codeine/kaolin/pectin | rel=r_associated | relid=0 | w=30 barite -- r_associated #0: 30 / 0.072 -> en:bismuth/metronidazole/tetracycline n1=barite | n2=en:bismuth/metronidazole/tetracycline | rel=r_associated | relid=0 | w=30 barite -- r_associated #0: 30 / 0.072 -> en:bispecific antibody 2b1 n1=barite | n2=en:bispecific antibody 2b1 | rel=r_associated | relid=0 | w=30 barite -- r_associated #0: 30 / 0.072 -> en:black currant preparation n1=barite | n2=en:black currant preparation | rel=r_associated | relid=0 | w=30 barite -- r_associated #0: 30 / 0.072 -> en:black tea extract n1=barite | n2=en:black tea extract | rel=r_associated | relid=0 | w=30 barite -- r_associated #0: 30 / 0.072 -> en:bone meal n1=barite | n2=en:bone meal | rel=r_associated | relid=0 | w=30 barite -- r_associated #0: 30 / 0.072 -> en:borate buffer n1=barite | n2=en:borate buffer | rel=r_associated | relid=0 | w=30 barite -- r_associated #0: 30 / 0.072 -> en:boric acid/edta/hydroxyethyl cellulose n1=barite | n2=en:boric acid/edta/hydroxyethyl cellulose | rel=r_associated | relid=0 | w=30 barite -- r_associated #0: 30 / 0.072 -> en:boric acid/sodium chloride n1=barite | n2=en:boric acid/sodium chloride | rel=r_associated | relid=0 | w=30 barite -- r_associated #0: 30 / 0.072 -> en:brain tumor initiating cell vaccine n1=barite | n2=en:brain tumor initiating cell vaccine | rel=r_associated | relid=0 | w=30 barite -- r_associated #0: 30 / 0.072 -> en:briciclib sodium n1=barite | n2=en:briciclib sodium | rel=r_associated | relid=0 | w=30 barite -- r_associated #0: 30 / 0.072 -> en:broccoli sprout/broccoli seed extract supplement n1=barite | n2=en:broccoli sprout/broccoli seed extract supplement | rel=r_associated | relid=0 | w=30 barite -- r_associated #0: 30 / 0.072 -> en:bromodomain inhibitor abbv-075 n1=barite | n2=en:bromodomain inhibitor abbv-075 | rel=r_associated | relid=0 | w=30 barite -- r_associated #0: 30 / 0.072 -> en:bupivacaine+glucose n1=barite | n2=en:bupivacaine+glucose | rel=r_associated | relid=0 | w=30 barite -- r_associated #0: 30 / 0.072 -> en:butacaine n1=barite | n2=en:butacaine | rel=r_associated | relid=0 | w=30 barite -- r_associated #0: 30 / 0.072 -> en:calcium gluconate n1=barite | n2=en:calcium gluconate | rel=r_associated | relid=0 | w=30 barite -- r_associated #0: 30 / 0.072 -> en:calcium-41 chloride aqueous solution n1=barite | n2=en:calcium-41 chloride aqueous solution | rel=r_associated | relid=0 | w=30 barite -- r_associated #0: 30 / 0.072 -> en:camptothecin-20(s)-o-propionate hydrate n1=barite | n2=en:camptothecin-20(s)-o-propionate hydrate | rel=r_associated | relid=0 | w=30 barite -- r_associated #0: 30 / 0.072 -> en:canarypox-hil-12 melanoma vaccine n1=barite | n2=en:canarypox-hil-12 melanoma vaccine | rel=r_associated | relid=0 | w=30 barite -- r_associated #0: 30 / 0.072 -> en:cancer peptide vaccine s-588410 n1=barite | n2=en:cancer peptide vaccine s-588410 | rel=r_associated | relid=0 | w=30 barite -- r_associated #0: 30 / 0.072 -> en:cannabidiol n1=barite | n2=en:cannabidiol | rel=r_associated | relid=0 | w=30 barite -- r_associated #0: 30 / 0.072 -> en:cannabis extract oil sr capsule n1=barite | n2=en:cannabis extract oil sr capsule | rel=r_associated | relid=0 | w=30 barite -- r_associated #0: 30 / 0.072 -> en:carbon c 11 choline n1=barite | n2=en:carbon c 11 choline | rel=r_associated | relid=0 | w=30 barite -- r_associated #0: 30 / 0.072 -> en:carboxylesterase-expressing allogeneic neural stem cells n1=barite | n2=en:carboxylesterase-expressing allogeneic neural stem cells | rel=r_associated | relid=0 | w=30 barite -- r_associated #0: 30 / 0.072 -> en:carrot/jilin ginseng/licorice root/tangerine peel/soy beverage n1=barite | n2=en:carrot/jilin ginseng/licorice root/tangerine peel/soy beverage | rel=r_associated | relid=0 | w=30 barite -- r_associated #0: 30 / 0.072 -> en:carvedilol phosphate extended-release capsule n1=barite | n2=en:carvedilol phosphate extended-release capsule | rel=r_associated | relid=0 | w=30 barite -- r_associated #0: 30 / 0.072 -> en:cathepsin-activatable cy5 fluorescent imaging probe lum015 n1=barite | n2=en:cathepsin-activatable cy5 fluorescent imaging probe lum015 | rel=r_associated | relid=0 | w=30 barite -- r_associated #0: 30 / 0.072 -> en:cationic liposome-encapsulated paclitaxel n1=barite | n2=en:cationic liposome-encapsulated paclitaxel | rel=r_associated | relid=0 | w=30 barite -- r_associated #0: 30 / 0.072 -> en:cb10-277 n1=barite | n2=en:cb10-277 | rel=r_associated | relid=0 | w=30 barite -- r_associated #0: 30 / 0.072 -> en:cd24 extracellular domain-igg1 fc domain recombinant fusion protein cd24fc n1=barite | n2=en:cd24 extracellular domain-igg1 fc domain recombinant fusion protein cd24fc | rel=r_associated | relid=0 | w=30 barite -- r_associated #0: 30 / 0.072 -> en:cd4+ cd25+ regulatory t cells n1=barite | n2=en:cd4+ cd25+ regulatory t cells | rel=r_associated | relid=0 | w=30 barite -- r_associated #0: 30 / 0.072 -> en:cdk inhibitor sns-032 n1=barite | n2=en:cdk inhibitor sns-032 | rel=r_associated | relid=0 | w=30 barite -- r_associated #0: 30 / 0.072 -> en:cdk4/6 inhibitor g1t28 n1=barite | n2=en:cdk4/6 inhibitor g1t28 | rel=r_associated | relid=0 | w=30 barite -- r_associated #0: 30 / 0.072 -> en:cell cycle checkpoint/dna repair antagonist ic83 n1=barite | n2=en:cell cycle checkpoint/dna repair antagonist ic83 | rel=r_associated | relid=0 | w=30 barite -- r_associated #0: 30 / 0.072 -> en:cenp-e inhibitor gsk-923295 n1=barite | n2=en:cenp-e inhibitor gsk-923295 | rel=r_associated | relid=0 | w=30 barite -- r_associated #0: 30 / 0.072 -> en:cetuximab-irdye 800cw n1=barite | n2=en:cetuximab-irdye 800cw | rel=r_associated | relid=0 | w=30 barite -- r_associated #0: 30 / 0.072 -> en:changchun marina n1=barite | n2=en:changchun marina | rel=r_associated | relid=0 | w=30 barite -- r_associated #0: 30 / 0.072 -> en:chk1 inhibitor gdc-0575 n1=barite | n2=en:chk1 inhibitor gdc-0575 | rel=r_associated | relid=0 | w=30 barite -- r_associated #0: 30 / 0.072 -> en:cidan herbal capsule n1=barite | n2=en:cidan herbal capsule | rel=r_associated | relid=0 | w=30 barite -- r_associated #0: 30 / 0.072 -> en:clino-san vaginal lubricant n1=barite | n2=en:clino-san vaginal lubricant | rel=r_associated | relid=0 | w=30 barite -- r_associated #0: 30 / 0.072 -> en:clobetasol propionate n1=barite | n2=en:clobetasol propionate | rel=r_associated | relid=0 | w=30 barite -- r_associated #0: 30 / 0.072 -> en:cmv n495 peptide n1=barite | n2=en:cmv n495 peptide | rel=r_associated | relid=0 | w=30 barite -- r_associated #0: 30 / 0.072 -> en:colesevelam hydrochloride n1=barite | n2=en:colesevelam hydrochloride | rel=r_associated | relid=0 | w=30 barite -- r_associated #0: 30 / 0.072 -> en:compound kushen injection n1=barite | n2=en:compound kushen injection | rel=r_associated | relid=0 | w=30 barite -- r_associated #0: 30 / 0.072 -> en:concentrated fortified collagen protein hydrolysate liquid supplement n1=barite | n2=en:concentrated fortified collagen protein hydrolysate liquid supplement | rel=r_associated | relid=0 | w=30 barite -- r_associated #0: 30 / 0.072 -> en:copp-abv regimen n1=barite | n2=en:copp-abv regimen | rel=r_associated | relid=0 | w=30 barite -- r_associated #0: 30 / 0.072 -> en:copper cu 64 tp3805 n1=barite | n2=en:copper cu 64 tp3805 | rel=r_associated | relid=0 | w=30 barite -- r_associated #0: 30 / 0.072 -> en:copper cu 64-dota-trastuzumab n1=barite | n2=en:copper cu 64-dota-trastuzumab | rel=r_associated | relid=0 | w=30 barite -- r_associated #0: 30 / 0.072 -> en:crenolanib besylate n1=barite | n2=en:crenolanib besylate | rel=r_associated | relid=0 | w=30 barite -- r_associated #0: 30 / 0.072 -> en:crisnatol mesylate n1=barite | n2=en:crisnatol mesylate | rel=r_associated | relid=0 | w=30 barite -- r_associated #0: 30 / 0.072 -> en:ctp-37-dt vaccine n1=barite | n2=en:ctp-37-dt vaccine | rel=r_associated | relid=0 | w=30 barite -- r_associated #0: 30 / 0.072 -> en:curcumin-based gel n1=barite | n2=en:curcumin-based gel | rel=r_associated | relid=0 | w=30 barite -- r_associated #0: 30 / 0.072 -> en:cyanobacteria n1=barite | n2=en:cyanobacteria | rel=r_associated | relid=0 | w=30 barite -- r_associated #0: 30 / 0.072 -> en:cyclopentenyl cytosine n1=barite | n2=en:cyclopentenyl cytosine | rel=r_associated | relid=0 | w=30 barite -- r_associated #0: 30 / 0.072 -> en:daptomycin n1=barite | n2=en:daptomycin | rel=r_associated | relid=0 | w=30 barite -- r_associated #0: 30 / 0.072 -> en:dasabuvir n1=barite | n2=en:dasabuvir | rel=r_associated | relid=0 | w=30 barite -- r_associated #0: 30 / 0.072 -> en:deferasirox n1=barite | n2=en:deferasirox | rel=r_associated | relid=0 | w=30 barite -- r_associated #0: 30 / 0.072 -> en:dehydroemetine n1=barite | n2=en:dehydroemetine | rel=r_associated | relid=0 | w=30 barite -- r_associated #0: 30 / 0.072 -> en:demeclocycline hydrochloride n1=barite | n2=en:demeclocycline hydrochloride | rel=r_associated | relid=0 | w=30 barite -- r_associated #0: 30 / 0.072 -> en:deoxycytidine analogue tas-109 n1=barite | n2=en:deoxycytidine analogue tas-109 | rel=r_associated | relid=0 | w=30 barite -- r_associated #0: 30 / 0.072 -> en:dimethiodal sodium n1=barite | n2=en:dimethiodal sodium | rel=r_associated | relid=0 | w=30 barite -- r_associated #0: 30 / 0.072 -> en:diphtheria toxoid/tetanus toxoid/acellular pertussis vaccine adsorbed n1=barite | n2=en:diphtheria toxoid/tetanus toxoid/acellular pertussis vaccine adsorbed | rel=r_associated | relid=0 | w=30 barite -- r_associated #0: 30 / 0.072 -> en:dn-101 n1=barite | n2=en:dn-101 | rel=r_associated | relid=0 | w=30 barite -- r_associated #0: 30 / 0.072 -> en:dna plasmid encoding interleukin-12 ino-9012 n1=barite | n2=en:dna plasmid encoding interleukin-12 ino-9012 | rel=r_associated | relid=0 | w=30 barite -- r_associated #0: 30 / 0.072 -> en:dovitinib lactate n1=barite | n2=en:dovitinib lactate | rel=r_associated | relid=0 | w=30 barite -- r_associated #0: 30 / 0.072 -> en:doxycycline hyclate n1=barite | n2=en:doxycycline hyclate | rel=r_associated | relid=0 | w=30 barite -- r_associated #0: 30 / 0.072 -> en:duborimycin n1=barite | n2=en:duborimycin | rel=r_associated | relid=0 | w=30 barite -- r_associated #0: 30 / 0.072 -> en:duligotuzumab n1=barite | n2=en:duligotuzumab | rel=r_associated | relid=0 | w=30 barite -- r_associated #0: 30 / 0.072 -> en:ferric subsulfate n1=barite | n2=en:ferric subsulfate | rel=r_associated | relid=0 | w=30 barite -- r_associated #0: 30 / 0.072 -> en:generic drug n1=barite | n2=en:generic drug | rel=r_associated | relid=0 | w=30 barite -- r_associated #0: 30 / 0.072 -> en:mertiatide n1=barite | n2=en:mertiatide | rel=r_associated | relid=0 | w=30 barite -- r_associated #0: 30 / 0.072 -> en:metrizoate meglumine n1=barite | n2=en:metrizoate meglumine | rel=r_associated | relid=0 | w=30 barite -- r_associated #0: 30 / 0.072 -> en:metrizoic acid n1=barite | n2=en:metrizoic acid | rel=r_associated | relid=0 | w=30 barite -- r_associated #0: 30 / 0.072 -> en:optical imaging contrast agent n1=barite | n2=en:optical imaging contrast agent | rel=r_associated | relid=0 | w=30 barite -- r_associated #0: 30 / 0.072 -> en:oral medication n1=barite | n2=en:oral medication | rel=r_associated | relid=0 | w=30 barite -- r_associated #0: 30 / 0.072 -> en:over the counter product n1=barite | n2=en:over the counter product | rel=r_associated | relid=0 | w=30 barite -- r_associated #0: 30 / 0.072 -> en:pesticide n1=barite | n2=en:pesticide | rel=r_associated | relid=0 | w=30 barite -- r_associated #0: 30 / 0.072 -> en:prescription drugs n1=barite | n2=en:prescription drugs | rel=r_associated | relid=0 | w=30 barite -- r_associated #0: 30 / 0.072 -> en:stabilized sulphur hexafluoride microbubble-based contrast agent n1=barite | n2=en:stabilized sulphur hexafluoride microbubble-based contrast agent | rel=r_associated | relid=0 | w=30 barite -- r_associated #0: 30 / 0.072 -> en:thiosulfates n1=barite | n2=en:thiosulfates | rel=r_associated | relid=0 | w=30 barite -- r_associated #0: 30 / 0.072 -> en:zoology n1=barite | n2=en:zoology | rel=r_associated | relid=0 | w=30 barite -- r_associated #0: 30 / 0.072 -> sulfate de baryum n1=barite | n2=sulfate de baryum | rel=r_associated | relid=0 | w=30 barite -- r_associated #0: 29 / 0.07 -> en:[18f]l-fac n1=barite | n2=en:[18f]l-fac | rel=r_associated | relid=0 | w=29 barite -- r_associated #0: 29 / 0.07 -> en:2-methoxyestradiol nanocrystal colloidal dispersion n1=barite | n2=en:2-methoxyestradiol nanocrystal colloidal dispersion | rel=r_associated | relid=0 | w=29 barite -- r_associated #0: 29 / 0.07 -> en:4-1bb agonist monoclonal antibody pf-05082566 n1=barite | n2=en:4-1bb agonist monoclonal antibody pf-05082566 | rel=r_associated | relid=0 | w=29 barite -- r_associated #0: 29 / 0.07 -> en:4-peptide melanoma vaccine n1=barite | n2=en:4-peptide melanoma vaccine | rel=r_associated | relid=0 | w=29 barite -- r_associated #0: 29 / 0.07 -> en:4'-iodo-4'-deoxydoxorubicin n1=barite | n2=en:4'-iodo-4'-deoxydoxorubicin | rel=r_associated | relid=0 | w=29 barite -- r_associated #0: 29 / 0.07 -> en:5-[18f]fluorouracil n1=barite | n2=en:5-[18f]fluorouracil | rel=r_associated | relid=0 | w=29 barite -- r_associated #0: 29 / 0.07 -> en:7-cyanoquinocarcinol n1=barite | n2=en:7-cyanoquinocarcinol | rel=r_associated | relid=0 | w=29 barite -- r_associated #0: 29 / 0.07 -> en:abacavir sulfate n1=barite | n2=en:abacavir sulfate | rel=r_associated | relid=0 | w=29 barite -- r_associated #0: 29 / 0.07 -> en:abt-510 n1=barite | n2=en:abt-510 | rel=r_associated | relid=0 | w=29 barite -- r_associated #0: 29 / 0.07 -> en:acetyl-l-carnitine hydrochloride n1=barite | n2=en:acetyl-l-carnitine hydrochloride | rel=r_associated | relid=0 | w=29 barite -- r_associated #0: 29 / 0.07 -> en:adenovector-transduced ap1903-inducible myd88/cd40-expressing autologous psma-specific prostate cancer vaccine bpx-201 n1=barite | n2=en:adenovector-transduced ap1903-inducible myd88/cd40-expressing autologous psma-specific prostate cancer vaccine bpx-201 | rel=r_associated | relid=0 | w=29 barite -- r_associated #0: 29 / 0.07 -> en:adenovirus rsv-tk n1=barite | n2=en:adenovirus rsv-tk | rel=r_associated | relid=0 | w=29 barite -- r_associated #0: 29 / 0.07 -> en:adh-1 n1=barite | n2=en:adh-1 | rel=r_associated | relid=0 | w=29 barite -- r_associated #0: 29 / 0.07 -> en:afuresertib n1=barite | n2=en:afuresertib | rel=r_associated | relid=0 | w=29 barite -- r_associated #0: 29 / 0.07 -> en:agent affecting cardiovascular system n1=barite | n2=en:agent affecting cardiovascular system | rel=r_associated | relid=0 | w=29 barite -- r_associated #0: 29 / 0.07 -> en:aglatimagene besadenovec n1=barite | n2=en:aglatimagene besadenovec | rel=r_associated | relid=0 | w=29 barite -- r_associated #0: 29 / 0.07 -> en:agonistic anti-ox40 monoclonal antibody medi6383 n1=barite | n2=en:agonistic anti-ox40 monoclonal antibody medi6383 | rel=r_associated | relid=0 | w=29 barite -- r_associated #0: 29 / 0.07 -> en:akt inhibitor gsk2141795 n1=barite | n2=en:akt inhibitor gsk2141795 | rel=r_associated | relid=0 | w=29 barite -- r_associated #0: 29 / 0.07 -> en:akt inhibitor mk2206 n1=barite | n2=en:akt inhibitor mk2206 | rel=r_associated | relid=0 | w=29 barite -- r_associated #0: 29 / 0.07 -> en:alemtuzumab n1=barite | n2=en:alemtuzumab | rel=r_associated | relid=0 | w=29 barite -- r_associated #0: 29 / 0.07 -> en:alitretinoin n1=barite | n2=en:alitretinoin | rel=r_associated | relid=0 | w=29 barite -- r_associated #0: 29 / 0.07 -> en:alpha-1-proteinase inhibitor human n1=barite | n2=en:alpha-1-proteinase inhibitor human | rel=r_associated | relid=0 | w=29 barite -- r_associated #0: 29 / 0.07 -> en:ammonium sulfate n1=barite | n2=en:ammonium sulfate | rel=r_associated | relid=0 | w=29 barite -- r_associated #0: 29 / 0.07 -> en:anastrozole n1=barite | n2=en:anastrozole | rel=r_associated | relid=0 | w=29 barite -- r_associated #0: 29 / 0.07 -> en:angelica sinensis root extract n1=barite | n2=en:angelica sinensis root extract | rel=r_associated | relid=0 | w=29 barite -- r_associated #0: 29 / 0.07 -> en:anti-allergic agents n1=barite | n2=en:anti-allergic agents | rel=r_associated | relid=0 | w=29 barite -- r_associated #0: 29 / 0.07 -> en:anti-c-fms monoclonal antibody amg 820 n1=barite | n2=en:anti-c-fms monoclonal antibody amg 820 | rel=r_associated | relid=0 | w=29 barite -- r_associated #0: 29 / 0.07 -> en:anti-cd123 x anti-cd3 bispecific antibody xmab1404 n1=barite | n2=en:anti-cd123 x anti-cd3 bispecific antibody xmab1404 | rel=r_associated | relid=0 | w=29 barite -- r_associated #0: 29 / 0.07 -> en:anti-cd20-engineered toxin body mt-3724 n1=barite | n2=en:anti-cd20-engineered toxin body mt-3724 | rel=r_associated | relid=0 | w=29 barite -- r_associated #0: 29 / 0.07 -> en:anti-cd22-car m971-bbz lentiviral vector-transduced autologous t lymphocytes n1=barite | n2=en:anti-cd22-car m971-bbz lentiviral vector-transduced autologous t lymphocytes | rel=r_associated | relid=0 | w=29 barite -- r_associated #0: 29 / 0.07 -> en:anti-ceacam5 antibody-drug conjugate sar408701 n1=barite | n2=en:anti-ceacam5 antibody-drug conjugate sar408701 | rel=r_associated | relid=0 | w=29 barite -- r_associated #0: 29 / 0.07 -> en:anti-csf1r monoclonal antibody fpa008 n1=barite | n2=en:anti-csf1r monoclonal antibody fpa008 | rel=r_associated | relid=0 | w=29 barite -- r_associated #0: 29 / 0.07 -> en:anti-ctla-4 monoclonal antibody agen1884 n1=barite | n2=en:anti-ctla-4 monoclonal antibody agen1884 | rel=r_associated | relid=0 | w=29 barite -- r_associated #0: 29 / 0.07 -> en:anti-dkk1 monoclonal antibody bhq880 n1=barite | n2=en:anti-dkk1 monoclonal antibody bhq880 | rel=r_associated | relid=0 | w=29 barite -- r_associated #0: 29 / 0.07 -> en:anti-egfr monoclonal antibody mixture mm-151 n1=barite | n2=en:anti-egfr monoclonal antibody mixture mm-151 | rel=r_associated | relid=0 | w=29 barite -- r_associated #0: 29 / 0.07 -> en:anti-enpp3 antibody-drug conjugate ags-16c3f n1=barite | n2=en:anti-enpp3 antibody-drug conjugate ags-16c3f | rel=r_associated | relid=0 | w=29 barite -- r_associated #0: 29 / 0.07 -> en:anti-epha3 monoclonal antibody kb004 n1=barite | n2=en:anti-epha3 monoclonal antibody kb004 | rel=r_associated | relid=0 | w=29 barite -- r_associated #0: 29 / 0.07 -> en:anti-erbb3 monoclonal antibody regn1400 n1=barite | n2=en:anti-erbb3 monoclonal antibody regn1400 | rel=r_associated | relid=0 | w=29 barite -- r_associated #0: 29 / 0.07 -> en:anti-ganglioside gm2 monoclonal antibody biw-8962 n1=barite | n2=en:anti-ganglioside gm2 monoclonal antibody biw-8962 | rel=r_associated | relid=0 | w=29 barite -- r_associated #0: 29 / 0.07 -> en:anti-hb-egf monoclonal antibody khk2866 n1=barite | n2=en:anti-hb-egf monoclonal antibody khk2866 | rel=r_associated | relid=0 | w=29 barite -- r_associated #0: 29 / 0.07 -> en:anti-her-2-car retroviral vector-transduced autologous peripheral blood lymphocytes n1=barite | n2=en:anti-her-2-car retroviral vector-transduced autologous peripheral blood lymphocytes | rel=r_associated | relid=0 | w=29 barite -- r_associated #0: 29 / 0.07 -> en:anti-her3 monoclonal antibody ljm716 n1=barite | n2=en:anti-her3 monoclonal antibody ljm716 | rel=r_associated | relid=0 | w=29 barite -- r_associated #0: 29 / 0.07 -> en:anti-human gitr monoclonal antibody trx518 n1=barite | n2=en:anti-human gitr monoclonal antibody trx518 | rel=r_associated | relid=0 | w=29 barite -- r_associated #0: 29 / 0.07 -> en:anti-interleukin 6 monoclonal antibody ald518 n1=barite | n2=en:anti-interleukin 6 monoclonal antibody ald518 | rel=r_associated | relid=0 | w=29 barite -- r_associated #0: 29 / 0.07 -> en:anti-lamp1 antibody-drug conjugate sar428926 n1=barite | n2=en:anti-lamp1 antibody-drug conjugate sar428926 | rel=r_associated | relid=0 | w=29 barite -- r_associated #0: 29 / 0.07 -> en:anti-myeloma monoclonal antibody-dm4 immunoconjugate bt-062 n1=barite | n2=en:anti-myeloma monoclonal antibody-dm4 immunoconjugate bt-062 | rel=r_associated | relid=0 | w=29 barite -- r_associated #0: 29 / 0.07 -> en:anti-ny-eso-1 immunotherapeutic gsk-2241658a n1=barite | n2=en:anti-ny-eso-1 immunotherapeutic gsk-2241658a | rel=r_associated | relid=0 | w=29 barite -- r_associated #0: 29 / 0.07 -> en:anti-ox40 monoclonal antibody gsk3174998 n1=barite | n2=en:anti-ox40 monoclonal antibody gsk3174998 | rel=r_associated | relid=0 | w=29 barite -- r_associated #0: 29 / 0.07 -> en:anti-pgf monoclonal antibody ro5323441 n1=barite | n2=en:anti-pgf monoclonal antibody ro5323441 | rel=r_associated | relid=0 | w=29 barite -- r_associated #0: 29 / 0.07 -> en:anti-plgf monoclonal antibody tb-403 n1=barite | n2=en:anti-plgf monoclonal antibody tb-403 | rel=r_associated | relid=0 | w=29 barite -- r_associated #0: 29 / 0.07 -> en:anti-prame immunotherapeutic gsk2302032a n1=barite | n2=en:anti-prame immunotherapeutic gsk2302032a | rel=r_associated | relid=0 | w=29 barite -- r_associated #0: 29 / 0.07 -> en:anti-psma monoclonal antibody-mmae conjugate n1=barite | n2=en:anti-psma monoclonal antibody-mmae conjugate | rel=r_associated | relid=0 | w=29 barite -- r_associated #0: 29 / 0.07 -> en:anti-sema4d monoclonal antibody vx15/2503 n1=barite | n2=en:anti-sema4d monoclonal antibody vx15/2503 | rel=r_associated | relid=0 | w=29 barite -- r_associated #0: 29 / 0.07 -> en:anti-ta-muc1 monoclonal antibody pankomab n1=barite | n2=en:anti-ta-muc1 monoclonal antibody pankomab | rel=r_associated | relid=0 | w=29 barite -- r_associated #0: 29 / 0.07 -> en:anti-vegfc monoclonal antibody vgx-100 n1=barite | n2=en:anti-vegfc monoclonal antibody vgx-100 | rel=r_associated | relid=0 | w=29 barite -- r_associated #0: 29 / 0.07 -> en:anticachexia agent mt-102 n1=barite | n2=en:anticachexia agent mt-102 | rel=r_associated | relid=0 | w=29 barite -- r_associated #0: 29 / 0.07 -> en:antigen-targeted personalized breast cancer vaccine n1=barite | n2=en:antigen-targeted personalized breast cancer vaccine | rel=r_associated | relid=0 | w=29 barite -- r_associated #0: 29 / 0.07 -> en:apoptotic autologous tumor cells-pulsed alpha-type-1 polarized dendritic cells n1=barite | n2=en:apoptotic autologous tumor cells-pulsed alpha-type-1 polarized dendritic cells | rel=r_associated | relid=0 | w=29 barite -- r_associated #0: 29 / 0.07 -> en:arsenic trioxide n1=barite | n2=en:arsenic trioxide | rel=r_associated | relid=0 | w=29 barite -- r_associated #0: 29 / 0.07 -> en:atropine sulfate n1=barite | n2=en:atropine sulfate | rel=r_associated | relid=0 | w=29 barite -- r_associated #0: 29 / 0.07 -> en:attenuated corynebacterium parvum n1=barite | n2=en:attenuated corynebacterium parvum | rel=r_associated | relid=0 | w=29 barite -- r_associated #0: 29 / 0.07 -> en:attenuated live listeria encoding hpv 16 e7 vaccine adxs11-001 n1=barite | n2=en:attenuated live listeria encoding hpv 16 e7 vaccine adxs11-001 | rel=r_associated | relid=0 | w=29 barite -- r_associated #0: 29 / 0.07 -> en:aurora a kinase inhibitor mk5108 n1=barite | n2=en:aurora a kinase inhibitor mk5108 | rel=r_associated | relid=0 | w=29 barite -- r_associated #0: 29 / 0.07 -> en:autologous dinitrophenyl-modified ovarian cancer vaccine n1=barite | n2=en:autologous dinitrophenyl-modified ovarian cancer vaccine | rel=r_associated | relid=0 | w=29 barite -- r_associated #0: 29 / 0.07 -> en:autologous hbv-specific tcr-redirected t-lymphocytes n1=barite | n2=en:autologous hbv-specific tcr-redirected t-lymphocytes | rel=r_associated | relid=0 | w=29 barite -- r_associated #0: 29 / 0.07 -> en:autologous her2 chimeric receptor/tgfbeta dominant negative receptor-expressing ebv-specific cytotoxic t lymphocytes n1=barite | n2=en:autologous her2 chimeric receptor/tgfbeta dominant negative receptor-expressing ebv-specific cytotoxic t lymphocytes | rel=r_associated | relid=0 | w=29 barite -- r_associated #0: 29 / 0.07 -> en:autologous lymphoid effector cells specific against tumor cells n1=barite | n2=en:autologous lymphoid effector cells specific against tumor cells | rel=r_associated | relid=0 | w=29 barite -- r_associated #0: 29 / 0.07 -> en:autologous lymphoma immunoglobulin-derived scfv-chemokine dna vaccine n1=barite | n2=en:autologous lymphoma immunoglobulin-derived scfv-chemokine dna vaccine | rel=r_associated | relid=0 | w=29 barite -- r_associated #0: 29 / 0.07 -> en:autologous melanoma lysate-pulsed autologous dendritic cell vaccine n1=barite | n2=en:autologous melanoma lysate-pulsed autologous dendritic cell vaccine | rel=r_associated | relid=0 | w=29 barite -- r_associated #0: 29 / 0.07 -> en:autologous melanoma lysate/ny-eso-1-pulsed autologous dendritic cell vaccine n1=barite | n2=en:autologous melanoma lysate/ny-eso-1-pulsed autologous dendritic cell vaccine | rel=r_associated | relid=0 | w=29 barite -- r_associated #0: 29 / 0.07 -> en:azlocillin n1=barite | n2=en:azlocillin | rel=r_associated | relid=0 | w=29 barite -- r_associated #0: 29 / 0.07 -> en:b [preparations] n1=barite | n2=en:b [preparations] | rel=r_associated | relid=0 | w=29 barite -- r_associated #0: 29 / 0.07 -> en:b16alphagal melanoma vaccine n1=barite | n2=en:b16alphagal melanoma vaccine | rel=r_associated | relid=0 | w=29 barite -- r_associated #0: 29 / 0.07 -> en:bacitracin/neomycin/polymyxin n1=barite | n2=en:bacitracin/neomycin/polymyxin | rel=r_associated | relid=0 | w=29 barite -- r_associated #0: 29 / 0.07 -> en:bagenema/bisacodyl/castile soap/castor oil n1=barite | n2=en:bagenema/bisacodyl/castile soap/castor oil | rel=r_associated | relid=0 | w=29 barite -- r_associated #0: 29 / 0.07 -> en:barium so4 454gm pwdr,rtl n1=barite | n2=en:barium so4 454gm pwdr,rtl | rel=r_associated | relid=0 | w=29 barite -- r_associated #0: 29 / 0.07 -> en:barium so4 8gm/cup pwdr n1=barite | n2=en:barium so4 8gm/cup pwdr | rel=r_associated | relid=0 | w=29 barite -- r_associated #0: 29 / 0.07 -> en:basis n1=barite | n2=en:basis | rel=r_associated | relid=0 | w=29 barite -- r_associated #0: 29 / 0.07 -> en:bcma-specific car-expressing t lymphocytes n1=barite | n2=en:bcma-specific car-expressing t lymphocytes | rel=r_associated | relid=0 | w=29 barite -- r_associated #0: 29 / 0.07 -> en:bcr-abl (b3a2)-derived peptide vaccine n1=barite | n2=en:bcr-abl (b3a2)-derived peptide vaccine | rel=r_associated | relid=0 | w=29 barite -- r_associated #0: 29 / 0.07 -> en:beetroot juice n1=barite | n2=en:beetroot juice | rel=r_associated | relid=0 | w=29 barite -- r_associated #0: 29 / 0.07 -> en:belladonna/charcoal n1=barite | n2=en:belladonna/charcoal | rel=r_associated | relid=0 | w=29 barite -- r_associated #0: 29 / 0.07 -> en:belotecan hydrochloride n1=barite | n2=en:belotecan hydrochloride | rel=r_associated | relid=0 | w=29 barite -- r_associated #0: 29 / 0.07 -> en:benzalkonium chloride/polyoxyethylene n1=barite | n2=en:benzalkonium chloride/polyoxyethylene | rel=r_associated | relid=0 | w=29 barite -- r_associated #0: 29 / 0.07 -> en:benzene n1=barite | n2=en:benzene | rel=r_associated | relid=0 | w=29 barite -- r_associated #0: 29 / 0.07 -> en:benzocaine/chlorobutanol/ethanol/menthol/tannic acid n1=barite | n2=en:benzocaine/chlorobutanol/ethanol/menthol/tannic acid | rel=r_associated | relid=0 | w=29 barite -- r_associated #0: 29 / 0.07 -> en:benzoxiquine / ichthammol n1=barite | n2=en:benzoxiquine / ichthammol | rel=r_associated | relid=0 | w=29 barite -- r_associated #0: 29 / 0.07 -> en:benzoyl peroxide + clindamycin n1=barite | n2=en:benzoyl peroxide + clindamycin | rel=r_associated | relid=0 | w=29 barite -- r_associated #0: 29 / 0.07 -> en:benzoyl peroxide, erythromycin drug combination n1=barite | n2=en:benzoyl peroxide, erythromycin drug combination | rel=r_associated | relid=0 | w=29 barite -- r_associated #0: 29 / 0.07 -> en:benzyl benzoate/bismuth/calcium/coconut oil/vegetable oil/zinc o n1=barite | n2=en:benzyl benzoate/bismuth/calcium/coconut oil/vegetable oil/zinc o | rel=r_associated | relid=0 | w=29 barite -- r_associated #0: 29 / 0.07 -> en:beta-thioguanine deoxyriboside n1=barite | n2=en:beta-thioguanine deoxyriboside | rel=r_associated | relid=0 | w=29 barite -- r_associated #0: 29 / 0.07 -> en:bilirubin/blood/glucose/ketone/leukocytes/nitrite/ph/protein te n1=barite | n2=en:bilirubin/blood/glucose/ketone/leukocytes/nitrite/ph/protein te | rel=r_associated | relid=0 | w=29 barite -- r_associated #0: 29 / 0.07 -> en:bilirubin/blood/glucose/ketone/ph/protein test n1=barite | n2=en:bilirubin/blood/glucose/ketone/ph/protein test | rel=r_associated | relid=0 | w=29 barite -- r_associated #0: 29 / 0.07 -> en:bismuth n1=barite | n2=en:bismuth | rel=r_associated | relid=0 | w=29 barite -- r_associated #0: 29 / 0.07 -> en:bismuth subcarbonate / morphine n1=barite | n2=en:bismuth subcarbonate / morphine | rel=r_associated | relid=0 | w=29 barite -- r_associated #0: 29 / 0.07 -> en:bismuth subcarbonate/kaolin/opium/pectin n1=barite | n2=en:bismuth subcarbonate/kaolin/opium/pectin | rel=r_associated | relid=0 | w=29 barite -- r_associated #0: 29 / 0.07 -> en:bismuth tribromophenate n1=barite | n2=en:bismuth tribromophenate | rel=r_associated | relid=0 | w=29 barite -- r_associated #0: 29 / 0.07 -> en:blood/glucose/ketone/ph/protein test n1=barite | n2=en:blood/glucose/ketone/ph/protein test | rel=r_associated | relid=0 | w=29 barite -- r_associated #0: 29 / 0.07 -> en:boceprevir n1=barite | n2=en:boceprevir | rel=r_associated | relid=0 | w=29 barite -- r_associated #0: 29 / 0.07 -> en:boric acid/lauramide dea/propylene glycol/tea-dodecylbenzenesulf n1=barite | n2=en:boric acid/lauramide dea/propylene glycol/tea-dodecylbenzenesulf | rel=r_associated | relid=0 | w=29 barite -- r_associated #0: 29 / 0.07 -> en:botulinum toxin type a n1=barite | n2=en:botulinum toxin type a | rel=r_associated | relid=0 | w=29 barite -- r_associated #0: 29 / 0.07 -> en:bretylium/dextrose n1=barite | n2=en:bretylium/dextrose | rel=r_associated | relid=0 | w=29 barite -- r_associated #0: 29 / 0.07 -> en:brivanib n1=barite | n2=en:brivanib | rel=r_associated | relid=0 | w=29 barite -- r_associated #0: 29 / 0.07 -> en:bromocriptine n1=barite | n2=en:bromocriptine | rel=r_associated | relid=0 | w=29 barite -- r_associated #0: 29 / 0.07 -> en:brompheniramine / phenylephrine / phenyltoloxamine n1=barite | n2=en:brompheniramine / phenylephrine / phenyltoloxamine | rel=r_associated | relid=0 | w=29 barite -- r_associated #0: 29 / 0.07 -> en:brompheniramine maleate + dextromethorphan hydrobromide + phenylpropanolamine hydrochloride n1=barite | n2=en:brompheniramine maleate + dextromethorphan hydrobromide + phenylpropanolamine hydrochloride | rel=r_associated | relid=0 | w=29 barite -- r_associated #0: 29 / 0.07 -> en:bupivacaine / hydromorphone n1=barite | n2=en:bupivacaine / hydromorphone | rel=r_associated | relid=0 | w=29 barite -- r_associated #0: 29 / 0.07 -> en:bupivacaine/sodium chloride n1=barite | n2=en:bupivacaine/sodium chloride | rel=r_associated | relid=0 | w=29 barite -- r_associated #0: 29 / 0.07 -> en:buprenorphine, naloxone drug combination n1=barite | n2=en:buprenorphine, naloxone drug combination | rel=r_associated | relid=0 | w=29 barite -- r_associated #0: 29 / 0.07 -> en:busulfan/melphalan regimen n1=barite | n2=en:busulfan/melphalan regimen | rel=r_associated | relid=0 | w=29 barite -- r_associated #0: 29 / 0.07 -> en:butabarbital/guaifenesin/pseudoephedrine/theophylline n1=barite | n2=en:butabarbital/guaifenesin/pseudoephedrine/theophylline | rel=r_associated | relid=0 | w=29 barite -- r_associated #0: 29 / 0.07 -> en:bw a773u n1=barite | n2=en:bw a773u | rel=r_associated | relid=0 | w=29 barite -- r_associated #0: 29 / 0.07 -> en:c-met inhibitor amg 208 n1=barite | n2=en:c-met inhibitor amg 208 | rel=r_associated | relid=0 | w=29 barite -- r_associated #0: 29 / 0.07 -> en:cafusertib hydrochloride n1=barite | n2=en:cafusertib hydrochloride | rel=r_associated | relid=0 | w=29 barite -- r_associated #0: 29 / 0.07 -> en:calcitonin salmon n1=barite | n2=en:calcitonin salmon | rel=r_associated | relid=0 | w=29 barite -- r_associated #0: 29 / 0.07 -> en:calcium aluminosilicate anti-diarrheal n1=barite | n2=en:calcium aluminosilicate anti-diarrheal | rel=r_associated | relid=0 | w=29 barite -- r_associated #0: 29 / 0.07 -> en:calcium chloride n1=barite | n2=en:calcium chloride | rel=r_associated | relid=0 | w=29 barite -- r_associated #0: 29 / 0.07 -> en:caldiamide n1=barite | n2=en:caldiamide | rel=r_associated | relid=0 | w=29 barite -- r_associated #0: 29 / 0.07 -> en:candesartan cilexetil n1=barite | n2=en:candesartan cilexetil | rel=r_associated | relid=0 | w=29 barite -- r_associated #0: 29 / 0.07 -> en:capsaicin n1=barite | n2=en:capsaicin | rel=r_associated | relid=0 | w=29 barite -- r_associated #0: 29 / 0.07 -> en:car.cd30-expressing autologous epstein-barr virus-specific cytotoxic t-lymphocytes n1=barite | n2=en:car.cd30-expressing autologous epstein-barr virus-specific cytotoxic t-lymphocytes | rel=r_associated | relid=0 | w=29 barite -- r_associated #0: 29 / 0.07 -> en:carbon c 11 pbr-28 n1=barite | n2=en:carbon c 11 pbr-28 | rel=r_associated | relid=0 | w=29 barite -- r_associated #0: 29 / 0.07 -> en:carbon c 11 sepantronium bromide n1=barite | n2=en:carbon c 11 sepantronium bromide | rel=r_associated | relid=0 | w=29 barite -- r_associated #0: 29 / 0.07 -> en:carbon c 14 lenvatinib mesylate n1=barite | n2=en:carbon c 14 lenvatinib mesylate | rel=r_associated | relid=0 | w=29 barite -- r_associated #0: 29 / 0.07 -> en:carbon c 14 oxaliplatin n1=barite | n2=en:carbon c 14 oxaliplatin | rel=r_associated | relid=0 | w=29 barite -- r_associated #0: 29 / 0.07 -> en:carcinoembryonic antigen peptide 1 n1=barite | n2=en:carcinoembryonic antigen peptide 1 | rel=r_associated | relid=0 | w=29 barite -- r_associated #0: 29 / 0.07 -> en:carubicin n1=barite | n2=en:carubicin | rel=r_associated | relid=0 | w=29 barite -- r_associated #0: 29 / 0.07 -> en:cbp/beta-catenin antagonist pri-724 n1=barite | n2=en:cbp/beta-catenin antagonist pri-724 | rel=r_associated | relid=0 | w=29 barite -- r_associated #0: 29 / 0.07 -> en:ccl21-expressing h1944 cell vaccine n1=barite | n2=en:ccl21-expressing h1944 cell vaccine | rel=r_associated | relid=0 | w=29 barite -- r_associated #0: 29 / 0.07 -> en:cd105/yb-1/sox2/cdh3/mdm2-polyepitope plasmid dna vaccine n1=barite | n2=en:cd105/yb-1/sox2/cdh3/mdm2-polyepitope plasmid dna vaccine | rel=r_associated | relid=0 | w=29 barite -- r_associated #0: 29 / 0.07 -> en:cd138car-cd137/tcrzeta-expressing t lymphocytes n1=barite | n2=en:cd138car-cd137/tcrzeta-expressing t lymphocytes | rel=r_associated | relid=0 | w=29 barite -- r_associated #0: 29 / 0.07 -> en:cd3/cd28 costimulated autologous t-cells n1=barite | n2=en:cd3/cd28 costimulated autologous t-cells | rel=r_associated | relid=0 | w=29 barite -- r_associated #0: 29 / 0.07 -> en:cd33car-cd3zeta-4-1bb-expressing autologous t-lymphocytes n1=barite | n2=en:cd33car-cd3zeta-4-1bb-expressing autologous t-lymphocytes | rel=r_associated | relid=0 | w=29 barite -- r_associated #0: 29 / 0.07 -> en:cdc7 inhibitor tak-931 n1=barite | n2=en:cdc7 inhibitor tak-931 | rel=r_associated | relid=0 | w=29 barite -- r_associated #0: 29 / 0.07 -> en:cediranib maleate n1=barite | n2=en:cediranib maleate | rel=r_associated | relid=0 | w=29 barite -- r_associated #0: 29 / 0.07 -> en:cephalexin n1=barite | n2=en:cephalexin | rel=r_associated | relid=0 | w=29 barite -- r_associated #0: 29 / 0.07 -> en:chk1 inhibitor pf-477736 n1=barite | n2=en:chk1 inhibitor pf-477736 | rel=r_associated | relid=0 | w=29 barite -- r_associated #0: 29 / 0.07 -> en:chlorpropamide n1=barite | n2=en:chlorpropamide | rel=r_associated | relid=0 | w=29 barite -- r_associated #0: 29 / 0.07 -> en:citrus bergamia extract n1=barite | n2=en:citrus bergamia extract | rel=r_associated | relid=0 | w=29 barite -- r_associated #0: 29 / 0.07 -> en:copper cu 64 anti-cea monoclonal antibody m5a n1=barite | n2=en:copper cu 64 anti-cea monoclonal antibody m5a | rel=r_associated | relid=0 | w=29 barite -- r_associated #0: 29 / 0.07 -> en:counterfeit drugs n1=barite | n2=en:counterfeit drugs | rel=r_associated | relid=0 | w=29 barite -- r_associated #0: 29 / 0.07 -> en:cyclophosphamide/dactinomycin/vincristine n1=barite | n2=en:cyclophosphamide/dactinomycin/vincristine | rel=r_associated | relid=0 | w=29 barite -- r_associated #0: 29 / 0.07 -> en:cytarabine n1=barite | n2=en:cytarabine | rel=r_associated | relid=0 | w=29 barite -- r_associated #0: 29 / 0.07 -> en:d-methionine formulation mrx-1024 n1=barite | n2=en:d-methionine formulation mrx-1024 | rel=r_associated | relid=0 | w=29 barite -- r_associated #0: 29 / 0.07 -> en:dabigatran etexilate mesylate n1=barite | n2=en:dabigatran etexilate mesylate | rel=r_associated | relid=0 | w=29 barite -- r_associated #0: 29 / 0.07 -> en:daclatasvir n1=barite | n2=en:daclatasvir | rel=r_associated | relid=0 | w=29 barite -- r_associated #0: 29 / 0.07 -> en:dalotuzumab n1=barite | n2=en:dalotuzumab | rel=r_associated | relid=0 | w=29 barite -- r_associated #0: 29 / 0.07 -> en:darbepoetin alfa n1=barite | n2=en:darbepoetin alfa | rel=r_associated | relid=0 | w=29 barite -- r_associated #0: 29 / 0.07 -> en:dcds0780a n1=barite | n2=en:dcds0780a | rel=r_associated | relid=0 | w=29 barite -- r_associated #0: 29 / 0.07 -> en:delta-tocotrienol n1=barite | n2=en:delta-tocotrienol | rel=r_associated | relid=0 | w=29 barite -- r_associated #0: 29 / 0.07 -> en:dianicline n1=barite | n2=en:dianicline | rel=r_associated | relid=0 | w=29 barite -- r_associated #0: 29 / 0.07 -> en:dihydrolenperone n1=barite | n2=en:dihydrolenperone | rel=r_associated | relid=0 | w=29 barite -- r_associated #0: 29 / 0.07 -> en:dimethylmyleran n1=barite | n2=en:dimethylmyleran | rel=r_associated | relid=0 | w=29 barite -- r_associated #0: 29 / 0.07 -> en:dinitrochlorobenzene n1=barite | n2=en:dinitrochlorobenzene | rel=r_associated | relid=0 | w=29 barite -- r_associated #0: 29 / 0.07 -> en:dioscorea nipponica makino extract dne3 n1=barite | n2=en:dioscorea nipponica makino extract dne3 | rel=r_associated | relid=0 | w=29 barite -- r_associated #0: 29 / 0.07 -> en:dkk1-neutralizing monoclonal antibody dkn-01 n1=barite | n2=en:dkk1-neutralizing monoclonal antibody dkn-01 | rel=r_associated | relid=0 | w=29 barite -- r_associated #0: 29 / 0.07 -> en:dolasetron mesylate n1=barite | n2=en:dolasetron mesylate | rel=r_associated | relid=0 | w=29 barite -- r_associated #0: 29 / 0.07 -> en:dolutegravir n1=barite | n2=en:dolutegravir | rel=r_associated | relid=0 | w=29 barite -- r_associated #0: 29 / 0.07 -> en:donor regulatory t-lymphocytes n1=barite | n2=en:donor regulatory t-lymphocytes | rel=r_associated | relid=0 | w=29 barite -- r_associated #0: 29 / 0.07 -> en:dot1l inhibitor epz-5676 n1=barite | n2=en:dot1l inhibitor epz-5676 | rel=r_associated | relid=0 | w=29 barite -- r_associated #0: 29 / 0.07 -> en:doxorubicin hydrochloride n1=barite | n2=en:doxorubicin hydrochloride | rel=r_associated | relid=0 | w=29 barite -- r_associated #0: 29 / 0.07 -> en:doxorubicin-magnetic targeted carrier complex n1=barite | n2=en:doxorubicin-magnetic targeted carrier complex | rel=r_associated | relid=0 | w=29 barite -- r_associated #0: 29 / 0.07 -> en:droperidol n1=barite | n2=en:droperidol | rel=r_associated | relid=0 | w=29 barite -- r_associated #0: 29 / 0.07 -> en:durvalumab n1=barite | n2=en:durvalumab | rel=r_associated | relid=0 | w=29 barite -- r_associated #0: 29 / 0.07 -> en:ferrosoferric oxide n1=barite | n2=en:ferrosoferric oxide | rel=r_associated | relid=0 | w=29 barite -- r_associated #0: 29 / 0.07 -> en:metrizoate calcium n1=barite | n2=en:metrizoate calcium | rel=r_associated | relid=0 | w=29 barite -- r_associated #0: 29 / 0.07 -> en:neuromuscular blocking agents n1=barite | n2=en:neuromuscular blocking agents | rel=r_associated | relid=0 | w=29 barite -- r_associated #0: 29 / 0.07 -> en:perflutren protein-type a microspheres n1=barite | n2=en:perflutren protein-type a microspheres | rel=r_associated | relid=0 | w=29 barite -- r_associated #0: 29 / 0.07 -> en:placebo administration n1=barite | n2=en:placebo administration | rel=r_associated | relid=0 | w=29 barite -- r_associated #0: 29 / 0.07 -> en:pyrogen n1=barite | n2=en:pyrogen | rel=r_associated | relid=0 | w=29 barite -- r_associated #0: 29 / 0.07 -> en:radiosensitizing agent n1=barite | n2=en:radiosensitizing agent | rel=r_associated | relid=0 | w=29 barite -- r_associated #0: 29 / 0.07 -> en:surface-active agent n1=barite | n2=en:surface-active agent | rel=r_associated | relid=0 | w=29 barite -- r_associated #0: 29 / 0.07 -> en:tyropanic acid n1=barite | n2=en:tyropanic acid | rel=r_associated | relid=0 | w=29 barite -- r_associated #0: 29 / 0.07 -> en:xenobiotics n1=barite | n2=en:xenobiotics | rel=r_associated | relid=0 | w=29 barite -- r_associated #0: 29 / 0.07 -> Zoologie n1=barite | n2=Zoologie | rel=r_associated | relid=0 | w=29 barite -- r_associated #0: 28 / 0.067 -> en:(61)cu-atsm n1=barite | n2=en:(61)cu-atsm | rel=r_associated | relid=0 | w=28 barite -- r_associated #0: 28 / 0.067 -> en:14c bms-275183 n1=barite | n2=en:14c bms-275183 | rel=r_associated | relid=0 | w=28 barite -- r_associated #0: 28 / 0.067 -> en:2-0, 3-0 desulfated heparin n1=barite | n2=en:2-0, 3-0 desulfated heparin | rel=r_associated | relid=0 | w=28 barite -- r_associated #0: 28 / 0.067 -> en:acenocoumarol n1=barite | n2=en:acenocoumarol | rel=r_associated | relid=0 | w=28 barite -- r_associated #0: 28 / 0.067 -> en:agaricus blazei murill extract n1=barite | n2=en:agaricus blazei murill extract | rel=r_associated | relid=0 | w=28 barite -- r_associated #0: 28 / 0.067 -> en:albuterol sulfate n1=barite | n2=en:albuterol sulfate | rel=r_associated | relid=0 | w=28 barite -- r_associated #0: 28 / 0.067 -> en:allogeneic large multivalent immunogen melanoma vaccine lp2307 n1=barite | n2=en:allogeneic large multivalent immunogen melanoma vaccine lp2307 | rel=r_associated | relid=0 | w=28 barite -- r_associated #0: 28 / 0.067 -> en:allosteric bcr-abl tyrosine kinase inhibitor abl001 n1=barite | n2=en:allosteric bcr-abl tyrosine kinase inhibitor abl001 | rel=r_associated | relid=0 | w=28 barite -- r_associated #0: 28 / 0.067 -> en:alpha-gal glycosphingolipids n1=barite | n2=en:alpha-gal glycosphingolipids | rel=r_associated | relid=0 | w=28 barite -- r_associated #0: 28 / 0.067 -> en:aluminum sulfate n1=barite | n2=en:aluminum sulfate | rel=r_associated | relid=0 | w=28 barite -- r_associated #0: 28 / 0.067 -> en:aminothiadiazole n1=barite | n2=en:aminothiadiazole | rel=r_associated | relid=0 | w=28 barite -- r_associated #0: 28 / 0.067 -> en:ammonium glycyrrhizate n1=barite | n2=en:ammonium glycyrrhizate | rel=r_associated | relid=0 | w=28 barite -- r_associated #0: 28 / 0.067 -> en:amoxicillin-clavulanate potassium n1=barite | n2=en:amoxicillin-clavulanate potassium | rel=r_associated | relid=0 | w=28 barite -- r_associated #0: 28 / 0.067 -> en:androgen antagonist apc-100 n1=barite | n2=en:androgen antagonist apc-100 | rel=r_associated | relid=0 | w=28 barite -- r_associated #0: 28 / 0.067 -> en:androgen receptor ligand-binding domain-encoding plasmid dna vaccine mvi-118 n1=barite | n2=en:androgen receptor ligand-binding domain-encoding plasmid dna vaccine mvi-118 | rel=r_associated | relid=0 | w=28 barite -- r_associated #0: 28 / 0.067 -> en:anidulafungin n1=barite | n2=en:anidulafungin | rel=r_associated | relid=0 | w=28 barite -- r_associated #0: 28 / 0.067 -> en:anthracycline analogue gpx-150 n1=barite | n2=en:anthracycline analogue gpx-150 | rel=r_associated | relid=0 | w=28 barite -- r_associated #0: 28 / 0.067 -> en:anti-ags-8 monoclonal antibody ags-8m4 n1=barite | n2=en:anti-ags-8 monoclonal antibody ags-8m4 | rel=r_associated | relid=0 | w=28 barite -- r_associated #0: 28 / 0.067 -> en:anti-c-met monoclonal antibody ly2875358 n1=barite | n2=en:anti-c-met monoclonal antibody ly2875358 | rel=r_associated | relid=0 | w=28 barite -- r_associated #0: 28 / 0.067 -> en:anti-ca6-dm4 immunoconjugate sar566658 n1=barite | n2=en:anti-ca6-dm4 immunoconjugate sar566658 | rel=r_associated | relid=0 | w=28 barite -- r_associated #0: 28 / 0.067 -> en:anti-cd200 monoclonal antibody alxn6000 n1=barite | n2=en:anti-cd200 monoclonal antibody alxn6000 | rel=r_associated | relid=0 | w=28 barite -- r_associated #0: 28 / 0.067 -> en:anti-dll4 monoclonal antibody medi0639 n1=barite | n2=en:anti-dll4 monoclonal antibody medi0639 | rel=r_associated | relid=0 | w=28 barite -- r_associated #0: 28 / 0.067 -> en:anti-dr5 agonistic antibody ds-8273a n1=barite | n2=en:anti-dr5 agonistic antibody ds-8273a | rel=r_associated | relid=0 | w=28 barite -- r_associated #0: 28 / 0.067 -> en:anti-egfrviii car-transduced allogeneic t-lymphocytes n1=barite | n2=en:anti-egfrviii car-transduced allogeneic t-lymphocytes | rel=r_associated | relid=0 | w=28 barite -- r_associated #0: 28 / 0.067 -> en:anti-epha2 monoclonal antibody-mmaf immunoconjugate medi-547 n1=barite | n2=en:anti-epha2 monoclonal antibody-mmaf immunoconjugate medi-547 | rel=r_associated | relid=0 | w=28 barite -- r_associated #0: 28 / 0.067 -> en:anti-hcv e2 monoclonal antibody mbl-hcv1 n1=barite | n2=en:anti-hcv e2 monoclonal antibody mbl-hcv1 | rel=r_associated | relid=0 | w=28 barite -- r_associated #0: 28 / 0.067 -> en:anti-her2 antibody-drug conjugate arx788 n1=barite | n2=en:anti-her2 antibody-drug conjugate arx788 | rel=r_associated | relid=0 | w=28 barite -- r_associated #0: 28 / 0.067 -> en:anti-lag-3 monoclonal antibody bms-986016 n1=barite | n2=en:anti-lag-3 monoclonal antibody bms-986016 | rel=r_associated | relid=0 | w=28 barite -- r_associated #0: 28 / 0.067 -> en:anti-liv-1 monoclonal antibody-mmae conjugate sgn-liv1a n1=barite | n2=en:anti-liv-1 monoclonal antibody-mmae conjugate sgn-liv1a | rel=r_associated | relid=0 | w=28 barite -- r_associated #0: 28 / 0.067 -> en:antiangiogenic drug combination tl-118 n1=barite | n2=en:antiangiogenic drug combination tl-118 | rel=r_associated | relid=0 | w=28 barite -- r_associated #0: 28 / 0.067 -> en:antibody-drug conjugate abbv-085 n1=barite | n2=en:antibody-drug conjugate abbv-085 | rel=r_associated | relid=0 | w=28 barite -- r_associated #0: 28 / 0.067 -> en:antibody-drug conjugate sc-003 n1=barite | n2=en:antibody-drug conjugate sc-003 | rel=r_associated | relid=0 | w=28 barite -- r_associated #0: 28 / 0.067 -> en:apomine n1=barite | n2=en:apomine | rel=r_associated | relid=0 | w=28 barite -- r_associated #0: 28 / 0.067 -> en:apoptosis inducer gcs-100 n1=barite | n2=en:apoptosis inducer gcs-100 | rel=r_associated | relid=0 | w=28 barite -- r_associated #0: 28 / 0.067 -> en:arnebia indigo jade pearl topical cream n1=barite | n2=en:arnebia indigo jade pearl topical cream | rel=r_associated | relid=0 | w=28 barite -- r_associated #0: 28 / 0.067 -> en:autologous cd171-specific car-cd28 zeta-4-1-bb-egfrt-expressing t lymphocytes n1=barite | n2=en:autologous cd171-specific car-cd28 zeta-4-1-bb-egfrt-expressing t lymphocytes | rel=r_associated | relid=0 | w=28 barite -- r_associated #0: 28 / 0.067 -> en:autologous dendritic cell-adenovirus ccl21 vaccine n1=barite | n2=en:autologous dendritic cell-adenovirus ccl21 vaccine | rel=r_associated | relid=0 | w=28 barite -- r_associated #0: 28 / 0.067 -> en:autologous ebv-transformed b lymphoblastoid-tumor fusion cell vaccine n1=barite | n2=en:autologous ebv-transformed b lymphoblastoid-tumor fusion cell vaccine | rel=r_associated | relid=0 | w=28 barite -- r_associated #0: 28 / 0.067 -> en:autologous il-21-modulated cd8+ mart1-specific t cells n1=barite | n2=en:autologous il-21-modulated cd8+ mart1-specific t cells | rel=r_associated | relid=0 | w=28 barite -- r_associated #0: 28 / 0.067 -> en:autologous tumor cell proteoliposome chronic lymphocytic leukemia vaccine n1=barite | n2=en:autologous tumor cell proteoliposome chronic lymphocytic leukemia vaccine | rel=r_associated | relid=0 | w=28 barite -- r_associated #0: 28 / 0.067 -> en:autologous tumor infiltrating lymphocytes ln-144 n1=barite | n2=en:autologous tumor infiltrating lymphocytes ln-144 | rel=r_associated | relid=0 | w=28 barite -- r_associated #0: 28 / 0.067 -> en:axl inhibitor bgb324 n1=barite | n2=en:axl inhibitor bgb324 | rel=r_associated | relid=0 | w=28 barite -- r_associated #0: 28 / 0.067 -> en:azapicyl n1=barite | n2=en:azapicyl | rel=r_associated | relid=0 | w=28 barite -- r_associated #0: 28 / 0.067 -> en:bacitracin / hydrocortisone / neomycin / polymyxin b n1=barite | n2=en:bacitracin / hydrocortisone / neomycin / polymyxin b | rel=r_associated | relid=0 | w=28 barite -- r_associated #0: 28 / 0.067 -> en:bacitracin / neomycin / polymyxin b n1=barite | n2=en:bacitracin / neomycin / polymyxin b | rel=r_associated | relid=0 | w=28 barite -- r_associated #0: 28 / 0.067 -> en:barium so4 300gm/bag pwdr,rtl n1=barite | n2=en:barium so4 300gm/bag pwdr,rtl | rel=r_associated | relid=0 | w=28 barite -- r_associated #0: 28 / 0.067 -> en:barium so4 35% susp,oral n1=barite | n2=en:barium so4 35% susp,oral | rel=r_associated | relid=0 | w=28 barite -- r_associated #0: 28 / 0.067 -> en:barium so4 55% enema n1=barite | n2=en:barium so4 55% enema | rel=r_associated | relid=0 | w=28 barite -- r_associated #0: 28 / 0.067 -> en:barium sulfate 95% oral suspension n1=barite | n2=en:barium sulfate 95% oral suspension | rel=r_associated | relid=0 | w=28 barite -- r_associated #0: 28 / 0.067 -> en:bath oil n1=barite | n2=en:bath oil | rel=r_associated | relid=0 | w=28 barite -- r_associated #0: 28 / 0.067 -> en:belladonna extract, usp n1=barite | n2=en:belladonna extract, usp | rel=r_associated | relid=0 | w=28 barite -- r_associated #0: 28 / 0.067 -> en:bendamustine-vorinostat fusion molecule edo-s101 n1=barite | n2=en:bendamustine-vorinostat fusion molecule edo-s101 | rel=r_associated | relid=0 | w=28 barite -- r_associated #0: 28 / 0.067 -> en:benegrastim n1=barite | n2=en:benegrastim | rel=r_associated | relid=0 | w=28 barite -- r_associated #0: 28 / 0.067 -> en:benzalkonium chloride/edta n1=barite | n2=en:benzalkonium chloride/edta | rel=r_associated | relid=0 | w=28 barite -- r_associated #0: 28 / 0.067 -> en:benzalkonium/oxyquinoline n1=barite | n2=en:benzalkonium/oxyquinoline | rel=r_associated | relid=0 | w=28 barite -- r_associated #0: 28 / 0.067 -> en:benzocaine / dextromethorphan / menthol n1=barite | n2=en:benzocaine / dextromethorphan / menthol | rel=r_associated | relid=0 | w=28 barite -- r_associated #0: 28 / 0.067 -> en:benzocaine / glycerin n1=barite | n2=en:benzocaine / glycerin | rel=r_associated | relid=0 | w=28 barite -- r_associated #0: 28 / 0.067 -> en:benzocaine / isopropyl alcohol / menthol n1=barite | n2=en:benzocaine / isopropyl alcohol / menthol | rel=r_associated | relid=0 | w=28 barite -- r_associated #0: 28 / 0.067 -> en:benzocaine/cetylpyridinium chloride/terpin hydrate n1=barite | n2=en:benzocaine/cetylpyridinium chloride/terpin hydrate | rel=r_associated | relid=0 | w=28 barite -- r_associated #0: 28 / 0.067 -> en:benzyl alcohol / sodium chloride n1=barite | n2=en:benzyl alcohol / sodium chloride | rel=r_associated | relid=0 | w=28 barite -- r_associated #0: 28 / 0.067 -> en:bet bromodomain inhibitor zen-3694 n1=barite | n2=en:bet bromodomain inhibitor zen-3694 | rel=r_associated | relid=0 | w=28 barite -- r_associated #0: 28 / 0.067 -> en:bi 831266 n1=barite | n2=en:bi 831266 | rel=r_associated | relid=0 | w=28 barite -- r_associated #0: 28 / 0.067 -> en:birinapant n1=barite | n2=en:birinapant | rel=r_associated | relid=0 | w=28 barite -- r_associated #0: 28 / 0.067 -> en:bismuth subsalicylate/magnesium silicate/salicylic acid/sodium s n1=barite | n2=en:bismuth subsalicylate/magnesium silicate/salicylic acid/sodium s | rel=r_associated | relid=0 | w=28 barite -- r_associated #0: 28 / 0.067 -> en:bivalirudin n1=barite | n2=en:bivalirudin | rel=r_associated | relid=0 | w=28 barite -- r_associated #0: 28 / 0.067 -> en:bleomycin/sodium chloride n1=barite | n2=en:bleomycin/sodium chloride | rel=r_associated | relid=0 | w=28 barite -- r_associated #0: 28 / 0.067 -> en:blinatumomab n1=barite | n2=en:blinatumomab | rel=r_associated | relid=0 | w=28 barite -- r_associated #0: 28 / 0.067 -> en:blood urea nitrogen test device n1=barite | n2=en:blood urea nitrogen test device | rel=r_associated | relid=0 | w=28 barite -- r_associated #0: 28 / 0.067 -> en:bms-817378 n1=barite | n2=en:bms-817378 | rel=r_associated | relid=0 | w=28 barite -- r_associated #0: 28 / 0.067 -> en:botanical lotion cg428 n1=barite | n2=en:botanical lotion cg428 | rel=r_associated | relid=0 | w=28 barite -- r_associated #0: 28 / 0.067 -> en:br96-doxorubicin immunoconjugate n1=barite | n2=en:br96-doxorubicin immunoconjugate | rel=r_associated | relid=0 | w=28 barite -- r_associated #0: 28 / 0.067 -> en:braf(v600e) kinase inhibitor ro5212054 n1=barite | n2=en:braf(v600e) kinase inhibitor ro5212054 | rel=r_associated | relid=0 | w=28 barite -- r_associated #0: 28 / 0.067 -> en:brimonidine + timolol n1=barite | n2=en:brimonidine + timolol | rel=r_associated | relid=0 | w=28 barite -- r_associated #0: 28 / 0.067 -> en:brompheniramine n1=barite | n2=en:brompheniramine | rel=r_associated | relid=0 | w=28 barite -- r_associated #0: 28 / 0.067 -> en:brompheniramine/codeine/guaifenesin/phenylephrine/phenylpropanol n1=barite | n2=en:brompheniramine/codeine/guaifenesin/phenylephrine/phenylpropanol | rel=r_associated | relid=0 | w=28 barite -- r_associated #0: 28 / 0.067 -> en:brucine n1=barite | n2=en:brucine | rel=r_associated | relid=0 | w=28 barite -- r_associated #0: 28 / 0.067 -> en:btk inhibitor bgb-3111 n1=barite | n2=en:btk inhibitor bgb-3111 | rel=r_associated | relid=0 | w=28 barite -- r_associated #0: 28 / 0.067 -> en:budesonide/formoterol fumarate dihydrate inhalation aerosol n1=barite | n2=en:budesonide/formoterol fumarate dihydrate inhalation aerosol | rel=r_associated | relid=0 | w=28 barite -- r_associated #0: 28 / 0.067 -> en:burdock preparation n1=barite | n2=en:burdock preparation | rel=r_associated | relid=0 | w=28 barite -- r_associated #0: 28 / 0.067 -> en:burixafor n1=barite | n2=en:burixafor | rel=r_associated | relid=0 | w=28 barite -- r_associated #0: 28 / 0.067 -> en:busulfan n1=barite | n2=en:busulfan | rel=r_associated | relid=0 | w=28 barite -- r_associated #0: 28 / 0.067 -> en:butcher's broom preparation n1=barite | n2=en:butcher's broom preparation | rel=r_associated | relid=0 | w=28 barite -- r_associated #0: 28 / 0.067 -> en:butocin n1=barite | n2=en:butocin | rel=r_associated | relid=0 | w=28 barite -- r_associated #0: 28 / 0.067 -> en:c3-targeted complement inhibitor apl-2 n1=barite | n2=en:c3-targeted complement inhibitor apl-2 | rel=r_associated | relid=0 | w=28 barite -- r_associated #0: 28 / 0.067 -> en:calaspargase pegol n1=barite | n2=en:calaspargase pegol | rel=r_associated | relid=0 | w=28 barite -- r_associated #0: 28 / 0.067 -> en:calendula ointment n1=barite | n2=en:calendula ointment | rel=r_associated | relid=0 | w=28 barite -- r_associated #0: 28 / 0.067 -> en:capmatinib n1=barite | n2=en:capmatinib | rel=r_associated | relid=0 | w=28 barite -- r_associated #0: 28 / 0.067 -> en:carbon c 13 acetate n1=barite | n2=en:carbon c 13 acetate | rel=r_associated | relid=0 | w=28 barite -- r_associated #0: 28 / 0.067 -> en:carbutamide n1=barite | n2=en:carbutamide | rel=r_associated | relid=0 | w=28 barite -- r_associated #0: 28 / 0.067 -> en:cd95 ecd/igg-fc fusion protein apg101 n1=barite | n2=en:cd95 ecd/igg-fc fusion protein apg101 | rel=r_associated | relid=0 | w=28 barite -- r_associated #0: 28 / 0.067 -> en:cdc7 kinase inhibitor nms-1116354 n1=barite | n2=en:cdc7 kinase inhibitor nms-1116354 | rel=r_associated | relid=0 | w=28 barite -- r_associated #0: 28 / 0.067 -> en:cdk2/5/9 inhibitor cyc065 n1=barite | n2=en:cdk2/5/9 inhibitor cyc065 | rel=r_associated | relid=0 | w=28 barite -- r_associated #0: 28 / 0.067 -> en:cebpa-targeting sarna mtl-cebpa liposome n1=barite | n2=en:cebpa-targeting sarna mtl-cebpa liposome | rel=r_associated | relid=0 | w=28 barite -- r_associated #0: 28 / 0.067 -> en:ceftobiprole medocaril n1=barite | n2=en:ceftobiprole medocaril | rel=r_associated | relid=0 | w=28 barite -- r_associated #0: 28 / 0.067 -> en:cfms tyrosine kinase inhibitor arry-382 n1=barite | n2=en:cfms tyrosine kinase inhibitor arry-382 | rel=r_associated | relid=0 | w=28 barite -- r_associated #0: 28 / 0.067 -> en:chelating agent n1=barite | n2=en:chelating agent | rel=r_associated | relid=0 | w=28 barite -- r_associated #0: 28 / 0.067 -> en:chiauranib n1=barite | n2=en:chiauranib | rel=r_associated | relid=0 | w=28 barite -- r_associated #0: 28 / 0.067 -> en:chining decoction n1=barite | n2=en:chining decoction | rel=r_associated | relid=0 | w=28 barite -- r_associated #0: 28 / 0.067 -> en:chlorambucil-prednisone regimen n1=barite | n2=en:chlorambucil-prednisone regimen | rel=r_associated | relid=0 | w=28 barite -- r_associated #0: 28 / 0.067 -> en:chp-ny-eso-1 peptide vaccine imf-001 n1=barite | n2=en:chp-ny-eso-1 peptide vaccine imf-001 | rel=r_associated | relid=0 | w=28 barite -- r_associated #0: 28 / 0.067 -> en:cinacalcet hydrochloride n1=barite | n2=en:cinacalcet hydrochloride | rel=r_associated | relid=0 | w=28 barite -- r_associated #0: 28 / 0.067 -> en:cisplatin-e therapeutic implant n1=barite | n2=en:cisplatin-e therapeutic implant | rel=r_associated | relid=0 | w=28 barite -- r_associated #0: 28 / 0.067 -> en:clofarabine n1=barite | n2=en:clofarabine | rel=r_associated | relid=0 | w=28 barite -- r_associated #0: 28 / 0.067 -> en:clomiphene citrate n1=barite | n2=en:clomiphene citrate | rel=r_associated | relid=0 | w=28 barite -- r_associated #0: 28 / 0.067 -> en:clostridium butyricum-containing probiotic n1=barite | n2=en:clostridium butyricum-containing probiotic | rel=r_associated | relid=0 | w=28 barite -- r_associated #0: 28 / 0.067 -> en:cmet car-mrna electroporated autologous t lymphocytes n1=barite | n2=en:cmet car-mrna electroporated autologous t lymphocytes | rel=r_associated | relid=0 | w=28 barite -- r_associated #0: 28 / 0.067 -> en:colloidal oatmeal cream n1=barite | n2=en:colloidal oatmeal cream | rel=r_associated | relid=0 | w=28 barite -- r_associated #0: 28 / 0.067 -> en:copper cu 64-atsm n1=barite | n2=en:copper cu 64-atsm | rel=r_associated | relid=0 | w=28 barite -- r_associated #0: 28 / 0.067 -> en:cord blood-derived expanded natural killer cell infusion pnk-007 n1=barite | n2=en:cord blood-derived expanded natural killer cell infusion pnk-007 | rel=r_associated | relid=0 | w=28 barite -- r_associated #0: 28 / 0.067 -> en:corticotropin releasing hormone n1=barite | n2=en:corticotropin releasing hormone | rel=r_associated | relid=0 | w=28 barite -- r_associated #0: 28 / 0.067 -> en:cositecan n1=barite | n2=en:cositecan | rel=r_associated | relid=0 | w=28 barite -- r_associated #0: 28 / 0.067 -> en:cp 461 n1=barite | n2=en:cp 461 | rel=r_associated | relid=0 | w=28 barite -- r_associated #0: 28 / 0.067 -> en:crl 1005 n1=barite | n2=en:crl 1005 | rel=r_associated | relid=0 | w=28 barite -- r_associated #0: 28 / 0.067 -> en:cyanocobalamin n1=barite | n2=en:cyanocobalamin | rel=r_associated | relid=0 | w=28 barite -- r_associated #0: 28 / 0.067 -> en:cyclodextrin-based polymer-camptothecin crlx101 n1=barite | n2=en:cyclodextrin-based polymer-camptothecin crlx101 | rel=r_associated | relid=0 | w=28 barite -- r_associated #0: 28 / 0.067 -> en:cycloserine n1=barite | n2=en:cycloserine | rel=r_associated | relid=0 | w=28 barite -- r_associated #0: 28 / 0.067 -> en:cyproheptadine hydrochloride n1=barite | n2=en:cyproheptadine hydrochloride | rel=r_associated | relid=0 | w=28 barite -- r_associated #0: 28 / 0.067 -> en:dec-205/ny-eso-1 fusion protein cdx-1401 n1=barite | n2=en:dec-205/ny-eso-1 fusion protein cdx-1401 | rel=r_associated | relid=0 | w=28 barite -- r_associated #0: 28 / 0.067 -> en:dendritic cell-autologous lung tumor vaccine n1=barite | n2=en:dendritic cell-autologous lung tumor vaccine | rel=r_associated | relid=0 | w=28 barite -- r_associated #0: 28 / 0.067 -> en:dher2 vaccine+as15 adjuvant n1=barite | n2=en:dher2 vaccine+as15 adjuvant | rel=r_associated | relid=0 | w=28 barite -- r_associated #0: 28 / 0.067 -> en:diammonium glycyrrhizinate n1=barite | n2=en:diammonium glycyrrhizinate | rel=r_associated | relid=0 | w=28 barite -- r_associated #0: 28 / 0.067 -> en:diatrizoate sodium n1=barite | n2=en:diatrizoate sodium | rel=r_associated | relid=0 | w=28 barite -- r_associated #0: 28 / 0.067 -> en:dicumarol n1=barite | n2=en:dicumarol | rel=r_associated | relid=0 | w=28 barite -- r_associated #0: 28 / 0.067 -> en:diethylhomospermine n1=barite | n2=en:diethylhomospermine | rel=r_associated | relid=0 | w=28 barite -- r_associated #0: 28 / 0.067 -> en:dinitrophenyl n1=barite | n2=en:dinitrophenyl | rel=r_associated | relid=0 | w=28 barite -- r_associated #0: 28 / 0.067 -> en:dm4-conjugated anti-cripto monoclonal antibody biib015 n1=barite | n2=en:dm4-conjugated anti-cripto monoclonal antibody biib015 | rel=r_associated | relid=0 | w=28 barite -- r_associated #0: 28 / 0.067 -> en:dna interference oligonucleotide pnt2258 n1=barite | n2=en:dna interference oligonucleotide pnt2258 | rel=r_associated | relid=0 | w=28 barite -- r_associated #0: 28 / 0.067 -> en:docetaxel lipid microspheres n1=barite | n2=en:docetaxel lipid microspheres | rel=r_associated | relid=0 | w=28 barite -- r_associated #0: 28 / 0.067 -> en:donor-derived wt1/prame/ny-eso-1/survivin-specific t-lymphocytes n1=barite | n2=en:donor-derived wt1/prame/ny-eso-1/survivin-specific t-lymphocytes | rel=r_associated | relid=0 | w=28 barite -- r_associated #0: 28 / 0.067 -> en:doxepin hydrochloride n1=barite | n2=en:doxepin hydrochloride | rel=r_associated | relid=0 | w=28 barite -- r_associated #0: 28 / 0.067 -> en:doxycycline hyclate injection n1=barite | n2=en:doxycycline hyclate injection | rel=r_associated | relid=0 | w=28 barite -- r_associated #0: 28 / 0.067 -> en:endoflas f.s. n1=barite | n2=en:endoflas f.s. | rel=r_associated | relid=0 | w=28 barite -- r_associated #0: 28 / 0.067 -> en:ethiodized oil n1=barite | n2=en:ethiodized oil | rel=r_associated | relid=0 | w=28 barite -- r_associated #0: 28 / 0.067 -> en:gastrointestinal agents n1=barite | n2=en:gastrointestinal agents | rel=r_associated | relid=0 | w=28 barite -- r_associated #0: 28 / 0.067 -> en:indocyanine green solution n1=barite | n2=en:indocyanine green solution | rel=r_associated | relid=0 | w=28 barite -- r_associated #0: 28 / 0.067 -> en:iodinated contrast agent n1=barite | n2=en:iodinated contrast agent | rel=r_associated | relid=0 | w=28 barite -- r_associated #0: 28 / 0.067 -> en:medication n1=barite | n2=en:medication | rel=r_associated | relid=0 | w=28 barite -- r_associated #0: 28 / 0.067 -> en:orabase with benzocaine n1=barite | n2=en:orabase with benzocaine | rel=r_associated | relid=0 | w=28 barite -- r_associated #0: 28 / 0.067 -> en:perflubron n1=barite | n2=en:perflubron | rel=r_associated | relid=0 | w=28 barite -- r_associated #0: 28 / 0.067 -> en:perflubutane microbubble n1=barite | n2=en:perflubutane microbubble | rel=r_associated | relid=0 | w=28 barite -- r_associated #0: 28 / 0.067 -> en:rhodamine labeled albumin n1=barite | n2=en:rhodamine labeled albumin | rel=r_associated | relid=0 | w=28 barite -- r_associated #0: 28 / 0.067 -> en:sodium sulfate n1=barite | n2=en:sodium sulfate | rel=r_associated | relid=0 | w=28 barite -- r_associated #0: 28 / 0.067 -> en:sulfates, inorganic n1=barite | n2=en:sulfates, inorganic | rel=r_associated | relid=0 | w=28 barite -- r_associated #0: 28 / 0.067 -> en:tocolytic agents n1=barite | n2=en:tocolytic agents | rel=r_associated | relid=0 | w=28 barite -- r_associated #0: 28 / 0.067 -> en:weight control agent n1=barite | n2=en:weight control agent | rel=r_associated | relid=0 | w=28 barite -- r_associated #0: 27 / 0.065 -> en:2-hydroxyoleic acid n1=barite | n2=en:2-hydroxyoleic acid | rel=r_associated | relid=0 | w=27 barite -- r_associated #0: 27 / 0.065 -> en:3'-aminomethyl nicotine-p. aeruginosa r-exoprotein a conjugate vaccine n1=barite | n2=en:3'-aminomethyl nicotine-p. aeruginosa r-exoprotein a conjugate vaccine | rel=r_associated | relid=0 | w=27 barite -- r_associated #0: 27 / 0.065 -> en:714-x n1=barite | n2=en:714-x | rel=r_associated | relid=0 | w=27 barite -- r_associated #0: 27 / 0.065 -> en:abp 215 n1=barite | n2=en:abp 215 | rel=r_associated | relid=0 | w=27 barite -- r_associated #0: 27 / 0.065 -> en:ac regimen n1=barite | n2=en:ac regimen | rel=r_associated | relid=0 | w=27 barite -- r_associated #0: 27 / 0.065 -> en:acai berry juice n1=barite | n2=en:acai berry juice | rel=r_associated | relid=0 | w=27 barite -- r_associated #0: 27 / 0.065 -> en:acetrizoate sodium n1=barite | n2=en:acetrizoate sodium | rel=r_associated | relid=0 | w=27 barite -- r_associated #0: 27 / 0.065 -> en:acolbifene hydrochloride n1=barite | n2=en:acolbifene hydrochloride | rel=r_associated | relid=0 | w=27 barite -- r_associated #0: 27 / 0.065 -> en:acridine carboxamide n1=barite | n2=en:acridine carboxamide | rel=r_associated | relid=0 | w=27 barite -- r_associated #0: 27 / 0.065 -> en:acyclovir n1=barite | n2=en:acyclovir | rel=r_associated | relid=0 | w=27 barite -- r_associated #0: 27 / 0.065 -> en:adrtvp-1-transduced prostate cancer cell-based vaccine n1=barite | n2=en:adrtvp-1-transduced prostate cancer cell-based vaccine | rel=r_associated | relid=0 | w=27 barite -- r_associated #0: 27 / 0.065 -> en:alectinib n1=barite | n2=en:alectinib | rel=r_associated | relid=0 | w=27 barite -- r_associated #0: 27 / 0.065 -> en:allogeneic gm-csf-secreting breast cancer vaccine n1=barite | n2=en:allogeneic gm-csf-secreting breast cancer vaccine | rel=r_associated | relid=0 | w=27 barite -- r_associated #0: 27 / 0.065 -> en:alpha fetoprotein plasmid dna vaccine n1=barite | n2=en:alpha fetoprotein plasmid dna vaccine | rel=r_associated | relid=0 | w=27 barite -- r_associated #0: 27 / 0.065 -> en:amiodarone hydrochloride n1=barite | n2=en:amiodarone hydrochloride | rel=r_associated | relid=0 | w=27 barite -- r_associated #0: 27 / 0.065 -> en:ampicillin sodium/sulbactam sodium n1=barite | n2=en:ampicillin sodium/sulbactam sodium | rel=r_associated | relid=0 | w=27 barite -- r_associated #0: 27 / 0.065 -> en:anetumab ravtansine n1=barite | n2=en:anetumab ravtansine | rel=r_associated | relid=0 | w=27 barite -- r_associated #0: 27 / 0.065 -> en:angiopoietin-2-specific fusion protein pf-04856884 n1=barite | n2=en:angiopoietin-2-specific fusion protein pf-04856884 | rel=r_associated | relid=0 | w=27 barite -- r_associated #0: 27 / 0.065 -> en:anti-a33 monoclonal antibody krn330 n1=barite | n2=en:anti-a33 monoclonal antibody krn330 | rel=r_associated | relid=0 | w=27 barite -- r_associated #0: 27 / 0.065 -> en:anti-cd25-pbd antibody-drug conjugate adct-301 n1=barite | n2=en:anti-cd25-pbd antibody-drug conjugate adct-301 | rel=r_associated | relid=0 | w=27 barite -- r_associated #0: 27 / 0.065 -> en:anti-cd33 antibody-drug conjugate imgn779 n1=barite | n2=en:anti-cd33 antibody-drug conjugate imgn779 | rel=r_associated | relid=0 | w=27 barite -- r_associated #0: 27 / 0.065 -> en:anti-fgfr3 antibody-drug conjugate ly3076226 n1=barite | n2=en:anti-fgfr3 antibody-drug conjugate ly3076226 | rel=r_associated | relid=0 | w=27 barite -- r_associated #0: 27 / 0.065 -> en:anti-her2 monoclonal antibody ct-p6 n1=barite | n2=en:anti-her2 monoclonal antibody ct-p6 | rel=r_associated | relid=0 | w=27 barite -- r_associated #0: 27 / 0.065 -> en:anti-igf-1r recombinant monoclonal antibody biib022 n1=barite | n2=en:anti-igf-1r recombinant monoclonal antibody biib022 | rel=r_associated | relid=0 | w=27 barite -- r_associated #0: 27 / 0.065 -> en:anti-il-4/il-13 combination agent qbx258 n1=barite | n2=en:anti-il-4/il-13 combination agent qbx258 | rel=r_associated | relid=0 | w=27 barite -- r_associated #0: 27 / 0.065 -> en:anti-inflammatory antibody alxn1007 n1=barite | n2=en:anti-inflammatory antibody alxn1007 | rel=r_associated | relid=0 | w=27 barite -- r_associated #0: 27 / 0.065 -> en:anti-integrin monoclonal antibody-dm4 immunoconjugate imgn388 n1=barite | n2=en:anti-integrin monoclonal antibody-dm4 immunoconjugate imgn388 | rel=r_associated | relid=0 | w=27 barite -- r_associated #0: 27 / 0.065 -> en:anti-kir monoclonal antibody iph 2101 n1=barite | n2=en:anti-kir monoclonal antibody iph 2101 | rel=r_associated | relid=0 | w=27 barite -- r_associated #0: 27 / 0.065 -> en:anti-nf-p2x7 antibody ointment bil-010t n1=barite | n2=en:anti-nf-p2x7 antibody ointment bil-010t | rel=r_associated | relid=0 | w=27 barite -- r_associated #0: 27 / 0.065 -> en:anti-ofa immunotherapeutic bb-mpi-03 n1=barite | n2=en:anti-ofa immunotherapeutic bb-mpi-03 | rel=r_associated | relid=0 | w=27 barite -- r_associated #0: 27 / 0.065 -> en:anti-pd-1 monoclonal antibody pdr001 n1=barite | n2=en:anti-pd-1 monoclonal antibody pdr001 | rel=r_associated | relid=0 | w=27 barite -- r_associated #0: 27 / 0.065 -> en:anti-tf monoclonal antibody alt-836 n1=barite | n2=en:anti-tf monoclonal antibody alt-836 | rel=r_associated | relid=0 | w=27 barite -- r_associated #0: 27 / 0.065 -> en:apricoxib n1=barite | n2=en:apricoxib | rel=r_associated | relid=0 | w=27 barite -- r_associated #0: 27 / 0.065 -> en:atr kinase inhibitor vx-970 n1=barite | n2=en:atr kinase inhibitor vx-970 | rel=r_associated | relid=0 | w=27 barite -- r_associated #0: 27 / 0.065 -> en:autologous anti-mart-1 f5 t-cell receptor gene-engineered peripheral blood lymphocytes n1=barite | n2=en:autologous anti-mart-1 f5 t-cell receptor gene-engineered peripheral blood lymphocytes | rel=r_associated | relid=0 | w=27 barite -- r_associated #0: 27 / 0.065 -> en:autologous beta-a(t87q)-globin gene-transduced cd34-positive cells n1=barite | n2=en:autologous beta-a(t87q)-globin gene-transduced cd34-positive cells | rel=r_associated | relid=0 | w=27 barite -- r_associated #0: 27 / 0.065 -> en:autologous ny-eso-1-melanoma-specific cd8+ t-lymphocytes n1=barite | n2=en:autologous ny-eso-1-melanoma-specific cd8+ t-lymphocytes | rel=r_associated | relid=0 | w=27 barite -- r_associated #0: 27 / 0.065 -> en:autologous sarcoma lysate-pulsed dendritic cell vaccine n1=barite | n2=en:autologous sarcoma lysate-pulsed dendritic cell vaccine | rel=r_associated | relid=0 | w=27 barite -- r_associated #0: 27 / 0.065 -> en:av2-dm antiviral spray n1=barite | n2=en:av2-dm antiviral spray | rel=r_associated | relid=0 | w=27 barite -- r_associated #0: 27 / 0.065 -> en:azacitidine n1=barite | n2=en:azacitidine | rel=r_associated | relid=0 | w=27 barite -- r_associated #0: 27 / 0.065 -> en:barium so4 105% susp n1=barite | n2=en:barium so4 105% susp | rel=r_associated | relid=0 | w=27 barite -- r_associated #0: 27 / 0.065 -> en:barium so4 60% cream,oral n1=barite | n2=en:barium so4 60% cream,oral | rel=r_associated | relid=0 | w=27 barite -- r_associated #0: 27 / 0.065 -> en:baza pro n1=barite | n2=en:baza pro | rel=r_associated | relid=0 | w=27 barite -- r_associated #0: 27 / 0.065 -> en:bazedoxifene n1=barite | n2=en:bazedoxifene | rel=r_associated | relid=0 | w=27 barite -- r_associated #0: 27 / 0.065 -> en:belladonna/chlorpheniramine/pheniramine/phenylpropanolamine n1=barite | n2=en:belladonna/chlorpheniramine/pheniramine/phenylpropanolamine | rel=r_associated | relid=0 | w=27 barite -- r_associated #0: 27 / 0.065 -> en:belladonna/phenobarbital/ergotamine n1=barite | n2=en:belladonna/phenobarbital/ergotamine | rel=r_associated | relid=0 | w=27 barite -- r_associated #0: 27 / 0.065 -> en:benoxinate/fluorescein n1=barite | n2=en:benoxinate/fluorescein | rel=r_associated | relid=0 | w=27 barite -- r_associated #0: 27 / 0.065 -> en:benzalkonium/cetylpyridinium/chloroxylenol/sodium/triacetin n1=barite | n2=en:benzalkonium/cetylpyridinium/chloroxylenol/sodium/triacetin | rel=r_associated | relid=0 | w=27 barite -- r_associated #0: 27 / 0.065 -> en:benzethonium/calamine/eucalyptol/zinc oxide n1=barite | n2=en:benzethonium/calamine/eucalyptol/zinc oxide | rel=r_associated | relid=0 | w=27 barite -- r_associated #0: 27 / 0.065 -> en:benzethonium/triclosan n1=barite | n2=en:benzethonium/triclosan | rel=r_associated | relid=0 | w=27 barite -- r_associated #0: 27 / 0.065 -> en:benzocaine / butamben / tetracaine n1=barite | n2=en:benzocaine / butamben / tetracaine | rel=r_associated | relid=0 | w=27 barite -- r_associated #0: 27 / 0.065 -> en:benzocaine / salicylic acid n1=barite | n2=en:benzocaine / salicylic acid | rel=r_associated | relid=0 | w=27 barite -- r_associated #0: 27 / 0.065 -> en:benzocaine/ephedrine/hydrocortisone/ichthammol/oxyquinoline/zinc n1=barite | n2=en:benzocaine/ephedrine/hydrocortisone/ichthammol/oxyquinoline/zinc | rel=r_associated | relid=0 | w=27 barite -- r_associated #0: 27 / 0.065 -> en:benzoin/podophyllin n1=barite | n2=en:benzoin/podophyllin | rel=r_associated | relid=0 | w=27 barite -- r_associated #0: 27 / 0.065 -> en:beta alethine n1=barite | n2=en:beta alethine | rel=r_associated | relid=0 | w=27 barite -- r_associated #0: 27 / 0.065 -> en:binetrakin n1=barite | n2=en:binetrakin | rel=r_associated | relid=0 | w=27 barite -- r_associated #0: 27 / 0.065 -> en:bisacodyl n1=barite | n2=en:bisacodyl | rel=r_associated | relid=0 | w=27 barite -- r_associated #0: 27 / 0.065 -> en:bispecific antibody mdx-h210 n1=barite | n2=en:bispecific antibody mdx-h210 | rel=r_associated | relid=0 | w=27 barite -- r_associated #0: 27 / 0.065 -> en:bizelesin n1=barite | n2=en:bizelesin | rel=r_associated | relid=0 | w=27 barite -- r_associated #0: 27 / 0.065 -> en:black cohosh n1=barite | n2=en:black cohosh | rel=r_associated | relid=0 | w=27 barite -- r_associated #0: 27 / 0.065 -> en:bleomycin sulfate n1=barite | n2=en:bleomycin sulfate | rel=r_associated | relid=0 | w=27 barite -- r_associated #0: 27 / 0.065 -> en:bms-184476 n1=barite | n2=en:bms-184476 | rel=r_associated | relid=0 | w=27 barite -- r_associated #0: 27 / 0.065 -> en:boric acid / zinc oxide n1=barite | n2=en:boric acid / zinc oxide | rel=r_associated | relid=0 | w=27 barite -- r_associated #0: 27 / 0.065 -> en:bovine cartilage n1=barite | n2=en:bovine cartilage | rel=r_associated | relid=0 | w=27 barite -- r_associated #0: 27 / 0.065 -> en:brassica vegetable n1=barite | n2=en:brassica vegetable | rel=r_associated | relid=0 | w=27 barite -- r_associated #0: 27 / 0.065 -> en:brilliant green / gentian violet / proflavine n1=barite | n2=en:brilliant green / gentian violet / proflavine | rel=r_associated | relid=0 | w=27 barite -- r_associated #0: 27 / 0.065 -> en:brompheniramine / dextromethorphan / phenylephrine n1=barite | n2=en:brompheniramine / dextromethorphan / phenylephrine | rel=r_associated | relid=0 | w=27 barite -- r_associated #0: 27 / 0.065 -> en:broxuridine n1=barite | n2=en:broxuridine | rel=r_associated | relid=0 | w=27 barite -- r_associated #0: 27 / 0.065 -> en:butamben n1=barite | n2=en:butamben | rel=r_associated | relid=0 | w=27 barite -- r_associated #0: 27 / 0.065 -> en:cadazolid n1=barite | n2=en:cadazolid | rel=r_associated | relid=0 | w=27 barite -- r_associated #0: 27 / 0.065 -> en:cdki r547 n1=barite | n2=en:cdki r547 | rel=r_associated | relid=0 | w=27 barite -- r_associated #0: 27 / 0.065 -> en:cefixime n1=barite | n2=en:cefixime | rel=r_associated | relid=0 | w=27 barite -- r_associated #0: 27 / 0.065 -> en:checkpoint kinase inhibitor xl844 n1=barite | n2=en:checkpoint kinase inhibitor xl844 | rel=r_associated | relid=0 | w=27 barite -- r_associated #0: 27 / 0.065 -> en:chlorogenic acid n1=barite | n2=en:chlorogenic acid | rel=r_associated | relid=0 | w=27 barite -- r_associated #0: 27 / 0.065 -> en:cladribine n1=barite | n2=en:cladribine | rel=r_associated | relid=0 | w=27 barite -- r_associated #0: 27 / 0.065 -> en:clonidine hydrochloride n1=barite | n2=en:clonidine hydrochloride | rel=r_associated | relid=0 | w=27 barite -- r_associated #0: 27 / 0.065 -> en:cocoa extract n1=barite | n2=en:cocoa extract | rel=r_associated | relid=0 | w=27 barite -- r_associated #0: 27 / 0.065 -> en:collagen/aloe vera/vitamin e/lidocaine topical hydrogel n1=barite | n2=en:collagen/aloe vera/vitamin e/lidocaine topical hydrogel | rel=r_associated | relid=0 | w=27 barite -- r_associated #0: 27 / 0.065 -> en:conjugated estrogens/bazedoxifene n1=barite | n2=en:conjugated estrogens/bazedoxifene | rel=r_associated | relid=0 | w=27 barite -- r_associated #0: 27 / 0.065 -> en:cp-609,754 n1=barite | n2=en:cp-609,754 | rel=r_associated | relid=0 | w=27 barite -- r_associated #0: 27 / 0.065 -> en:cxcr4 antagonist bl-8040 n1=barite | n2=en:cxcr4 antagonist bl-8040 | rel=r_associated | relid=0 | w=27 barite -- r_associated #0: 27 / 0.065 -> en:cyclosporine ophthalmic emulsion n1=barite | n2=en:cyclosporine ophthalmic emulsion | rel=r_associated | relid=0 | w=27 barite -- r_associated #0: 27 / 0.065 -> en:cyp17 inhibitor vt-464 n1=barite | n2=en:cyp17 inhibitor vt-464 | rel=r_associated | relid=0 | w=27 barite -- r_associated #0: 27 / 0.065 -> en:cytochlor n1=barite | n2=en:cytochlor | rel=r_associated | relid=0 | w=27 barite -- r_associated #0: 27 / 0.065 -> en:cytomegalovirus ie-1-specific cytotoxic t lymphocytes n1=barite | n2=en:cytomegalovirus ie-1-specific cytotoxic t lymphocytes | rel=r_associated | relid=0 | w=27 barite -- r_associated #0: 27 / 0.065 -> en:dach-platin micelle nc-4016 n1=barite | n2=en:dach-platin micelle nc-4016 | rel=r_associated | relid=0 | w=27 barite -- r_associated #0: 27 / 0.065 -> en:deferoxamine mesylate n1=barite | n2=en:deferoxamine mesylate | rel=r_associated | relid=0 | w=27 barite -- r_associated #0: 27 / 0.065 -> en:delta-8-tetrahydrocannabinol n1=barite | n2=en:delta-8-tetrahydrocannabinol | rel=r_associated | relid=0 | w=27 barite -- r_associated #0: 27 / 0.065 -> en:desvenlafaxine succinate n1=barite | n2=en:desvenlafaxine succinate | rel=r_associated | relid=0 | w=27 barite -- r_associated #0: 27 / 0.065 -> en:deuterated 3-methylhistidine n1=barite | n2=en:deuterated 3-methylhistidine | rel=r_associated | relid=0 | w=27 barite -- r_associated #0: 27 / 0.065 -> en:dexniguldipine n1=barite | n2=en:dexniguldipine | rel=r_associated | relid=0 | w=27 barite -- r_associated #0: 27 / 0.065 -> en:dinoprost tromethamine n1=barite | n2=en:dinoprost tromethamine | rel=r_associated | relid=0 | w=27 barite -- r_associated #0: 27 / 0.065 -> en:ditiocarb n1=barite | n2=en:ditiocarb | rel=r_associated | relid=0 | w=27 barite -- r_associated #0: 27 / 0.065 -> en:dna vector ppra-psm vaccine n1=barite | n2=en:dna vector ppra-psm vaccine | rel=r_associated | relid=0 | w=27 barite -- r_associated #0: 27 / 0.065 -> en:docetaxel-loaded nanopharmaceutical crlx301 n1=barite | n2=en:docetaxel-loaded nanopharmaceutical crlx301 | rel=r_associated | relid=0 | w=27 barite -- r_associated #0: 27 / 0.065 -> en:docosahexaenoic acid n1=barite | n2=en:docosahexaenoic acid | rel=r_associated | relid=0 | w=27 barite -- r_associated #0: 27 / 0.065 -> en:fluciclovine (18f) n1=barite | n2=en:fluciclovine (18f) | rel=r_associated | relid=0 | w=27 barite -- r_associated #0: 27 / 0.065 -> en:hematologic agents n1=barite | n2=en:hematologic agents | rel=r_associated | relid=0 | w=27 barite -- r_associated #0: 27 / 0.065 -> en:magnesium sulfate n1=barite | n2=en:magnesium sulfate | rel=r_associated | relid=0 | w=27 barite -- r_associated #0: 27 / 0.065 -> en:manganese sulfate n1=barite | n2=en:manganese sulfate | rel=r_associated | relid=0 | w=27 barite -- r_associated #0: 27 / 0.065 -> en:medical marijuana n1=barite | n2=en:medical marijuana | rel=r_associated | relid=0 | w=27 barite -- r_associated #0: 27 / 0.065 -> en:muscle relaxant n1=barite | n2=en:muscle relaxant | rel=r_associated | relid=0 | w=27 barite -- r_associated #0: 26 / 0.063 -> en:18f-fluoroazomycin arabinoside n1=barite | n2=en:18f-fluoroazomycin arabinoside | rel=r_associated | relid=0 | w=26 barite -- r_associated #0: 26 / 0.063 -> en:50% oxygen/50% nitrous oxide premix n1=barite | n2=en:50% oxygen/50% nitrous oxide premix | rel=r_associated | relid=0 | w=26 barite -- r_associated #0: 26 / 0.063 -> en:absorbable adhesion barrier gel n1=barite | n2=en:absorbable adhesion barrier gel | rel=r_associated | relid=0 | w=26 barite -- r_associated #0: 26 / 0.063 -> en:ac-t regimen n1=barite | n2=en:ac-t regimen | rel=r_associated | relid=0 | w=26 barite -- r_associated #0: 26 / 0.063 -> en:acetic acid n1=barite | n2=en:acetic acid | rel=r_associated | relid=0 | w=26 barite -- r_associated #0: 26 / 0.063 -> en:ad5-ycd/muttksr39rep-hil12 n1=barite | n2=en:ad5-ycd/muttksr39rep-hil12 | rel=r_associated | relid=0 | w=26 barite -- r_associated #0: 26 / 0.063 -> en:adecatumumab n1=barite | n2=en:adecatumumab | rel=r_associated | relid=0 | w=26 barite -- r_associated #0: 26 / 0.063 -> en:adipose-derived stromal vascular fraction cells n1=barite | n2=en:adipose-derived stromal vascular fraction cells | rel=r_associated | relid=0 | w=26 barite -- r_associated #0: 26 / 0.063 -> en:aerosolized aldesleukin n1=barite | n2=en:aerosolized aldesleukin | rel=r_associated | relid=0 | w=26 barite -- r_associated #0: 26 / 0.063 -> en:algenpantucel-l n1=barite | n2=en:algenpantucel-l | rel=r_associated | relid=0 | w=26 barite -- r_associated #0: 26 / 0.063 -> en:allogeneic dendritic cell vaccine combig-dc n1=barite | n2=en:allogeneic dendritic cell vaccine combig-dc | rel=r_associated | relid=0 | w=26 barite -- r_associated #0: 26 / 0.063 -> en:allogeneic renal cell carcinoma vaccine mgn1601 n1=barite | n2=en:allogeneic renal cell carcinoma vaccine mgn1601 | rel=r_associated | relid=0 | w=26 barite -- r_associated #0: 26 / 0.063 -> en:alprazolam n1=barite | n2=en:alprazolam | rel=r_associated | relid=0 | w=26 barite -- r_associated #0: 26 / 0.063 -> en:alvimopan n1=barite | n2=en:alvimopan | rel=r_associated | relid=0 | w=26 barite -- r_associated #0: 26 / 0.063 -> en:amonafide l-malate n1=barite | n2=en:amonafide l-malate | rel=r_associated | relid=0 | w=26 barite -- r_associated #0: 26 / 0.063 -> en:androgen receptor antisense oligonucleotide ezn-4176 n1=barite | n2=en:androgen receptor antisense oligonucleotide ezn-4176 | rel=r_associated | relid=0 | w=26 barite -- r_associated #0: 26 / 0.063 -> en:anguidine n1=barite | n2=en:anguidine | rel=r_associated | relid=0 | w=26 barite -- r_associated #0: 26 / 0.063 -> en:annonaceous acetogenins n1=barite | n2=en:annonaceous acetogenins | rel=r_associated | relid=0 | w=26 barite -- r_associated #0: 26 / 0.063 -> en:anti-b7-h3 antibody ds-5573a n1=barite | n2=en:anti-b7-h3 antibody ds-5573a | rel=r_associated | relid=0 | w=26 barite -- r_associated #0: 26 / 0.063 -> en:anti-cd3 x anti-cd20 bispecific antibody-armed activated t cells n1=barite | n2=en:anti-cd3 x anti-cd20 bispecific antibody-armed activated t cells | rel=r_associated | relid=0 | w=26 barite -- r_associated #0: 26 / 0.063 -> en:anti-cea/cd3 bispecific antibody ro6958688 n1=barite | n2=en:anti-cea/cd3 bispecific antibody ro6958688 | rel=r_associated | relid=0 | w=26 barite -- r_associated #0: 26 / 0.063 -> en:anti-egp-2 immunotoxin moc31-pe n1=barite | n2=en:anti-egp-2 immunotoxin moc31-pe | rel=r_associated | relid=0 | w=26 barite -- r_associated #0: 26 / 0.063 -> en:anti-fgfr3 monoclonal antibody mfgr1877s n1=barite | n2=en:anti-fgfr3 monoclonal antibody mfgr1877s | rel=r_associated | relid=0 | w=26 barite -- r_associated #0: 26 / 0.063 -> en:anti-hla-dr monoclonal antibody immu-114 n1=barite | n2=en:anti-hla-dr monoclonal antibody immu-114 | rel=r_associated | relid=0 | w=26 barite -- r_associated #0: 26 / 0.063 -> en:anti-inflammatory agents n1=barite | n2=en:anti-inflammatory agents | rel=r_associated | relid=0 | w=26 barite -- r_associated #0: 26 / 0.063 -> en:anti-pd-1 checkpoint inhibitor pf-06801591 n1=barite | n2=en:anti-pd-1 checkpoint inhibitor pf-06801591 | rel=r_associated | relid=0 | w=26 barite -- r_associated #0: 26 / 0.063 -> en:atamestane n1=barite | n2=en:atamestane | rel=r_associated | relid=0 | w=26 barite -- r_associated #0: 26 / 0.063 -> en:aurora kinase inhibitor pf-03814735 n1=barite | n2=en:aurora kinase inhibitor pf-03814735 | rel=r_associated | relid=0 | w=26 barite -- r_associated #0: 26 / 0.063 -> en:autologous dendritic cells/cmv pp65 peptide n1=barite | n2=en:autologous dendritic cells/cmv pp65 peptide | rel=r_associated | relid=0 | w=26 barite -- r_associated #0: 26 / 0.063 -> en:baclofen n1=barite | n2=en:baclofen | rel=r_associated | relid=0 | w=26 barite -- r_associated #0: 26 / 0.063 -> en:balanced salt solution/bicarbonate/dextrose/glutathione n1=barite | n2=en:balanced salt solution/bicarbonate/dextrose/glutathione | rel=r_associated | relid=0 | w=26 barite -- r_associated #0: 26 / 0.063 -> en:banaba n1=barite | n2=en:banaba | rel=r_associated | relid=0 | w=26 barite -- r_associated #0: 26 / 0.063 -> en:barium so4 1.2% susp n1=barite | n2=en:barium so4 1.2% susp | rel=r_associated | relid=0 | w=26 barite -- r_associated #0: 26 / 0.063 -> en:barium so4 100% pwdr n1=barite | n2=en:barium so4 100% pwdr | rel=r_associated | relid=0 | w=26 barite -- r_associated #0: 26 / 0.063 -> en:baza/peri-wash n1=barite | n2=en:baza/peri-wash | rel=r_associated | relid=0 | w=26 barite -- r_associated #0: 26 / 0.063 -> en:beeswax/mineral oil/rose oil/rose soluble/sodium borate/spermace n1=barite | n2=en:beeswax/mineral oil/rose oil/rose soluble/sodium borate/spermace | rel=r_associated | relid=0 | w=26 barite -- r_associated #0: 26 / 0.063 -> en:belladonna/methenamine/salicylamide n1=barite | n2=en:belladonna/methenamine/salicylamide | rel=r_associated | relid=0 | w=26 barite -- r_associated #0: 26 / 0.063 -> en:bendroflumethiazide / potassium chloride n1=barite | n2=en:bendroflumethiazide / potassium chloride | rel=r_associated | relid=0 | w=26 barite -- r_associated #0: 26 / 0.063 -> en:bentonite n1=barite | n2=en:bentonite | rel=r_associated | relid=0 | w=26 barite -- r_associated #0: 26 / 0.063 -> en:benzethonium chloride/lidocaine n1=barite | n2=en:benzethonium chloride/lidocaine | rel=r_associated | relid=0 | w=26 barite -- r_associated #0: 26 / 0.063 -> en:benzocaine n1=barite | n2=en:benzocaine | rel=r_associated | relid=0 | w=26 barite -- r_associated #0: 26 / 0.063 -> en:benzocaine / bismuth subnitrate / cerium oxalate n1=barite | n2=en:benzocaine / bismuth subnitrate / cerium oxalate | rel=r_associated | relid=0 | w=26 barite -- r_associated #0: 26 / 0.063 -> en:benzoic acid + salicylic acid n1=barite | n2=en:benzoic acid + salicylic acid | rel=r_associated | relid=0 | w=26 barite -- r_associated #0: 26 / 0.063 -> en:benzquinamide n1=barite | n2=en:benzquinamide | rel=r_associated | relid=0 | w=26 barite -- r_associated #0: 26 / 0.063 -> en:benzyl alcohol n1=barite | n2=en:benzyl alcohol | rel=r_associated | relid=0 | w=26 barite -- r_associated #0: 26 / 0.063 -> en:bi-shrna-furin/gm-csf-expressing autologous tumor cell vaccine n1=barite | n2=en:bi-shrna-furin/gm-csf-expressing autologous tumor cell vaccine | rel=r_associated | relid=0 | w=26 barite -- r_associated #0: 26 / 0.063 -> en:bibx 1382 n1=barite | n2=en:bibx 1382 | rel=r_associated | relid=0 | w=26 barite -- r_associated #0: 26 / 0.063 -> en:bifidobacterium/lactobacillus/streptococcus n1=barite | n2=en:bifidobacterium/lactobacillus/streptococcus | rel=r_associated | relid=0 | w=26 barite -- r_associated #0: 26 / 0.063 -> en:boswellia serrata extract n1=barite | n2=en:boswellia serrata extract | rel=r_associated | relid=0 | w=26 barite -- r_associated #0: 26 / 0.063 -> en:bowman-birk inhibitor concentrate n1=barite | n2=en:bowman-birk inhibitor concentrate | rel=r_associated | relid=0 | w=26 barite -- r_associated #0: 26 / 0.063 -> en:brachyury-expressing yeast vaccine gi-6301 n1=barite | n2=en:brachyury-expressing yeast vaccine gi-6301 | rel=r_associated | relid=0 | w=26 barite -- r_associated #0: 26 / 0.063 -> en:brilacidin oral rinse n1=barite | n2=en:brilacidin oral rinse | rel=r_associated | relid=0 | w=26 barite -- r_associated #0: 26 / 0.063 -> en:brinzolamide n1=barite | n2=en:brinzolamide | rel=r_associated | relid=0 | w=26 barite -- r_associated #0: 26 / 0.063 -> en:bromelains n1=barite | n2=en:bromelains | rel=r_associated | relid=0 | w=26 barite -- r_associated #0: 26 / 0.063 -> en:buprenorphine transdermal matrix patch n1=barite | n2=en:buprenorphine transdermal matrix patch | rel=r_associated | relid=0 | w=26 barite -- r_associated #0: 26 / 0.063 -> en:butabarbital / epinephrine / theophylline n1=barite | n2=en:butabarbital / epinephrine / theophylline | rel=r_associated | relid=0 | w=26 barite -- r_associated #0: 26 / 0.063 -> en:calculus bovis/moschus/olibanum/myrrha capsule n1=barite | n2=en:calculus bovis/moschus/olibanum/myrrha capsule | rel=r_associated | relid=0 | w=26 barite -- r_associated #0: 26 / 0.063 -> en:canada balsam n1=barite | n2=en:canada balsam | rel=r_associated | relid=0 | w=26 barite -- r_associated #0: 26 / 0.063 -> en:carbenicillin n1=barite | n2=en:carbenicillin | rel=r_associated | relid=0 | w=26 barite -- r_associated #0: 26 / 0.063 -> en:carbon c 11 methylaminoisobutyrate n1=barite | n2=en:carbon c 11 methylaminoisobutyrate | rel=r_associated | relid=0 | w=26 barite -- r_associated #0: 26 / 0.063 -> en:carbon c 13 octanoate n1=barite | n2=en:carbon c 13 octanoate | rel=r_associated | relid=0 | w=26 barite -- r_associated #0: 26 / 0.063 -> en:carbon c11 temozolomide n1=barite | n2=en:carbon c11 temozolomide | rel=r_associated | relid=0 | w=26 barite -- r_associated #0: 26 / 0.063 -> en:carcinoembryonic antigen peptide 1-6d virus-like replicon particles vaccine n1=barite | n2=en:carcinoembryonic antigen peptide 1-6d virus-like replicon particles vaccine | rel=r_associated | relid=0 | w=26 barite -- r_associated #0: 26 / 0.063 -> en:carcinoembryonic antigen rna-pulsed dc cancer vaccine n1=barite | n2=en:carcinoembryonic antigen rna-pulsed dc cancer vaccine | rel=r_associated | relid=0 | w=26 barite -- r_associated #0: 26 / 0.063 -> en:cd19car-cd3zeta-4-1bb-expressing allogeneic t-lymphocyte cells n1=barite | n2=en:cd19car-cd3zeta-4-1bb-expressing allogeneic t-lymphocyte cells | rel=r_associated | relid=0 | w=26 barite -- r_associated #0: 26 / 0.063 -> en:cdk4 inhibitor p1446a-05 n1=barite | n2=en:cdk4 inhibitor p1446a-05 | rel=r_associated | relid=0 | w=26 barite -- r_associated #0: 26 / 0.063 -> en:cefazolin sodium n1=barite | n2=en:cefazolin sodium | rel=r_associated | relid=0 | w=26 barite -- r_associated #0: 26 / 0.063 -> en:chinese herbal formulation changtai keli n1=barite | n2=en:chinese herbal formulation changtai keli | rel=r_associated | relid=0 | w=26 barite -- r_associated #0: 26 / 0.063 -> en:clotrimazole n1=barite | n2=en:clotrimazole | rel=r_associated | relid=0 | w=26 barite -- r_associated #0: 26 / 0.063 -> en:contrast agent n1=barite | n2=en:contrast agent | rel=r_associated | relid=0 | w=26 barite -- r_associated #0: 26 / 0.063 -> en:copper gluconate n1=barite | n2=en:copper gluconate | rel=r_associated | relid=0 | w=26 barite -- r_associated #0: 26 / 0.063 -> en:creatine monohydrate n1=barite | n2=en:creatine monohydrate | rel=r_associated | relid=0 | w=26 barite -- r_associated #0: 26 / 0.063 -> en:d4064a n1=barite | n2=en:d4064a | rel=r_associated | relid=0 | w=26 barite -- r_associated #0: 26 / 0.063 -> en:dalantercept n1=barite | n2=en:dalantercept | rel=r_associated | relid=0 | w=26 barite -- r_associated #0: 26 / 0.063 -> en:danusertib n1=barite | n2=en:danusertib | rel=r_associated | relid=0 | w=26 barite -- r_associated #0: 26 / 0.063 -> en:dendritic cell-mart-1 peptide vaccine n1=barite | n2=en:dendritic cell-mart-1 peptide vaccine | rel=r_associated | relid=0 | w=26 barite -- r_associated #0: 26 / 0.063 -> en:depdc1/mphosh1 peptide vaccine n1=barite | n2=en:depdc1/mphosh1 peptide vaccine | rel=r_associated | relid=0 | w=26 barite -- r_associated #0: 26 / 0.063 -> en:deslorelin n1=barite | n2=en:deslorelin | rel=r_associated | relid=0 | w=26 barite -- r_associated #0: 26 / 0.063 -> en:diaziquone n1=barite | n2=en:diaziquone | rel=r_associated | relid=0 | w=26 barite -- r_associated #0: 26 / 0.063 -> en:dna-pk/tor kinase inhibitor cc-115 n1=barite | n2=en:dna-pk/tor kinase inhibitor cc-115 | rel=r_associated | relid=0 | w=26 barite -- r_associated #0: 26 / 0.063 -> en:dobutamine n1=barite | n2=en:dobutamine | rel=r_associated | relid=0 | w=26 barite -- r_associated #0: 26 / 0.063 -> en:drug products by generic ingredient combinations n1=barite | n2=en:drug products by generic ingredient combinations | rel=r_associated | relid=0 | w=26 barite -- r_associated #0: 26 / 0.063 -> en:drugs, essential n1=barite | n2=en:drugs, essential | rel=r_associated | relid=0 | w=26 barite -- r_associated #0: 26 / 0.063 -> en:dual pi3 kinase/mtor inhibitor gdc-0980 n1=barite | n2=en:dual pi3 kinase/mtor inhibitor gdc-0980 | rel=r_associated | relid=0 | w=26 barite -- r_associated #0: 26 / 0.063 -> en:ferumoxides non-stoichiometric magnetite n1=barite | n2=en:ferumoxides non-stoichiometric magnetite | rel=r_associated | relid=0 | w=26 barite -- r_associated #0: 26 / 0.063 -> en:indocyanine green n1=barite | n2=en:indocyanine green | rel=r_associated | relid=0 | w=26 barite -- r_associated #0: 26 / 0.063 -> en:mangafodipir trisodium n1=barite | n2=en:mangafodipir trisodium | rel=r_associated | relid=0 | w=26 barite -- r_associated #0: 25 / 0.06 -> en:alk inhibitor x-396 n1=barite | n2=en:alk inhibitor x-396 | rel=r_associated | relid=0 | w=25 barite -- r_associated #0: 25 / 0.06 -> en:ancestim n1=barite | n2=en:ancestim | rel=r_associated | relid=0 | w=25 barite -- r_associated #0: 25 / 0.06 -> en:angiogenesis inhibitor gt-111 n1=barite | n2=en:angiogenesis inhibitor gt-111 | rel=r_associated | relid=0 | w=25 barite -- r_associated #0: 25 / 0.06 -> en:anti-egfr/c-met bispecific antibody jnj-61186372 n1=barite | n2=en:anti-egfr/c-met bispecific antibody jnj-61186372 | rel=r_associated | relid=0 | w=25 barite -- r_associated #0: 25 / 0.06 -> en:astragalus-based formulation qing shu yi qi tang n1=barite | n2=en:astragalus-based formulation qing shu yi qi tang | rel=r_associated | relid=0 | w=25 barite -- r_associated #0: 25 / 0.06 -> en:autologous hpv-16/18 e6/e7-specific tgf-beta-resistant t lymphocytes n1=barite | n2=en:autologous hpv-16/18 e6/e7-specific tgf-beta-resistant t lymphocytes | rel=r_associated | relid=0 | w=25 barite -- r_associated #0: 25 / 0.06 -> en:barium sulfate (2:1) n1=barite | n2=en:barium sulfate (2:1) | rel=r_associated | relid=0 | w=25 barite -- r_associated #0: 25 / 0.06 -> en:beta-carotene n1=barite | n2=en:beta-carotene | rel=r_associated | relid=0 | w=25 barite -- r_associated #0: 25 / 0.06 -> en:cesium cs 137 n1=barite | n2=en:cesium cs 137 | rel=r_associated | relid=0 | w=25 barite -- r_associated #0: 25 / 0.06 -> en:dextroamphetamine sulfate n1=barite | n2=en:dextroamphetamine sulfate | rel=r_associated | relid=0 | w=25 barite -- r_associated #0: 25 / 0.06 -> en:dimethyl sulfoxide n1=barite | n2=en:dimethyl sulfoxide | rel=r_associated | relid=0 | w=25 barite -- r_associated #0: 24 / 0.058 -> en:anti-cd44 monoclonal antibody ro5429083 n1=barite | n2=en:anti-cd44 monoclonal antibody ro5429083 | rel=r_associated | relid=0 | w=24 barite -- r_associated #0: 24 / 0.058 -> en:anti-gd2 monoclonal antibody hu14.18k322a n1=barite | n2=en:anti-gd2 monoclonal antibody hu14.18k322a | rel=r_associated | relid=0 | w=24 barite -- r_associated #0: 24 / 0.058 -> en:bismuth/calcium/opium/pectin/zinc n1=barite | n2=en:bismuth/calcium/opium/pectin/zinc | rel=r_associated | relid=0 | w=24 barite -- r_associated #0: 24 / 0.058 -> en:bms-986205 n1=barite | n2=en:bms-986205 | rel=r_associated | relid=0 | w=24 barite -- r_associated #0: 24 / 0.058 -> en:cndo-109-activated allogeneic natural killer cells n1=barite | n2=en:cndo-109-activated allogeneic natural killer cells | rel=r_associated | relid=0 | w=24 barite -- r_associated #0: 24 / 0.058 -> en:dexamethasone intravitreal implant n1=barite | n2=en:dexamethasone intravitreal implant | rel=r_associated | relid=0 | w=24 barite -- r_associated #0: 24 / 0.058 -> en:dextran sulfate sodium n1=barite | n2=en:dextran sulfate sodium | rel=r_associated | relid=0 | w=24 barite -- r_associated #0: 24 / 0.058 -> en:dtgm fusion protein n1=barite | n2=en:dtgm fusion protein | rel=r_associated | relid=0 | w=24 barite -- r_associated #0: 23 / 0.055 -> en:alk inhibitor asp3026 n1=barite | n2=en:alk inhibitor asp3026 | rel=r_associated | relid=0 | w=23 barite -- r_associated #0: 23 / 0.055 -> en:anti-cd70 antibody-drug conjugate sgn-cd70a n1=barite | n2=en:anti-cd70 antibody-drug conjugate sgn-cd70a | rel=r_associated | relid=0 | w=23 barite -- r_associated #0: 23 / 0.055 -> en:anti-pd-1 monoclonal antibody shr-1210 n1=barite | n2=en:anti-pd-1 monoclonal antibody shr-1210 | rel=r_associated | relid=0 | w=23 barite -- r_associated #0: 23 / 0.055 -> en:anti-pd-l1 monoclonal antibody mdx-1105 n1=barite | n2=en:anti-pd-l1 monoclonal antibody mdx-1105 | rel=r_associated | relid=0 | w=23 barite -- r_associated #0: 23 / 0.055 -> en:autologous cd8+ melanoma specific t cells n1=barite | n2=en:autologous cd8+ melanoma specific t cells | rel=r_associated | relid=0 | w=23 barite -- r_associated #0: 23 / 0.055 -> en:azurin:50-77 cell penetrating peptide p28 n1=barite | n2=en:azurin:50-77 cell penetrating peptide p28 | rel=r_associated | relid=0 | w=23 barite -- r_associated #0: 23 / 0.055 -> en:barium so4 210% susp,oral n1=barite | n2=en:barium so4 210% susp,oral | rel=r_associated | relid=0 | w=23 barite -- r_associated #0: 23 / 0.055 -> en:belladonna/bile salts/pancreatin/pepsin/phenobarbital n1=barite | n2=en:belladonna/bile salts/pancreatin/pepsin/phenobarbital | rel=r_associated | relid=0 | w=23 barite -- r_associated #0: 23 / 0.055 -> en:bevacizumab-irdye 800cw n1=barite | n2=en:bevacizumab-irdye 800cw | rel=r_associated | relid=0 | w=23 barite -- r_associated #0: 23 / 0.055 -> en:butylated hydroxytoluene n1=barite | n2=en:butylated hydroxytoluene | rel=r_associated | relid=0 | w=23 barite -- r_associated #0: 23 / 0.055 -> en:carboplatin n1=barite | n2=en:carboplatin | rel=r_associated | relid=0 | w=23 barite -- r_associated #0: 23 / 0.055 -> en:ciprofloxacin n1=barite | n2=en:ciprofloxacin | rel=r_associated | relid=0 | w=23 barite -- r_associated #0: 23 / 0.055 -> en:copper cu 62-ptsm n1=barite | n2=en:copper cu 62-ptsm | rel=r_associated | relid=0 | w=23 barite -- r_associated #0: 23 / 0.055 -> en:custirsen sodium n1=barite | n2=en:custirsen sodium | rel=r_associated | relid=0 | w=23 barite -- r_associated #0: 23 / 0.055 -> en:cxcr4 peptide antagonist ly2510924 n1=barite | n2=en:cxcr4 peptide antagonist ly2510924 | rel=r_associated | relid=0 | w=23 barite -- r_associated #0: 23 / 0.055 -> en:diphenhydramine hydrochloride/dexamethasone/nystatin magic mouthwash n1=barite | n2=en:diphenhydramine hydrochloride/dexamethasone/nystatin magic mouthwash | rel=r_associated | relid=0 | w=23 barite -- r_associated #0: 23 / 0.055 -> en:progestin n1=barite | n2=en:progestin | rel=r_associated | relid=0 | w=23 barite -- r_associated #0: 22 / 0.053 -> en:abvd regimen n1=barite | n2=en:abvd regimen | rel=r_associated | relid=0 | w=22 barite -- r_associated #0: 22 / 0.053 -> en:allodepleted t cell immunotherapeutic atir101 n1=barite | n2=en:allodepleted t cell immunotherapeutic atir101 | rel=r_associated | relid=0 | w=22 barite -- r_associated #0: 22 / 0.053 -> en:auranofin n1=barite | n2=en:auranofin | rel=r_associated | relid=0 | w=22 barite -- r_associated #0: 22 / 0.053 -> en:blood/glucose/ketone/leukocytes/nitrite/ph/protein test n1=barite | n2=en:blood/glucose/ketone/leukocytes/nitrite/ph/protein test | rel=r_associated | relid=0 | w=22 barite -- r_associated #0: 22 / 0.053 -> en:c-met inhibitor mk8033 n1=barite | n2=en:c-met inhibitor mk8033 | rel=r_associated | relid=0 | w=22 barite -- r_associated #0: 22 / 0.053 -> en:denosumab n1=barite | n2=en:denosumab | rel=r_associated | relid=0 | w=22 barite -- r_associated #0: 22 / 0.053 -> en:mitogen n1=barite | n2=en:mitogen | rel=r_associated | relid=0 | w=22 barite -- r_associated #0: 21 / 0.05 -> en:aclarubicin n1=barite | n2=en:aclarubicin | rel=r_associated | relid=0 | w=21 barite -- r_associated #0: 21 / 0.05 -> en:american ginseng n1=barite | n2=en:american ginseng | rel=r_associated | relid=0 | w=21 barite -- r_associated #0: 21 / 0.05 -> en:amg 224 n1=barite | n2=en:amg 224 | rel=r_associated | relid=0 | w=21 barite -- r_associated #0: 21 / 0.05 -> en:anti-ox40 antibody pf-04518600 n1=barite | n2=en:anti-ox40 antibody pf-04518600 | rel=r_associated | relid=0 | w=21 barite -- r_associated #0: 21 / 0.05 -> en:asparaginase n1=barite | n2=en:asparaginase | rel=r_associated | relid=0 | w=21 barite -- r_associated #0: 21 / 0.05 -> en:bifidobacterium n1=barite | n2=en:bifidobacterium | rel=r_associated | relid=0 | w=21 barite -- r_associated #0: 21 / 0.05 -> en:bispecific human anti-ang-2/anti-vegf-a antibody ro5520985 n1=barite | n2=en:bispecific human anti-ang-2/anti-vegf-a antibody ro5520985 | rel=r_associated | relid=0 | w=21 barite -- r_associated #0: 21 / 0.05 -> en:cd40 agonist monoclonal antibody cp-870,893 n1=barite | n2=en:cd40 agonist monoclonal antibody cp-870,893 | rel=r_associated | relid=0 | w=21 barite -- r_associated #0: 21 / 0.05 -> en:cromolyn sodium inhalant pa101 n1=barite | n2=en:cromolyn sodium inhalant pa101 | rel=r_associated | relid=0 | w=21 barite -- r_associated #0: 21 / 0.05 -> en:dacomitinib n1=barite | n2=en:dacomitinib | rel=r_associated | relid=0 | w=21 barite -- r_associated #0: 21 / 0.05 -> en:declopramide n1=barite | n2=en:declopramide | rel=r_associated | relid=0 | w=21 barite -- r_associated #0: 21 / 0.05 -> en:ferumoxtran-10 n1=barite | n2=en:ferumoxtran-10 | rel=r_associated | relid=0 | w=21 barite -- r_associated #0: 21 / 0.05 -> technique n1=barite | n2=technique | rel=r_associated | relid=0 | w=21 barite -- r_associated #0: 20 / 0.048 -> en:also barite n1=barite | n2=en:also barite | rel=r_associated | relid=0 | w=20 barite -- r_associated #0: 20 / 0.048 -> en:baryte n1=barite | n2=en:baryte | rel=r_associated | relid=0 | w=20 barite -- r_associated #0: 20 / 0.048 -> en:heavy spar n1=barite | n2=en:heavy spar | rel=r_associated | relid=0 | w=20 barite -- r_associated #0: 15 / 0.036 -> aves n1=barite | n2=aves | rel=r_associated | relid=0 | w=15 barite -- r_associated #0: 15 / 0.036 -> Bartter (syndrome de) n1=barite | n2=Bartter (syndrome de) | rel=r_associated | relid=0 | w=15 barite -- r_associated #0: 15 / 0.036 -> Chimie minérale n1=barite | n2=Chimie minérale | rel=r_associated | relid=0 | w=15 barite -- r_associated #0: 15 / 0.036 -> chymie n1=barite | n2=chymie | rel=r_associated | relid=0 | w=15 barite -- r_associated #0: 15 / 0.036 -> en:aves n1=barite | n2=en:aves | rel=r_associated | relid=0 | w=15 barite -- r_associated #0: 15 / 0.036 -> en:inorganic chemistry n1=barite | n2=en:inorganic chemistry | rel=r_associated | relid=0 | w=15 barite -- r_associated #0: 15 / 0.036 -> en:mineralogy n1=barite | n2=en:mineralogy | rel=r_associated | relid=0 | w=15 barite -- r_associated #0: 15 / 0.036 -> en:technique n1=barite | n2=en:technique | rel=r_associated | relid=0 | w=15 barite -- r_associated #0: 15 / 0.036 -> mineralogy n1=barite | n2=mineralogy | rel=r_associated | relid=0 | w=15 barite -- r_associated #0: 10 / 0.024 -> barytite n1=barite | n2=barytite | rel=r_associated | relid=0 | w=10 barite -- r_associated #0: 6 / 0.014 -> radiologie n1=barite | n2=radiologie | rel=r_associated | relid=0 | w=6 barite -- r_associated #0: 5 / 0.012 -> Bartter n1=barite | n2=Bartter | rel=r_associated | relid=0 | w=5 barite -- r_associated #0: 5 / 0.012 -> barytes n1=barite | n2=barytes | rel=r_associated | relid=0 | w=5 barite -- r_associated #0: 5 / 0.012 -> barytose n1=barite | n2=barytose | rel=r_associated | relid=0 | w=5 barite -- r_associated #0: 5 / 0.012 -> BAS n1=barite | n2=BAS | rel=r_associated | relid=0 | w=5 barite -- r_associated #0: 5 / 0.012 -> bouillie barytée n1=barite | n2=bouillie barytée | rel=r_associated | relid=0 | w=5 barite -- r_associated #0: 5 / 0.012 -> BSND (gène) n1=barite | n2=BSND (gène) | rel=r_associated | relid=0 | w=5 barite -- r_associated #0: 5 / 0.012 -> CASR g e ne n1=barite | n2=CASR g e ne | rel=r_associated | relid=0 | w=5 barite -- r_associated #0: 5 / 0.012 -> cotransporteur NaKCl de type 2 n1=barite | n2=cotransporteur NaKCl de type 2 | rel=r_associated | relid=0 | w=5 barite -- r_associated #0: 5 / 0.012 -> défécographie n1=barite | n2=défécographie | rel=r_associated | relid=0 | w=5 barite -- r_associated #0: 5 / 0.012 -> diverticule n1=barite | n2=diverticule | rel=r_associated | relid=0 | w=5 barite -- r_associated #0: 5 / 0.012 -> duodénum n1=barite | n2=duodénum | rel=r_associated | relid=0 | w=5 barite -- r_associated #0: 5 / 0.012 -> eau de baryte n1=barite | n2=eau de baryte | rel=r_associated | relid=0 | w=5 barite -- r_associated #0: 5 / 0.012 -> en:barium n1=barite | n2=en:barium | rel=r_associated | relid=0 | w=5 barite -- r_associated #0: 5 / 0.012 -> en:barium enema n1=barite | n2=en:barium enema | rel=r_associated | relid=0 | w=5 barite -- r_associated #0: 5 / 0.012 -> en:barium follow-through n1=barite | n2=en:barium follow-through | rel=r_associated | relid=0 | w=5 barite -- r_associated #0: 5 / 0.012 -> en:contrast enema n1=barite | n2=en:contrast enema | rel=r_associated | relid=0 | w=5 barite -- r_associated #0: 5 / 0.012 -> en:defecography n1=barite | n2=en:defecography | rel=r_associated | relid=0 | w=5 barite -- r_associated #0: 5 / 0.012 -> en:double-contrast barium enema n1=barite | n2=en:double-contrast barium enema | rel=r_associated | relid=0 | w=5 barite -- r_associated #0: 5 / 0.012 -> en:gastro-intestinal X-rays n1=barite | n2=en:gastro-intestinal X-rays | rel=r_associated | relid=0 | w=5 barite -- r_associated #0: 5 / 0.012 -> en:stibine n1=barite | n2=en:stibine | rel=r_associated | relid=0 | w=5 barite -- r_associated #0: 5 / 0.012 -> en:synthetic baryta n1=barite | n2=en:synthetic baryta | rel=r_associated | relid=0 | w=5 barite -- r_associated #0: 5 / 0.012 -> estomac n1=barite | n2=estomac | rel=r_associated | relid=0 | w=5 barite -- r_associated #0: 5 / 0.012 -> examen radiologique n1=barite | n2=examen radiologique | rel=r_associated | relid=0 | w=5 barite -- r_associated #0: 5 / 0.012 -> hyperaldostéronisme n1=barite | n2=hyperaldostéronisme | rel=r_associated | relid=0 | w=5 barite -- r_associated #0: 5 / 0.012 -> imagerie médicale n1=barite | n2=imagerie médicale | rel=r_associated | relid=0 | w=5 barite -- r_associated #0: 5 / 0.012 -> intestin grêle n1=barite | n2=intestin grêle | rel=r_associated | relid=0 | w=5 barite -- r_associated #0: 5 / 0.012 -> KCNJ1 gene n1=barite | n2=KCNJ1 gene | rel=r_associated | relid=0 | w=5 barite -- r_associated #0: 5 / 0.012 -> lavement baryté n1=barite | n2=lavement baryté | rel=r_associated | relid=0 | w=5 barite -- r_associated #0: 5 / 0.012 -> lavement baryté à contraste aérique n1=barite | n2=lavement baryté à contraste aérique | rel=r_associated | relid=0 | w=5 barite -- r_associated #0: 5 / 0.012 -> NKCC2 gene pour n1=barite | n2=NKCC2 gene pour | rel=r_associated | relid=0 | w=5 barite -- r_associated #0: 5 / 0.012 -> polype n1=barite | n2=polype | rel=r_associated | relid=0 | w=5 barite -- r_associated #0: 5 / 0.012 -> procédure médicale n1=barite | n2=procédure médicale | rel=r_associated | relid=0 | w=5 barite -- r_associated #0: 5 / 0.012 -> repas baryté n1=barite | n2=repas baryté | rel=r_associated | relid=0 | w=5 barite -- r_associated #0: 5 / 0.012 -> SLC12A1 g e ne n1=barite | n2=SLC12A1 g e ne | rel=r_associated | relid=0 | w=5 barite -- r_associated #0: 5 / 0.012 -> SLC12A1gene n1=barite | n2=SLC12A1gene | rel=r_associated | relid=0 | w=5 barite -- r_associated #0: 5 / 0.012 -> stibine n1=barite | n2=stibine | rel=r_associated | relid=0 | w=5 barite -- r_associated #0: 5 / 0.012 -> syndrome n1=barite | n2=syndrome | rel=r_associated | relid=0 | w=5 barite -- r_associated #0: 5 / 0.012 -> syndrome de Bartter n1=barite | n2=syndrome de Bartter | rel=r_associated | relid=0 | w=5 barite -- r_associated #0: 5 / 0.012 -> syndrome de Gitelman n1=barite | n2=syndrome de Gitelman | rel=r_associated | relid=0 | w=5 barite -- r_associated #0: 5 / 0.012 -> transit n1=barite | n2=transit | rel=r_associated | relid=0 | w=5 barite -- r_associated #0: 5 / 0.012 -> transit œsogastroduodénal n1=barite | n2=transit œsogastroduodénal | rel=r_associated | relid=0 | w=5 barite -- r_associated #0: 5 / 0.012 -> transit baryté n1=barite | n2=transit baryté | rel=r_associated | relid=0 | w=5 barite -- r_associated #0: 5 / 0.012 -> transit du grêle n1=barite | n2=transit du grêle | rel=r_associated | relid=0 | w=5 barite -- r_associated #0: 5 / 0.012 -> tube digestif n1=barite | n2=tube digestif | rel=r_associated | relid=0 | w=5 barite -- r_associated #0: 5 / 0.012 -> tube digestif haut n1=barite | n2=tube digestif haut | rel=r_associated | relid=0 | w=5 barite -- r_associated #0: 5 / 0.012 -> tumeur n1=barite | n2=tumeur | rel=r_associated | relid=0 | w=5 barite -- r_associated #0: 5 / 0.012 -> valérate de baryte n1=barite | n2=valérate de baryte | rel=r_associated | relid=0 | w=5 barite -- r_associated #0: 2 / 0.005 -> matière n1=barite | n2=matière | rel=r_associated | relid=0 | w=2

≈ 80 relations entrantes zoologie --- r_associated #0: 370 --> barite n1=zoologie | n2=barite | rel=r_associated | relid=0 | w=370 oiseaux --- r_associated #0: 280 --> barite n1=oiseaux | n2=barite | rel=r_associated | relid=0 | w=280 minéralogie --- r_associated #0: 246 --> barite n1=minéralogie | n2=barite | rel=r_associated | relid=0 | w=246 ornithologie --- r_associated #0: 234 --> barite n1=ornithologie | n2=barite | rel=r_associated | relid=0 | w=234 chimie --- r_associated #0: 210 --> barite n1=chimie | n2=barite | rel=r_associated | relid=0 | w=210 barite chauve --- r_associated #0: 147 --> barite n1=barite chauve | n2=barite | rel=r_associated | relid=0 | w=147 en:aves --- r_associated #0: 90 --> barite n1=en:aves | n2=barite | rel=r_associated | relid=0 | w=90 aves --- r_associated #0: 89 --> barite n1=aves | n2=barite | rel=r_associated | relid=0 | w=89 substance --- r_associated #0: 52 --> barite n1=substance | n2=barite | rel=r_associated | relid=0 | w=52 Zoologie --- r_associated #0: 42 --> barite n1=Zoologie | n2=barite | rel=r_associated | relid=0 | w=42 barytine --- r_associated #0: 42 --> barite n1=barytine | n2=barite | rel=r_associated | relid=0 | w=42 mineralogy --- r_associated #0: 41 --> barite n1=mineralogy | n2=barite | rel=r_associated | relid=0 | w=41 en:barite --- r_associated #0: 40 --> barite n1=en:barite | n2=barite | rel=r_associated | relid=0 | w=40 en:mineralogy --- r_associated #0: 38 --> barite n1=en:mineralogy | n2=barite | rel=r_associated | relid=0 | w=38 baryte --- r_associated #0: 37 --> barite n1=baryte | n2=barite | rel=r_associated | relid=0 | w=37 en:heavy spar --- r_associated #0: 35 --> barite n1=en:heavy spar | n2=barite | rel=r_associated | relid=0 | w=35 Minéralogie --- r_associated #0: 33 --> barite n1=Minéralogie | n2=barite | rel=r_associated | relid=0 | w=33 sulfate de baryte --- r_associated #0: 31 --> barite n1=sulfate de baryte | n2=barite | rel=r_associated | relid=0 | w=31 Chimie --- r_associated #0: 30 --> barite n1=Chimie | n2=barite | rel=r_associated | relid=0 | w=30 bluteau --- r_associated #0: 30 --> barite n1=bluteau | n2=barite | rel=r_associated | relid=0 | w=30 blutoir --- r_associated #0: 29 --> barite n1=blutoir | n2=barite | rel=r_associated | relid=0 | w=29 en:baryte --- r_associated #0: 29 --> barite n1=en:baryte | n2=barite | rel=r_associated | relid=0 | w=29 barote --- r_associated #0: 28 --> barite n1=barote | n2=barite | rel=r_associated | relid=0 | w=28 en:barium meal --- r_associated #0: 28 --> barite n1=en:barium meal | n2=barite | rel=r_associated | relid=0 | w=28 produit de contraste --- r_associated #0: 28 --> barite n1=produit de contraste | n2=barite | rel=r_associated | relid=0 | w=28 -ite --- r_associated #0: 27 --> barite n1=-ite | n2=barite | rel=r_associated | relid=0 | w=27 chymie --- r_associated #0: 27 --> barite n1=chymie | n2=barite | rel=r_associated | relid=0 | w=27 en:zoology --- r_associated #0: 27 --> barite n1=en:zoology | n2=barite | rel=r_associated | relid=0 | w=27 bleu charron --- r_associated #0: 26 --> barite n1=bleu charron | n2=barite | rel=r_associated | relid=0 | w=26 en:also barite --- r_associated #0: 26 --> barite n1=en:also barite | n2=barite | rel=r_associated | relid=0 | w=26 Bartter (syndrome de) --- r_associated #0: 22 --> barite n1=Bartter (syndrome de) | n2=barite | rel=r_associated | relid=0 | w=22 baryté --- r_associated #0: 22 --> barite n1=baryté | n2=barite | rel=r_associated | relid=0 | w=22 oiseau --- r_associated #0: 22 --> barite n1=oiseau | n2=barite | rel=r_associated | relid=0 | w=22 Mali --- r_associated #0: 21 --> barite n1=Mali | n2=barite | rel=r_associated | relid=0 | w=21 baryum --- r_associated #0: 21 --> barite n1=baryum | n2=barite | rel=r_associated | relid=0 | w=21 caustique --- r_associated #0: 21 --> barite n1=caustique | n2=barite | rel=r_associated | relid=0 | w=21 en:Aves --- r_associated #0: 21 --> barite n1=en:Aves | n2=barite | rel=r_associated | relid=0 | w=21 baryter --- r_associated #0: 20 --> barite n1=baryter | n2=barite | rel=r_associated | relid=0 | w=20 barytique --- r_associated #0: 20 --> barite n1=barytique | n2=barite | rel=r_associated | relid=0 | w=20 chimie inorganique --- r_associated #0: 20 --> barite n1=chimie inorganique | n2=barite | rel=r_associated | relid=0 | w=20 chimie minérale --- r_associated #0: 20 --> barite n1=chimie minérale | n2=barite | rel=r_associated | relid=0 | w=20 dispositif mécanique --- r_associated #0: 20 --> barite n1=dispositif mécanique | n2=barite | rel=r_associated | relid=0 | w=20 en:baryta --- r_associated #0: 20 --> barite n1=en:baryta | n2=barite | rel=r_associated | relid=0 | w=20 minéral --- r_associated #0: 20 --> barite n1=minéral | n2=barite | rel=r_associated | relid=0 | w=20 médecine --- r_associated #0: 20 --> barite n1=médecine | n2=barite | rel=r_associated | relid=0 | w=20 oxyde de baryum --- r_associated #0: 20 --> barite n1=oxyde de baryum | n2=barite | rel=r_associated | relid=0 | w=20 bleu charron (Nom) --- r_associated #0: 15 --> barite n1=bleu charron (Nom) | n2=barite | rel=r_associated | relid=0 | w=15 Barytine --- r_associated #0: 11 --> barite n1=Barytine | n2=barite | rel=r_associated | relid=0 | w=11 Baryte --- r_associated #0: 10 --> barite n1=Baryte | n2=barite | rel=r_associated | relid=0 | w=10 Bluteau --- r_associated #0: 10 --> barite n1=Bluteau | n2=barite | rel=r_associated | relid=0 | w=10 Blutoir --- r_associated #0: 10 --> barite n1=Blutoir | n2=barite | rel=r_associated | relid=0 | w=10 Chymie --- r_associated #0: 10 --> barite n1=Chymie | n2=barite | rel=r_associated | relid=0 | w=10 Mineralogy --- r_associated #0: 10 --> barite n1=Mineralogy | n2=barite | rel=r_associated | relid=0 | w=10 Oiseaux --- r_associated #0: 10 --> barite n1=Oiseaux | n2=barite | rel=r_associated | relid=0 | w=10 en:barium sulfate --- r_associated #0: 10 --> barite n1=en:barium sulfate | n2=barite | rel=r_associated | relid=0 | w=10 en:barium sulphate --- r_associated #0: 10 --> barite n1=en:barium sulphate | n2=barite | rel=r_associated | relid=0 | w=10 transit baryté --- r_associated #0: 10 --> barite n1=transit baryté | n2=barite | rel=r_associated | relid=0 | w=10 céruse --- r_associated #0: 7 --> barite n1=céruse | n2=barite | rel=r_associated | relid=0 | w=7 pigment --- r_associated #0: 7 --> barite n1=pigment | n2=barite | rel=r_associated | relid=0 | w=7 pyromorphite --- r_associated #0: 7 --> barite n1=pyromorphite | n2=barite | rel=r_associated | relid=0 | w=7 Barite chauve --- r_associated #0: 5 --> barite n1=Barite chauve | n2=barite | rel=r_associated | relid=0 | w=5 Chimie inorganique --- r_associated #0: 5 --> barite n1=Chimie inorganique | n2=barite | rel=r_associated | relid=0 | w=5 Oxyde de baryum --- r_associated #0: 5 --> barite n1=Oxyde de baryum | n2=barite | rel=r_associated | relid=0 | w=5 baryte anhydre --- r_associated #0: 5 --> barite n1=baryte anhydre | n2=barite | rel=r_associated | relid=0 | w=5 barytose --- r_associated #0: 5 --> barite n1=barytose | n2=barite | rel=r_associated | relid=0 | w=5 ferrodolomite --- r_associated #0: 5 --> barite n1=ferrodolomite | n2=barite | rel=r_associated | relid=0 | w=5 karsténite --- r_associated #0: 5 --> barite n1=karsténite | n2=barite | rel=r_associated | relid=0 | w=5 syndrome de Bartter --- r_associated #0: 5 --> barite n1=syndrome de Bartter | n2=barite | rel=r_associated | relid=0 | w=5 cobaltodolomite --- r_associated #0: 4 --> barite n1=cobaltodolomite | n2=barite | rel=r_associated | relid=0 | w=4 belyankite --- r_associated #0: 3 --> barite n1=belyankite | n2=barite | rel=r_associated | relid=0 | w=3 gurhofite --- r_associated #0: 3 --> barite n1=gurhofite | n2=barite | rel=r_associated | relid=0 | w=3 magnésiodolomite --- r_associated #0: 3 --> barite n1=magnésiodolomite | n2=barite | rel=r_associated | relid=0 | w=3 muricalcite --- r_associated #0: 3 --> barite n1=muricalcite | n2=barite | rel=r_associated | relid=0 | w=3 phosphomimétite --- r_associated #0: 3 --> barite n1=phosphomimétite | n2=barite | rel=r_associated | relid=0 | w=3 soude muriatée gypsifère --- r_associated #0: 3 --> barite n1=soude muriatée gypsifère | n2=barite | rel=r_associated | relid=0 | w=3 cyanuration à la barite --- r_associated #0: 2 --> barite n1=cyanuration à la barite | n2=barite | rel=r_associated | relid=0 | w=2 geldolomite --- r_associated #0: 2 --> barite n1=geldolomite | n2=barite | rel=r_associated | relid=0 | w=2 teruelite --- r_associated #0: 2 --> barite n1=teruelite | n2=barite | rel=r_associated | relid=0 | w=2 dolomite zincifère --- r_associated #0: 1 --> barite n1=dolomite zincifère | n2=barite | rel=r_associated | relid=0 | w=1 fluorescence de barite --- r_associated #0: 1 --> barite n1=fluorescence de barite | n2=barite | rel=r_associated | relid=0 | w=1